Innovations in Photochemical C-C and C-N Bond Forming Reactions by McAtee, Rory
Innovations in Photochemical C−C and C−N 












A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Chemistry) 
















 Professor Corey R. J. Stephenson, Chair 
 Assistant Professor Andrew P. Ault 
 Associate Professor Corinna S. Schindler 














ORCID iD: 0000-0003-4879-3583 
 
 































For my grandmothers - 











 My time at the University of Michigan has been filled with valuable learning opportunities 
that have been facilitated by so many supportive people. I am especially grateful for the mentorship 
my advisor, Corey, has provided me during my graduate studies. Even before I embarked on my 
graduate studies, Corey was an invaluable mentor. In the summer of 2014, he accepted me into his 
lab as an REU student—that experience solidified my ambitions to pursue graduate studies in 
organic chemistry. Since then, I have seen the group change, grow, and evolve into the amazing 
and productive research program that it is today. But I always believed that as new lab members 
came onboard and old members moved on, that there was value in being a part of the group when 
a few of the original lab members (who built the lab from the bottom up) were still here. I learned 
from them perseverance, discipline, and how to challenge myself to be the best chemist I could be. 
I set high standards and lofty goals for myself before entering graduate school; Corey helped me 
achieve these goals and even challenged me to make new and more ambitious objectives. His high 
standards and expectations of me certainly enabled me to have a successful, productive, and 
worthwhile graduate school experience. Thank you, Corey, for the exciting opportunities you 
provided for me in your lab, the intellectual freedom to pursue my own curiosities, encouraging 
me to attend national and international conferences, and setting me up for success in the next steps 
of my scientific career.  
 iv 
 I am very grateful to my dissertation committee members, Prof. Andrew P. Ault, Prof. 
Corinna S. Schindler, and Prof. John P. Wolfe for all the valuable guidance they have provided to 
me over the past five years. I truly appreciate all the insight and feedback you have given me 
during every step of my graduate career. I would also like to express gratitude to Prof. Schindler 
for providing me the opportunity to rotate in her lab. This was a memorable experience and I am 
grateful that it resulted in published work. Thank you, Prof. Ault, for agreeing to serve on my 
committee—you have been a tremendous help over the past four years. In addition, your 
environmental chemistry course was a valuable learning experience for me; one that has shaped 
my perception of the relationship between humans and the environment. Thank you, Prof. Wolfe, 
for being such a valuable resource and a friendly and approachable mentor over the years. Finally, 
thank you, Prof. Melanie Sanford, for being an invaluable resource to me over the past few years, 
serving as a professional reference letter writer, and your support in the next stages of my career. 
 My time in the Stephenson lab has been highlighted by the company and guidance of so 
many intelligent and hard-working co-workers. First and foremost, I would like to thank Drs. Tim 
Monos and Joel Beatty for serving as my initial mentors and inspiring me to be the best chemist I 
could be. Dr. Tim Monos served as my REU mentor and held high expectations for me, even as 
an undergraduate, and his guidance certainly set the stage for my graduate school career. Dr. Joel 
Beatty was an influential first-year mentor. He approached me with a research proposal during my 
summer 2015 rotation and allowed me to “run with it” and make it my own. The belief he had in 
me was incredible. I will always value his hands-off mentoring strategy which forced me to figure 
out solutions to problems on my own and greatly increased my self-confidence as a young chemist.  
 I owe a special thank you to those who I worked with on various projects during my time 
at Michigan. They include; Dr. James Douglas, Prof. Jim Devery, Dr. Daryl Staveness, Ms. Alex 
 v 
Sun, Mr. James Collins, Mr. Ted McClain, Mr. Anthony Allen, and Mr. Efrey Noten. Each of you 
allowed my graduate school experience to be as successful as it has been. All of my co-workers 
have been amazing to work with over the years, including, post-docs and fellow graduate students. 
Thank you to each of you for making my time at Michigan memorable and constantly challenging 
me to be a better chemist—these experiences, friendships and collaborations will be invaluable 
throughout career. Finally, I owe a special thank you to the other G5s in Corey’s group who I have 
shared these past five years with; Ms. Taylor Sodano, Ms. Alex Sun, and Mr. Kevin Romero. I 
could not ask for better “year-mates” I have had a blast traversing the ups-and-downs of graduate 
school with you three and I cannot wait to see where each of your careers are headed!  
 Before my journey at Michigan began, I had the amazing opportunity to learn from 
amazing teachers at Wilson Area High School. My first foray into chemistry began in my 10th-
grade AP Chemistry course taught by Mr. Paul Stewart. In this course I struggled often, failed 
gracefully, and more importantly, learned the significance of redemption. I enjoyed the challenges 
this course presented and from then on, my passions for chemistry continued to grow. From there, 
I quickly found myself studying organic chemistry at Lycoming College in Williamsport, PA. 
While the opportunities and experiences I acquired at this small liberal arts college are too many 
to mention here, I know for certain each of them helped to solidify my ability to pose scientific 
questions and my passion for carrying out laboratory research. As a young and naive 
undergraduate, I was fortunate enough to work in the labs of Profs. Mary Morrison, Charles 
Mahler, and Holly Bendorf. I owe each of them a great deal of gratitude for believing in me and, 
most importantly, giving me a chance. I hope I have reciprocated to younger students, who I have 
mentored, the amazing mentorship each of them bestowed upon me. Lastly, Prof. Katherine Franz 
happily welcomed me into her laboratory at Duke University for my first REU in 2013. This was 
 vi 
my first, real taste of graduate level research and from this experience my confidence certainly 
increased.  
 I know, for certain, the best thing to have happened to me in graduate school was meeting 
Liz. We quickly built our life together in Ann Arbor and grew our family to include our two playful 
and curious kitties, Tiggy and Tully, and our rambunctious and perpetually happy puppy, Poppy. 
Besides spoiling these three, you helped me find hobbies (including, home-brewing and meat 
smoking) that I know will continue to be life-long passions of mine. There was not a single success 
in my graduate career you haven’t played a role in or a single obstacle you haven’t helped me 
overcome. You have been the trailblazer and I have always been far, far behind in your footsteps. 
You have sacrificed and brunted much burden for me, which I will never forget. Liz, thank you 
for your endless love, support, encouragement, and your delicious old fashioneds throughout these 
busy and stress-filled years and I am so excited for our next steps in life together. 
 There may only be a handful of people, ever, who can say they went through an organic 
chemistry graduate program together with their twin brother. Christopher and I are two of them. 
We are even more fortunate to have co-authored papers together. Christopher, you have set the bar 
high for me. Every day when I am at the hood, I know in the back of my head that there is someone 
else more adept and skilled than me. This subconscious has always driven my lofty ambitions and 
desires to achieve more. Christopher, thank you for being an invaluable resource for anything 
chemistry, commiserating with me throughout our graduate school years, and for being a frequent 
drinking buddy. I cannot wait to see where your career takes you! 
 I am indebted to my entire family for their love and support throughout my graduate studies 
and all the years before. I know that each of you sacrificed to make my dreams and aspirations 
come true. I am lucky to have parents who have always been in my corner. They have encouraged 
 vii 
me to do amazing things in my life and I hope I have not let them down. Mom, thank you for 
always reminding me that the most important thing in life is finding happiness—I truly agree. Dad, 
thank you for showing me how to persevere even when it seems as though all odds are against 
me—I will carry these lessons throughout my entire life. Patrick, I couldn’t ask for a more loyal, 
smart, or witty older brother. You lead by example and we all follow you. Brigid, thank you for 
always lending an open ear, always being my advocate, and encouraging me through every step of 
life. Ed, thank you for always being the joyful relief in the room and for always making sure your 
younger siblings are doing, OK.  Jimmy, thank you for being so even-keeled and leading by 
example. To Michele and Ben, always know that I am so appreciative of all that you do for Liz 
and me and I will always be grateful to have you in my life. Thank you all for your everlasting 
love and support. Finally, I would like to acknowledge my grandmothers who loved us with 
everything they had. The model lives you led and the love you two shared made this all possible. 
























LIST OF FIGURES....................................................................................................................,....xi 
 
LIST OF TABLES.........................................................................................................................xv 
 




CHAPTER 1. General Principles, Recent Trends, and Applications of Photoredox 
Catalysis..........................................................................................................................................1 
1.1 Introduction................................................................................................................................1 
1.2 Photoredox Catalysis as a Modern Approach to Generate Radicals..........................................2 
 
1.3 Light Mediated-Excitation of Polypyridyl Photocatalysts…………………………………….4 
 
1.4 Evolution of Light Sources for Enhanced Reactivity and Scalability……………………...…5 
 
1.5 Selective Oxidation of Aliphatic Amines……………………………………………………..8 
 
1.6 Complementary Reaction Paradigms for Anti-Markovnikov Additions to Alkenes……...…11 
 
1.7 Recent Applications of Photoredox Catalysis…………………………………………..……14 
 







CHAPTER 2. Photochemical Chlorodifluoromethylation of Arenes and Heteroarenes…....25 
2.1 Introduction..............................................................................................................................25 
2.1.1 Minisci Type Functionalization of Arenes with Photoredox Catalysis………………….28 
 
2.1.2 Radical Trifluoromethylation of (Hetero)arenes with Photoredox Catalysis……………35 
 
2.1.3 Trifluoromethylation with TFAA and Pyridine N-Oxides………………………………37 
 
2.1.4 Radical Approaches to Chlorodifluoromethylation of Arenes and Alkenes…………….43 
 
2.2 Results and Discussion............................................................................................................45 
2.3 Conclusions.............................................................................................................................52 
2.4 Experimental Procedures and Characterization of Compounds..............................................54 
2.4.1 General Information, Procedures, and Mechanistic Studies……………………………..54 
 




CHAPTER 3. Arylsulfonylacetamides as Bifunctional Reagents for Alkene Aminoarylation 
......................................................................................................................................................112 
3.1 Introduction............................................................................................................................112 
3.1.1 Significance of Alkene Difunctionalization Reactions and Arylethylamine Scaffolds...112 
 
3.1.2 Transition-Metal Catalyzed Aminoarylation Reactions………………………………..114 
 
3.1.3 Visible Light-Mediated Carboamination Reactions……………………………………116 
 
3.1.4 Photochemical Smiles Rearrangements – The Potential for Alkene Aminoarylation….120 
 
3.2 Results and Discussion...........................................................................................................124 
3.3 Conclusions............................................................................................................................129 
3.4 Experimental Procedures and Characterization of Compounds.............................................130 
 x 
3.4.1 General Procedures, Reaction Optimization, Materials and Methods…………….……130 
 
3.4.2 Reaction Profiling and Mechanism Elucidation Experiments………………………….137 
 
3.4.3 Synthesis and Characterization of Reagents, Starting Materials, and Aminoarylation 
Products…………………………………………………………………………………160 




CHAPTER 4. Arene Dearomatization via a Catalytic N-Centered Radical Cascade 
Reaction......................................................................................................................................223 
4.1 Introduction............................................................................................................................223 
4.2 Results and Discussion...........................................................................................................229 
4.3 Conclusions............................................................................................................................239 
4.4 Experimental Procedures and Characterization of Compounds..............................................240 
4.4.1 General Procedures, Materials, and Methods…………………………………………..240 
 
4.4.2 Substrate and Reagent Synthesis and Characterization………………………………...246 
 
4.4.3 Dearomatized Product Synthesis and Characterization………………………………...279 
 
4.4.4 Mechanistic Investigations……………………………………………………………...301 
 














LIST OF FIGURES 
 
Figure 1.1. Photoredox catalysis as a modern approach to radical intermediate generation……..3 
Figure 1.2. Light mediated-excitation of polypyridyl photocatalysts…………………………….5 
Figure 1.3. Evolution of light array designs for enhanced reaction efficiency and scalability…...6  
Figure 1.4. Selective oxidation of aliphatic amines enabled by photoredox catalysis and 
subsequent synthetic applications…………………………………………………………………9 
Figure 1.5. Complementary mechanistic paradigms for anti-Markovnikov additions to 
alkenes……………………………………………………………………………………………12 
Figure 1.6. Recent applications of photoredox catalysis in total synthesis and the industrial 
sector………………………………………………………………………………………..……15 
Figure 2.1. The importance of the trifluoromethyl group and synthesis on industrial scale……26 
Figure 2.2. Inspiration for the reported radical chlorodifluoromethylation of (hetero)arenes…..28 
Figure 2.3. The Minisci alkylation of N-heteroarenes…………………………………………..29 
Figure 2.4. Seminal studies for the radical decarboxylation of aliphatic carboxylic acids and 
their activated derivatives for the Minisci functionalization (hetero)arenes…………………….31 
Figure 2.5. Enantioselective synthesis of α-heterocyclic amines using a Brønsted 
acid/photoredox catalytic platform………………………………………………………………32 
Figure 2.6. Photoredox Minisci alkylation using boronic acid alkylating reagents……………..33 
 xii 
Figure 2.7. Organophotocatalytic Minisci alkylation using alkyltrifluoroborate radical 
precursors………………………………………………………………………………………...34 
Figure 2.8. Photoredox catalysis for the radical trifluoromethylation of arenes and 
heteroarenes……………………………………………………………………………………...36 
Figure 2.9. Trifluoromethylation of boronic acids based on dual catalysis……………………..37 
Figure 2.10. Library of commonly employed trifluoromethylating reagents…………………...38 
Figure 2.11. Trifluoromethylation of aryl halides with methyl chlorodifluoroacetate………….39 
Figure 2.12. Electrochemical trifluoromethylation through oxidation of TFA salts……………39 
Figure 2.13. Our design strategy for trifluoromethylation with TFAA and pyridine N-oxide as a 
redox auxiliary…………………………………………………………………………………...41 
Figure 2.14. Proposed mechanism for the use of TFAA and pyridine N-oxide for the radical 
trifluoromethylation of (hetero)arenes…………………………………………………………...41 
Figure 2.15. Scope of radical trifluoromethylation with TFAA and pyridine N-oxide…………42 
Figure 2.16. The electronic advantage of employing chlorodifluoromethyl radicals…………...44 
Figure 2.17. Reported methods for the generation of chlorodifluoromethyl radicals…………...45 
Figure 2.18. Radical chlorodifluoromethylation for (hetero)arene functionalization…………...46 
Figure 2.19. Scope of chlorodifluoromethylation of (hetero)arenes…………………………….49 
Figure 2.20. Electronic effects of fluoroalkyl radicals to functionalize 4-tBu-anisole………….50 
Figure 2.21. Synthetic utility of the chlorodifluoromethyl group……………………………….51 
Figure 2.22. Chlorodifluoromethylation and diversification of internal aryl alkynes…………..52 
Figure 2.23. Set-up of the flow reactor for radical chlorodifluoromethylation in flow…………58 
Figure 3.1. The importance of alkene difunctionalization reactions and the arylethylamine 
pharmacaphore……………………………………………………………………………….…114 
 xiii 
Figure 3.2. General representation of transition-metal mediated alkene aminoarylation 
reactions……………………………………………………………………………………...…115 
Figure 3.3. Enantioselective copper-catalyzed alkene aminoarylation reaction………….…....116 
Figure 3.4. Intermolecular carboamination reaction using a bifunctional reagent…………….116 
Figure 3.5. Markovnikov-selective Meerwein aminoarylation enabled by phoptoredeox 
catalysis…………………………………………………………………………………………117 
Figure 3.6. Activation of native N−H bonds (amines and amides) for hydro- and carboamination 
of alkenes……………………………………………………………………………………….118 
Figure 3.7. Alkene oxidation for hydro- and carboamination of alkenes……………………...119 
Figure 3.8. Classic aryl transfer strategies……………………………………………………..121 
Figure 3.9. Employing a photochemical Smiles rearrangement for the synthesis of gem-
difluoroaryl ethanol motifs………………………………………………………………….….122 
Figure 3.10. General design strategy for the reported alkene aminoarylation employing 
arylsulfonylacetamides as bifunctional reagents…………………………………………...…..123 
Figure 3.11. Proposed reaction design for aminoarylation with arylsulfonylacetamides……...125 
Figure 3.12. Exploration of substrate scope……………………………………………...…….127 
Figure 3.13. Experiments to probe reaction mechanism………………………………...……..129 
Figure 4.1. Arene dearomatization reactions to rapidly build molecular complexly……………224 
 
Figure 4.2. Cascade approach to deliver complex, three dimensional frameworks…………..…225 
Figure 4.3. PCET mediated intermolecular hydroamination with sulfonamides……………….226 
Figure 4.4. Sulfonamide-based N-radical alkene carboamination platforms……………….…..227 
Figure 4.5. This work: catalytic radical cyclization/dearomatization cascade………………….228 
Figure 4.6. Sultams as valuable motifs in biologically active compounds and in chiral 
auxiliaries……………………………………………………………………………………….228 
 xiv 
Figure 4.7. Reaction scope……………………………………………………………………...233 
Figure 4.8. Experiment to probe mechanism and proposed catalytic cycle……………………..236 
Figure 4.9. Proposed approach for the synthesis of arylethylamines via the intermediary of N-
centered radicals………………………………………………………………………………...237 
 






























LIST OF TABLES 
 
Table 2.1. Optimization of the radical chlorodifluoromethylation with benzene……………….47 
Table 3.1. Reaction optimization for the alkene aminoarylation with arylsulfonylacetamides…134 
Table 3.2. Chemical structures of screened photocatalysts and their associated redox 
potentials………………………………………………………………………………………..135 
Table 3.3. Unreactive alkenes and sulfonamides screened for the aminoarylation reaction..…136 
Table 3.4. Crystal data and structure refinement for 3.15…………………………………...…216 
Table 3.5. Crystal data and structure refinement for 3.23……………………………………...218 
Table 4.1 Reaction optimization and control experiments……………………………………..231 
Table 4.2. Structure of screened photocatalysts………………………………………………..244 
Table 4.3. Reaction optimization………………………………………………………………245 















LIST OF ABREVIATIONS 
 
[O]  oxidant  
°C   degree Celsius  
Ac  acetyl  
AIBN  azobisisobutyronitrile  
aq   aqueous  
Ar   aryl  
ATRA  atom transfer radical addition  
BF4   tetrafluoroborate anion  
Bn   benzyl  
Boc   tert-butoxycarbonyl  
bpy   2,2‘-bipyridine  
bpz   2,2‘-bipyrazine  
BrCF3   bromotrichloromethane  
Cbz   carboxybenzyl  
CF3   trifluoromethyl  
CF3I   trifluoromethyliodide  
CFL   compact fluorescent lightbulb  
cm   centimeter  
Cu   copper  
CV   cyclic voltammetry  
d   doublet  
DABCO  1,4-diazabicyclo[2.2.2]octane  
DBU   1,8-diazabicyclo[5.4.0]undec-7-ene  
DCM   dichloromethane  
DDQ   2,3-dichloro-5,6-dicyano-1,4-benzoquinone  
dF(CF3)ppy  2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine  
DIPEA  N,N-diisopropylethylamine  
DMF   dimethylformamide  
DMSO  dimethylsulfoxide  
d.r.   diastereomeric ratio  
dtbbpy  4,4'-di-tert-butyl-2,2'-bipyridine  
equiv   equivalents  
e.r.   enantiomeric ratio  
Ered   reduction potential  
ESI   electrospray ionization  
Et   ethyl  
Fac  facial  
Fc   ferrocene  
 xvii 
g   grams  
h   hours  
Het  heteroarene 
HCF3   fluoroform  
HRMS  high resolution mass spectroscopy  
Hz   hertz  
IR   infrared  
Ir   iridium  
J   coupling constant  
K   Kelvin  
L   liters  
LED   light emitting diode  
Li   lithium  
M   molar concentration  
m   multiplet  
MCDFA  methyl chlorodifluoroacetate  
Me   methyl  
Mes   mesityl  
mg   milligrams  
MHz   megahertz  
min   minutes  
mL   milliliters  
MLCT  metal to ligand charge transfer  
mm   millimeters  
mmol   millimoles  
mol   moles  
mol%   mole percent  
MW   molecular weight  
nm   nanometers  
NMR   nuclear magnetic resonance  
ns   nanosecond  
PC   photocatalyst  
PF6   hexafluorophosphate anion  
Ph   phenyl 
phen   1,10-phenanthroline 
PMP  paramethoxyphenyl 
PNO   pyridine N-oxide  
ppm   parts per million  
PPNO   4-phenylpyridine N-oxide  
ppy   2-phenylpyridine  
ps   picoseconds  
py or pyr pyridine  
q   quartet  
rt or RT  room temperature  
Ru   ruthenium  
s   singlet  
 xviii 
SCE   saturated calomel electrode  
t   triplet  
Tf   triflyl  
TFA   trifluoroacetic acid  
TFAA  trifluoroacetic anhydride  
THF   tetrahydrofuran  
THIQ   tetrahydroisoquinoline  
TMEDA  tetramethylethylenediamine  
TMSCF3  trifluoromethyltrimethylsilane  
UV   ultraviolet  
V   volts  
W   watt  
δ   chemical shift in parts per million  
λmax   maximum wavelength  































Over the past decade, photoredox catalysis has risen to the forefront of synthetic organic 
chemistry as an indispensable tool for selective small-molecule activation and chemical-bond 
formation. New bond forming strategies have the potential to impact a variety of synthetic 
endeavors including, pharmaceuticals, natural product synthesis, and material sciences. This 
cutting-edge platform allows photosensitizers to convert visible light into chemical energy, 
prompting generation of reactive radical intermediates. In particular, the formation of new C−C 
and C−N bonds is fundamental to organic synthesis. This thesis describes some of our 
contributions to the design, optimization, implementation, and mechanistic underpinnings of novel 
C−C and C−N bond forming reactions mediated by photoredox catalysis.  
Chapter 1 provides a detailed summary of the importance of photoredox catalysis in 
organic synthesis and its appeal as an enabling technology for free radical generation. The history. 
key contributions in the field, the impact of light arrays on reactivity, aliphatic amine 
functionalization, designing complementary mechanistic paradigms, and applications of 
photoredox catalysis in industry is reviewed.  
Chapter 2 focuses on a method for the radical chlorodifluoromethylation of (hetero)arenes 
using chlorodifluoroacetic anhydride. A historical perspective on (hetero)arene functionalization 
via the classic Minisci reaction, along with strategies for radical (perfluoro)alkylation, are 
 xx 
presented. Optimization studies, elucidation of scope, and product diversification of 
chlorodifluoromethylated (hetero)arenes is described.  
Chapter 3 describes our efforts in the area of alkene aminoarylation using simple 
bifunctional arylsulfonylacetamide reagents to synthesize 2,2-diarylethylamines. In this process, 
single-electron alkene oxidation enables C−N bond formation to provide a key benzylic radical 
poised for a Smiles-Truce 1,5-aryl shift. This reaction is redox-neutral, exhibits broad functional 
group compatibility, and occurs at room temperature with loss of sulfur dioxide. The ability of 
photoredox catalysis to mediate the formation C−C and C−N bonds in a single operation is 
established in this Chapter.  
Chapter 4 continues to explore the utility of bifunctional arylsulfonylacetamide reagents; 
now in the context of arene dearomatization. Arene dearomatization reactions are an important 
class of synthetic technologies for the rapid assembly of unique chemical architectures. Here, we 
describe a catalytic protocol to initiate a carboamination/dearomatization cascade that proceeds 
through transient sulfonamidyl radical intermediates formed from strong N−H bonds leading to 
1,4-cyclohexadiene-fused sultams. Reaction optimization, substrate scope, and mechanistic 
features of this transformation are presented. Additionally, several new substrate classes are 
identified which undergo N-radical aryl transfer reactivity with electron-neutral olefins leading to 








General Principles, Recent Trends, and Applications of 
Photoredox Catalysis 
 
*Portions of this chapter have been published in R. C. McAtee, E. J. McClain, C. R. J. Stephenson. 
Illuminating photoredox catalysis. Trends in Chemistry 2019, 1, 111−125. 
1.1. Introduction 
 
Over the past decade, photoredox catalysis has risen to the forefront of synthetic organic 
chemistry as an indispensable tool for selective small-molecule activation and chemical-bond 
formation. This cutting-edge platform allows photosensitizers to convert visible light into chemical 
energy (400-600 nm, 40-70 kcal/mol) prompting generation of reactive radical intermediates. The 
use of light for promoting chemical reactivity has far-reaching implications in minimizing the 
environmental impact of the chemical industry. While traditional photochemistry has generally 
utilized ultraviolet light for initiating chemical transformations, visible light is a more desirable 
energy source due to an increased level of selectivity and control of reactivity. Visible light is 
absorbed by relatively few organic molecules, and therefore it can be used to selectively activate 
specific molecules or even transient species in solution. In addition to the promise of reduced waste 
streams, the use of a more sustainable energy source (e.g. sunlight), and the avoidance of the 
hazardous and/or toxic reagents classically-employed for carbon-centered radical formation (e.g., 
AIBN, Bu3SnH, BEt3/O2), photoredox catalysis has gained meaningful traction due to its ability 
to integrate with continuous flow technology.1-4 The enhanced light penetration available in flow 
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can lead to order(s) of magnitude improvements in material throughput, and the applicability of 
these combined strategies will only increase as methods for in-line manipulation of materials 
continue to improve.1 Importantly, photoredox catalysis is already exerting a significant influence 
on industrial chemistry by enabling otherwise infeasible bond disconnections and aiding 
sustainability efforts.  
Given the ever-increasing industrial investment (e.g., Merck1,2 Eli Lilly,1,5-8 AbbVie9), 
photoredox catalysis promises to be the most enabling synthetic technology since Pd-based cross-
coupling, which happens to be the only methodology invented in the last few decades to 
dramatically impact industrial synthesis.10 
1.2. Photoredox Catalysis as a Modern Approach to Generate 
Radicals 
 
Radical intermediates are molecules that are transiently generated during a reaction and 
contain an unpaired electron (Figure 1.1A). Classic chemical approaches to generate these 
intermediates rely on hazardous radical initiators (e.g., AIBN and BEt3), toxic reagents (e.g., 
Bu3SnH), and in many cases, high temperature or high energy UV irradiation.11-13 These modes of 
traditional radical generation have partly led to radical intermediates being both underexploited 
and underappreciated in chemical synthesis.  
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Figure 1.1. Photoredox catalysis as a modern approach to radical intermediate generation. 
(A) The classic (left) and modern (right; photoredox catalysis) approach to radical intermediates. 
(B) Commonly employed metal-centered and organic photocatalysts. (C) A general representation 
of the oxidative and reductive quenching cycle of Ru(bpy)32+. MLCT and ISC are metal-to-ligand 
charge transfer and intersystem coupling, respectively.  
 
For nearly fifty years, photoredox catalysis has found widespread utility in the areas of 
carbon dioxide reduction,14 water splitting,15 and solar-cell materials.16 Only recently, have these 
fundamental principles been translated to radical generation for chemical synthesis by recognizing 
that visible light can be converted to chemical energy for synthetic applicability in a controlled 
and mild fashion.17-23 Common photocatalysts include Ru(II) (1.1) and Ir(III) (1.2, 1.3) complexes, 
as well as organic dyes (1.4) (Figure 1.1B). Upon irradiation with visible light, metal-centered 
catalysts undergo a metal-to-ligand charge transfer (MLCT) followed by intersystem crossing 
(ISC) revealing a relatively long-lived triplet excited-state species (e.g., for Ru(bpy)32+*, τ = 1100 
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ns) (Figure 1.1C).24-26 From the excited state, these catalysts can engage in single-electron transfer 
(SET) events with organic substrates providing access to reactive open-shell intermediates. 
Notably, excited-state species may act as both a strong oxidant and strong reductant 
simultaneously (generating Ru(bpy)33+ or Ru(bpy)3+, respectively) allowing for exceptional 
operator flexibility. Additional catalyst tuning (e.g., metal center and ligand sphere) allows one to 
predictively modify the catalyst’s redox potential and thus the inherent catalyst properties. In 
contrast to classic chemical approaches to radical intermediate generation, methods in photoredox 
catalysis are exceptionally mild relying on easily accessible and bench-stable materials with 
ambient-temperature operation. Despite remarkable advances in classical UV radical 
photochemistry,27 the need for specialized equipment and lack of predictable product outcomes 
have ultimately skewed the perception and industrial adaptation of such methods. Fortunately, a 
modern era of radical chemistry dawns with photoredox catalysis (and electrocatalysis28), which 
promises to be a steadfast and translatable tool for years to come.29 
1.3. Light Mediated-Excitation of Polypyridyl Photocatalysts 
Visible light irradiation of the polypyridyl photocatalysts leads to an excitation event that 
ultimately furnishes a triplet excited state which is sufficiently long-lived (i.e., rate of relaxation 
is slower than the rate of diffusion) to allow for single electron transfer events to occur (Figure 
1.2).30 To access the triplet excited state, the photocatalyst first undergoes a metal-to-ligand 
charge-transfer (MLCT) event upon visible light irradiation. This photophysical process is 
characterized by the promotion of an electron from a metal-centered t2g orbital to a ligand-centered 
π* orbital, resulting in a singlet excited state (S1) of the photocatalyst. Following MLCT, the singlet 
excited state undergoes intersystem crossing (ISC), which is characterized as a configurational 
spin flip of the electron in the ligand-centered π* orbital, to give the lowest energy triplet excited 
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state (T1). The resultant triplet excited state is a long-lived excited state, capable of undergoing 
single-electron transfer events with organic substrates. Importantly, these processes result in the 
oxidation of the metal center, reduction of the ligand, and a configurational spin flip of the 
promoted electron; but the overall charge of the complex remains unchanged. 
 
Figure 1.2. Light mediated-excitation of polypyridyl photocatalysts. 
Metal-to-ligand charge-transfer (MLCT) and intersystem crossing (ISC) events from the ground 
state to the triplet excited state for the prototypical transition-metal photocatalyst, Ru(bpy)32+, upon 
visible light irradiation. 
 
1.4. Evolution of Light Sources for Enhanced Reactivity and 
Scalability 
 
The diverse reaction profiles accessible via photochemical approaches have reinvigorated 
researchers in both academia and industry to solve a host of synthetic challenges.27, 31 Significant 
effort has been expended on novel reaction invention; however, there has also been significant 
interest in decreasing reaction times, developing standardized operating protocols to improve 
reproducibility, and scaling photochemical reactions for industrial applications. As revealed by the 
Beer-Lambert-Bouguer law, photon flux decreases exponentially with increasing path length and 
concentration. Thus, in large batch reactors, incomplete irradiation of reaction solutions causes the 
photoexcited catalyst to exist only at the reactor surface.32 This phenomenon leads to both long 
reaction times and poor reaction efficiencies for larger reaction volumes. It is clear that an increase 
in light intensity will proportionally lead to an increase in photon capture by the photocatalyst 
affording a higher concentration of the excited-state species.33  
 6 
 
Figure 1.3. Evolution of light array designs for enhanced reaction efficiency and scalability.  
(A) Small library of commonly employed light array designs over the past decade. (B) The 
demonstration of enhanced reaction efficiency with the use of an integrated photoreactor. (C) The 
comparison of batch and flow processing for the trifluoromethylation of N-Boc pyrrole. 
 
The synthetic photoredox community has witnessed a rapid evolution of light sources 
employed to improve established photochemical transformations and aid in the discovery of novel 
bond-forming reactions (Figure 1.3A). Importantly, a suite of light setups of varying intensities 
and wavelengths allows for modular reaction tailoring to best fit the selected photocatalyst. For 
example, common household compact fluorescent lightbulbs (CFL, broadband emission) can be 
easily converted to light-emitting diode (LED) arrays of both specific wavelengths and varying 
intensities. One unique development toward improving reaction efficiencies and rates has been the 
design of a small-scale integrated photoreactor by MacMillan and co-workers (Figure 1.3B).3 The 
photoreactor was optimized for maximum power output from the chosen LED array, electronic 
interface for operating simplicity, and outcome reproducibility. Of note, calorimeter measurements 
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revealed a 10× increase in total incident radiant power with their chosen high power 450 nm LED 
array (>1.1 W output per LED) system relative to a standard LED lamp apparatus. This reactor 
was shown to provide significantly shorter reaction times in eight photoredox transformations 
commonly employed in medicinal chemistry, thereby supporting its further utility. 
There is an increasing drive from industry to employ photoredox catalysis because it is 
well-suited to operate in continuous flow, allowing for more uniform light penetration, and 
therefore, efficient catalyst excitation relative to batch processes.34-37 Further, continuous flow 
processing enhances scalability while simultaneously reducing occupational hazards and industrial 
waste streams. A successful demonstration of photoredox continuous flow processing was 
exemplified by Beatty and co-workers radical trifluoromethylation method seeking to address the 
limited number of scalable trifluoromethylation protocols (Figure 1.3C).5 In collaboration with 
Eli Lilly, the authors identified trifluoroacetic anhydride (TFAA) as a trifluoromethyl radical 
source, in conjunction with pyridine N-oxide (PNO) as a sacrificial redox auxiliary. This low cost 
and operationally simple procedure uses 0.1 mol% Ru(bpy)3Cl2 as the photocatalyst and is 
proposed to proceed via single-electron reduction of acylated pyridine N-oxide, followed by 
fragmentation to give the reactive trifluoromethyl radical, CO2, and pyridine. Comparison of the 
trifluormethylation of N-Boc pyrrole revealed that the reaction efficiency was significantly 
superior with flow processing compared with that of batch processing, generating 3.33 g (71% 
yield, Rt = 10 min) of product per hour (compared with 17.8 g, 57% yield over 15 hours in batch). 
Later, this method was efficiently performed on kilogram scale (0.95 kg isolated, 20 g h-1, 50% 
yield).6 Very recently, Harper and co-workers reported on the design of a continuous flow stirred-
tank reactor equipped with a high intensity laser to achieve kg/day throughput for several 
commonly encountered photochemical coupling reactions.9 Using this 100 mL reactor, the authors 
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reported tremendous reaction-time acceleration and catalysts-loading optimization. Continued 
advancements in light array designs will ensure optimal photocatalyst loadings, reduced waste 
streams, and decreased reaction times ultimately leading to a more sustainable approach to 
chemical synthesis. 
1.5. Selective Oxidation of Aliphatic Amines 
Aliphatic amines represent a ubiquitous functionality in biologically active compounds and 
pharmaceuticals. As such, selective and efficient functionalization of aliphatic amines has 
represented a major point of emphasis for organic chemists.38-39 The direct oxidation of 
trisubstituted aliphatic amines has an astounding impact on the bond dissociation energy of α-C–
R bonds (Figure 1.4A).40 Initial efforts in this area focused on in situ generation and subsequent 
functionalization of imines from N-aryl tetrahydroquinoline core structures (Figure 1.4B).41-42 
This work served as an important proof-of-concept, as the reductive quenching of the photocatalyst 
excited state (PC*) can give rise to radical cations of tri-substituted amines; subsequent hydrogen-
atom transfer led to the formation of imines that could be efficiently trapped upon the addition of 
a nucleophile.   
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Figure 1.4. Selective oxidation of aliphatic amines enabled by photoredox catalysis and 
subsequent synthetic applications.  
 10 
(A) The resultant impact on the oxidation of aliphatic amines. (B) Initial efforts aimed at the direct 
oxidation of N-aryl tetrahydroquinoline and subsequent functionalization. (C) Amine oxidation to 
mimic the proposed biosynthesis of several catharanthine derived alkaloids. (D) The utility of 
photoredox catalysis in providing new tools for the synthesis of saturated building blocks of 
interest to the pharmaceutical sector.  
 
As the breadth of reactivity enabled by photoredox catalysis expanded, Stephenson and co-
workers applied these methods to novel bond disconnections in organic synthesis.43 Based on the 
proposed biosynthesis of several catharanthine derived alkaloids, it was hypothesized that (+)-
catharanthine would be an ideal entry point to the selective modification of complex molecular 
scaffolds through amine oxidation. Following amine oxidation to intermediate 1.5, subsequent 
strain driven cleavage of the C16-C21 bond (α to the amine) led to the facile production of an 
imine (not shown).  Trapping of the imine with an equivalent of cyanide followed by single-
electron reduction and protonation of intermediate 1.6 led to α-amino nitrile 1.7; a common 
intermediate in the synthesis of several structurally related alkaloids (Figure 1.4C). The synthetic 
utility of α-amino nitrile 1.7 was demonstrated as it was readily converted to (−)-
pseudotabersonine, (+)-coronaridine, and (−)-pseudovincadifformine in 90%, 48%, and 55% 
yields, respectively.  
New and mild tools enabled by photoredox catalysis have afforded the preparation of new 
saturated compounds of interest to the pharmaceutical sector because they are less prone to adverse 
metabolic processing. Anilines represent a common structural alert motif known to predispose a 
potential drug candidate to metabolism-driven toxicities.44 However, this functionality is 
commonly found in modern drug discovery screening libraries due to the cornucopia of methods 
for its preparation.10 1-Aminonorbornanes represent a class of molecules that are well suited to 
serve as bioisosteres for anilines, providing a core saturated structure likely less prone to adverse 
metabolic processing events (Figure 1.4D). Although historical examples of 1-aminonorbornanes 
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applications exist, their application to drug discovery has been precluded by limited synthetic 
accessibility. Recently, Stephenson and co-workers provided a solution to this need by reporting 
the application of photoredox catalysis to access a formal (3+2) cycloaddition of 
aminocyclopropanes with tethered olefins to provide the corresponding 1-aminonorbornane 
products.45 In this work, the oxidation of aminocyclopropanes allows for the strain-driven 
homolysis of the α-amino C–C bond, and subsequent serial 6-exo-trig and 5-exo-trig radical 
cyclizations furnishes the desired 1-aminonorbornane core. This methodology proved general as 
it allowed access to a variety of C2-, C3-, C4-, and C7- substituted 1-aminonorbornanes. Metabolic 
stability studies supported the initial hypothesis that the saturated 1-aminonorbornanes is less 
prone to metabolic processing than their aniline counterparts. In all cases, the 1-aminonorbornanes 
were found to outperform, or were on par, with the stability of the most robust aniline compounds. 
1.6. Complementary Reaction Paradigms for Anti-Markovnikov 
Additions to Alkenes 
 
Photoredox catalysis offers unique opportunities for developing complementary 
mechanistic profiles depending on how a given substrate is initially activated. For example, 
photocatalytic anti-Markovnikov selective hydrofunctionalization of alkenes was recently 
demonstrated by both Nicewicz46 and Knowles47 through contrasting C–nucleophile bond forming 
strategies while using a common photoredox catalysis cycle (Figure 1.5). Despite the 
pervasiveness of Markovnikov-selective additions (H–nucleophiles to alkenes) in organic 
chemistry, methods to access the opposite selectivity with the same substrates remains challenging 
and is limited to forcing transition metal catalysis and monosubstituted activated alkenes.48-49  
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Figure 1.5. Complementary mechanistic paradigms for anti-Markovnikov additions to 
alkenes. 
(A) Anti-Markovnikov selective hydrofunctionalization of alkenes via alkene radical cations. (B) 
Anti-Markovnikov selective hydrofunctionalization of alkenes via concerted proton-coupled 
electron transfer approach.  
 
Over the past several years, Nicewicz and colleagues have developed powerful strategies 
that reverse selectivity of traditional hydrofunctionalization reactions of alkenes by taking 
advantage of the known reactivity of transiently generated radical cations (Figure 1.5A).50-52 In 
these cases, polar nucleophiles selectively add to the least hindered site of radical cations 
generating a stabilized radical adduct. Key to the success of this single-electron alkene oxidation 
strategy is the judicious choice of a potent oxidizing photocatalyst.53-54 Notably, many terminal 
styrenes, as well as mono-, di-, and trisubstituted alkenes, have oxidation potentials outside the 
range of commonly employed transition-metal-based polypyridyl catalysts. Consequently, the 
group has spent tremendous effort on designing acridinium photocatalysts with potent redox 
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behaviors.55 Following mechanistic studies, the authors propose the following steps for their 
reported anti-Markovnikov hydrofunctionalization reactions of alkenes.50, 56 Initial single-electron 
transfer from the alkene to an excited-state acridinium photocatalyst provides the reactive radical 
cation intermediate 1.8. Inter- or intramolecular nucleophilic addition to the radical cation 
followed by a hydrogen atom transfer (HAT) event between a suitable donor, such as 2-
phenylmalonitrile, furnishes the functionalized anti-Markovnikov product. The authors have 
successfully extended this photoredox HAT strategy to accomplish anti-Markovnikov 
hydroetherifications,46 hydroaminations,51, 57 hydroacetoxylations,58 and hydrohalogentaions59-60 
of alkenes. These reports illustrate the power of alkenes radical cations to provide access to 
valuable chemical motifs in a succinct manner.  
Instead of alkene oxidation, nucleophile activation via non-covalent catalysis in 
conjunction with photoredox catalysis has enabled a wide breadth of fundamentally distinct 
transformations. Knowles and colleagues have pioneered the use of concerted proton-coupled 
electron transfer (PCET) in organic synthesis.61-62 PCETs are unconventional elementary redox 
processes resulting in the concomitant transfer of a proton and an electron to or from two 
independent donor/acceptor species. This strategy for homolytic activation of strong bonds, often 
in the presence of weaker ones, allows access to radical species that would be kinetically 
challenging to form via sequential proton and electron transfer steps. To showcase the synthetic 
utility of photoredox PCET, the group has developed anti-Markovnikov alkene functionalization 
methods through the oxidative generation of amidyl radicals (1.9) from the corresponding amides 
(Figure 1.5B).47, 63-65 Following homolytic cleavage of a redox activated amide N−H bond (BDFE 
= 110 kcal mol−1), the generated amidyl radical is poised to cyclize onto pendent alkenes to provide 
a nucleophilic carbon−centered radical. Depending on the nature of the reaction conditions, the 
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radical intermediate can (i) be trapped with a suitable Michael acceptor for a C−C bond forming 
event or (ii) abstract an H-atom from a HAT catalyst (such as thiophenol) to provide 
hydroamination products. Overall, given the exceptionally mild nature of both photoredox alkene 
oxidation and PCET methods, a wide range of functional groups are tolerated and will aid in 
accelerating the synthetic utility of these complementary approaches for substrate activation. 
1.7. Recent Applications of Photoredox Catalysis 
Since 2008, the field of photoredox catalysis has experienced exponential growth, 
providing synthetic chemists with novel bond-disconnection strategies and direct approaches to 
targeting native functionalities (including C−H bonds66-67) under exceptionally mild conditions. 
Photoredox catalysis has also proven useful in the synthesis of congested quaternary centers 
through either oxidative68 or reductive generation69-73 of radical intermediates. Given these 
qualities, it is unsurprising that photoredox catalysis has served as a key bond-forming strategy in 
the total synthesis of complex natural products (including (+)-gliocladin C,74 heitziamide A,75 and 
(−)-aplyviolene76-77), as well as medicinally relevant compounds (Figure 1.6A).31  
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Figure 1.6. Recent applications of photoredox catalysis in total synthesis and the industrial 
sector.  
(A) The use of photoredox catalysis as a key step in the synthesis of natural products. (B) The use 
of photoredox catalysis in the direct late-stage C−H methylation, ethylation, and cyclopropanation 
of pharmaceutical and agrochemical agents. (C) Photocatalytic indoline dehydrogenation as a key 
step in the sustainable synthesis of elbasvir. (D) A practical photoredox-mediated hydrogen atom 




The feasibility of translating small-scale photoredox reactions to large-scale flow-
platforms has attracted industrial chemists for applications in late-stage drug modifications and 
large-scale production of key synthetic intermediates.35 For example, DiRocco and co-workers 
have reported a direct late-stage C−H methylation, ethylation, and cyclopropanation of 
pharmaceutical and agrochemical agents (Figure 1.6B).78 From high-throughput experimentation, 
it was found that photoredox catalysis can activate organic peroxides to be suitable radical 
alkylating agents. Given that the method exhibits exceptional functional group tolerance, it is 
ideally suited for drug discovery. In a subsequent report, the Merck team in collaboration with 
Knowles and colleagues, reported on a photocatalytic indoline dehydrogenation as a key step in 
the sustainable synthesis of elbasvir, a clinically investigated inhibitor of the hepatitis C virus 
(Figure 1.6C).2 The photocatalyst 1.2 could be used in combination with tert-butyl perbenzoate 
to provide good yield and excellent ee (85% yield, >99% ee) of the dehydrogenative product. 
Notably, the reaction could be scaled to 100 g and processed over 5 h with a residence time of 60 
min using Merck’s in-house flow reactor. More recently, MacMillan and colleagues reported a 
practical photoredox-mediated hydrogen atom transfer protocol to selectively deuterate and tritiate 
α-amino sp3 C−H bonds of 18 pharmaceutical compounds (Figure 1.6D).79 Isotopically labeled 
molecules are essential diagnostic tools in drug discovery as they provide information about 
compound metabolism and biological uptake.80-81 This single-step operation, which uses 
isotopically labeled water as the heavy atom source, is anticipated to be broadly enabling for 
interrogating the biological activity of novel drug candidates in the future. 
1.8. Conclusions and Future Outlook 
Modern advances in visible-light photoredox catalysis have led to a myriad of novel 
synthetic methodologies. The ability of excited state photocatlysts to simultaneously act as both 
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an oxidant and reductant and their ability to convert visible light into useful chemical energy have 
led to unprecedented reactivity, holding significant promise for enabling the continued discovery 
of valuable organic transformations. As the pharmaceutical sector continues to embrace 
photoredox catalysis, there is an ever-increasing opportunity for academic discoveries to be 
immediately translated to future technologies. Moreover, in an era when sustainable chemical 
practices are of crucial importance, further development of novel visible light-mediated 
methodologies and easily adaptable platforms for scaling reactions are needed for this field to 
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Photochemical Chlorodifluoromethylation of Arenes and 
Heteroarenes 
 
*Portions of this chapter have been published in J. W. Beatty, J. J. Douglas, R. Millar, R. C. 
McAtee, K. P. Cole, C. R. J. Stephenson. Photochemical perfluoroalkylation with pyridine N-
oxides: mechanistic insights and performance on kilogram scale. Chem 2016, 1, 456–472.; R. C. 
McAtee, J. W. Beatty, C. C. McAtee, C. R. J. Stephenson. Radical chlorodifluoromethylation: 
providing a versatile motif for (hetero)arene diversification. Org. Lett. 2018, 20, 3491–3495.; A. 
C. Sun, R. C. McAtee, E. J. McClain, C. R. J. Stephenson. Advancements in visible light-enabled 
radical C(sp)2–H alkylation of (hetero)arenes. Synthesis 2019, 51, 1063–1072. 
2.1. Introduction 
 
Fluorine has the unique ability to alter the physiochemical properties of small molecules,1-
6 meaning that the introduction of fluorine into molecular scaffolds can dramatically affect their 
behavior in biological systems, often increasing metabolic stability.1-3, 5, 7 Consequently, the 
fluorine atom is widely acknowledged to be a valuable heteroatomic surrogate.5 Moreover, 
organofluorine chemistry has recently found many diverse applications in the development of new 
pharmaceuticals,2-4 agrochemicals,3 and materials.8-9 
Since the late 1950s, fluorinated drugs have consisted of roughly 5–15% of newly launched 
pharmaceuticals on a yearly basis, and about 200 fluorine-containing drugs have been approved to 
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date (Figure 2.1A).2 Commodity trifluoromethylated arenes are produced industrially through 
direct halogen-fluoride exchange of benzotrichlorides; however, this process is limited to 
methylated arenes of significant oxidative and thermal stability (Figure 2.1B).10 Alternative 
strategies are required to produce electron-rich and acid-sensitive benzotrifluorides. Because of 
the challenges and limited substrate scope associated with direct C–F bond formation, many 
reagents for the direct incorporation of organofluorinated groups have found widespread synthetic 
utility. This is particularly true for the trifluoromethyl group which may be incorporated through 
nucleophilic,11 electrophilic,12-13 or radical14-16 addition chemistry. 
 
Figure 2.1. The importance of the trifluoromethyl group and synthesis on industrial scale.  
(A) Selected examples of trifluoromethylated arenes and heteroarenes in pharmaceuticals. (B) The 
Swarts reaction for industrial preparation of the trifluoromethyl group.  
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While a great deal of effort has been directed toward developing new methodologies for 
introducing the trifluoromethyl (CF3) moiety into organic molecules,17-21 procedures for 
incorporating the corresponding, yet chemically distinct,22 difluoromethylene functionality (CF2X) 
are less established. In particular, the difluoromethyl group (CF2H) has garnered recent interest in 
medicinal chemistry as a lipophilic hydrogen-bond donor and is considered a competent 
bioisostere for thiols and alcohols (Figure 2.2, left).23-24 As a consequence, there is a growing 
demand to develop efficient and practical methods for the introduction of the difluoromethylene 
motif, in particular, the difluoromethyl group,25-28 into organic and medicinally relevant 
compounds. Within the past decade, numerous radical based difluoromethylation reaction 
platforms have been reported.15, 29-34 Many of these methods demonstrate excellent functional 
group tolerance and have potential to be adopted for applications beyond discovery scale. A 
notable limitation though of direct radical difluoromethylation may be partly attributed to the 
limited substrate scope, arising from the difluoromethyl radical preferentially functionalizing 
electron-deficient π-systems. Therefore, the development of a simple and complementary protocol 
capable of overcoming the inherent electronic paradigm of existing radical difluoromethylation 




Figure 2.2. Inspiration for the reported radical chlorodifluoromethylation of (hetero)arenes. 
2.1.1. Minisci Type Functionalization of Arenes with Photoredox 
Catalysis 
 
Nitrogen-containing heterocycles constitute the backbone of natural products, medicinally 
valuable small molecules, and agrochemicals (Figure 2.3A).35 Methodologies for the direct C–H 
alkylation and perfluoroalkylation of N-heteroarenes enable both the late-stage modification of 
clinical leads and rapid diversification of drug-like libraries.35-37 These strategies allow for 
expedient access to unexplored chemical space and circumvent conventional de novo chemical 
syntheses.37 Notably, the medicinal chemistry community has placed growing interest on late-stage 
functionalization technologies, as they allow for rapid modulation of drug metabolism and 
pharmacokinetic profiles of lead compounds.37-38 Thus, synthetic approaches that are not 
dependent on strong oxidants/reductants, high reaction temperatures, or pre-functionalized 
substrates are of high-value to both academic and industrial sectors. 
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Figure 2.3. The Minisci alkylation of N-heteroarenes. 
(A) Nitrogen containing heterocycles in selected pharmaceuticals. (B) The classic Minisci 
reaction. (C) A general representation of the mechanism for the Minisci reaction.  
 
The addition of open-shell alkyl and perfluoroalkyl radical intermediates to heteroarenes 
is referred to as the Minisci reaction (Figure 2.3B).39-41 Minisci’s original protocol relied on free 
radical formation from carboxylic acids via formation of their corresponding silver salts, followed 
by oxidative decarboxylation upon treatment with a persulfate oxidizing agent. Addition of an 
alkyl radical intermediate onto a protonated heteroarene, followed by rearomatization, yields the 
desired alkylated heterocyclic product (Figure 2.3C). Based on Studer and Curran’s mechanistic 
studies, rearomatization is proposed to occur via deprotonation and sequential single electron 
oxidation of the functionalized heteroarene upon radical addition.42 Since Minisci’s seminal 
contributions, this reactive paradigm for the alkylation of (hetero)arenes has been a stalwart 
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foundation for modern drug discovery and development.43 Furthermore, renewed interest in the 
mild and operationally simple generation of radical intermediates has spurred rapid evolution in 
the area of (hetero)arene alkylation.15 In part, the driving inertia for this interest has been the 
emergence of visible-light-mediated photoredox catalysis, which facilitates exceptionally mild 
single-electron-transfer (SET) events with organic substrates.44-46 Given that state-of-the-art 
photochemical methods are already employed in drug development (see Chapter 1), we anticipate 
that the photoredox radical (perfluoro)alkylation of (hetero)arenes will be an invaluable synthetic 
technology for years to come. 
Alkyl Carboxylic Acids and Carboxylic Acid Derivatives 
 Alkyl carboxylic acids are versatile feedstock chemicals that are ubiquitous throughout 
nature and have been widely used as chemical building blocks.47-48 Owing to their low cost, 
stability, minimal toxicity, and commercial availability, alkyl carboxylic acids have been widely 
utilized across a variety of synthetic transformations and represent preeminent building blocks for 
combinatorial chemistry (e.g. amide bond formation).  In recent years, the radical decarboxylation 
of aliphatic carboxylic acids and their activated derivatives has emerged as a powerful strategy for 
the Minisci functionalization of bioactive organic molecules.   
A broad selection of methods have been developed to promote the decarboxylation of alkyl 
carboxylic acid derivatives through a reductive pathway. In the context of photoredox catalysis, 
the formation of alkyl radicals via a reductive pathway would enable a net redox neutral catalytic 
cycle, thereby eliminating the need for a terminal oxidant. At the same time, a reductive alkylation 
strategy has the potential to expand upon the scope of alkylation reagents, allowing access to 
compounds with significantly higher oxidation potentials.49 Pioneering studies on the reductive 
decarboxylative generation of alkyl radicals were conducted by Barton and co-workers in the 
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1960s (Figure 2.4A).50-51 Barton et al. utilized N-hydroxypryidine-2-thione in the reductive 
activation of carboxylic acids for applications such as carbonyl reduction and reductive 
halogenation. In 1991, Oda and Okada disclosed the use of N-(acyloxy)phthalimides (NAP) as 
redox auxiliaries to enable the decarboxylative generation of alkyl radicals upon single electron 
reductive fragmentation (E1/2  = -1.26 to -1.39 V vs. SCE (saturated calomel electrode)), using 
visible light-mediated photoredox catalysis (Figure 2.4B).52 
 
Figure 2.4. Seminal studies for the radical decarboxylation of aliphatic carboxylic acids and 
their activated derivatives for the Minisci functionalization (hetero)arenes.   
(A) Barton’s decarboxylative reduction of thiohydroxamate esters. (B) Oda’s and Okada’s N-
(acyloxy)phthalimide reductive decarboxylation 
 
Since 2017, NAP esters have been employed in several visible light-driven Minisci 
alkylation protocols to promote reductive alkyl radical generation.53-57 Notably, Phipps and co-
workers have reported an enantioselective variant of the Minisci reaction (Figure 2.5) which 
utilizes a combination of asymmetric Brønsted acid catalysis and photoredox catalysis.55 The use 
of a chiral phosphoric acid catalyst provides both stereo- and regiocontrol in the direct addition of 
prochiral α-amino alkyl radicals to the 2-position of a variety of pyridine and quinoline-based 
substrates. This strategy elegantly facilitates the synthesis of enantioenriched α-heterocyclic 
amines through an efficient late-stage functionalization approach. In 2018, Sherwood and co-
workers at Bristol-Meyers Squibb developed an operationally simple, one-pot protocol for the in 
 32 
situ generation of NAP esters, which obviates the need for isolating the pre-functionalized alkyl 
partner and facilitates the rapid generation of analog libraries.57 
 
Figure 2.5. Enantioselective synthesis of α-heterocyclic amines using a Brønsted 
acid/photoredox catalytic platform 
 
Alkylboronic Acids 
In 2016, Chen and coworkers disclosed the Minisci C–H alkylation of N-heteroarenes with 
primary and secondary alkyl boronic acids using the photocatalyst Ru(bpy)3Cl2 and 
acetoxybenziodoxole as a sacrificial oxidant (Figure 2.6).58 Diversely substituted primary and 
secondary boronic acids (e.g., alkyl bromide, aryl iodide, ester, amide, carbamate, terminal alkyne, 
and benzyl chloride) were well tolerated. Pyridines, pyrimidines, and a purine riboside substrate 
were all efficiently functionalized. It should be noted that more electron-rich heteroarenes, 
including benzothiazole and benzoimidazole, could also be successfully alkylated. The authors 
propose that the reaction is initiated by a single-electron reduction from the photoexcited Ru(II)* 
to acetoxybenziodoxole, providing an oxygen-centered radical intermediate. This radical species 
is then proposed to react with the alkyl boronic acid reagent to form the desired alkyl radical via a 
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radical “ate” transition state. DFT calculations support that this is a facile and highly exothermic 
process at room temperature. 
 
Figure 2.6. Photoredox Minisci alkylation using boronic acid alkylating reagents. 
 
Potassium Alkyl- and Alkoxymethyltrifluoroborates 
Potassium organotrifluoroborates are considerably more attractive radical precursors than 
their corresponding boronic acids, given their lack of an empty p-orbital, which increases their 
overall stability and robustness toward harsh reaction conditions.59 In 2011, Molander and 
coworkers reported the first use of potassium alkyl- and alkoxymethyltrifluoroborates as radical 
precursors in the direct C−H alkylation of (hetero)arenes employing manganese(III) acetate as an 
oxidant in the presence of trifluoroacetic acid.60-61 Under the optimized reaction conditions, the 
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authors were able to functionalize several nitrogen-containing heterocycles all in good to excellent 
yields.  
 
Figure 2.7. Organophotocatalytic Minisci alkylation using alkyltrifluoroborate radical 
precursors. 
 
In 2017, the Molander group reported an impressive advance from their earlier 
manganese(III) acetate-mediated Minisci chemistry by showcasing that alkyltrifluoroborates 
(many of which are commercially available) can be activated by an inexpensive, sustainable 
organophotocatalyst (Figure 2.7).62 Following reaction optimization, the authors found the utility 
of a mesityl acridinium photocatalyst, potassium persulfate (as a sacrificial oxidant), and 
trifluoroacetic acid to be the optimal  reagent combination for the C–H functionalization of 
heteroarenes. Under the title reaction conditions, medicinally important cores including 
quinolines, isoquinolines, indazoles, pyridines, and quinazolinones, could all be functionalized 
 35 
with an impressive scope of primary, secondary, and tertiary alkyltrifluoroborates in good to 
excellent yields. As expected, electron-rich cores such as benzimidazole, were unreactive toward 
these Minisci alkylation conditions. These conditions proved tolerant of a diverse array of 
functional groups including aryl halides, unprotected amines, thioethers, and amides. Notably, 
quinine, which features a free alcohol, terminal alkene, and a tertiary amine (which has a known 
propensity for competitive photocatalytic oxidation) was efficiently (54% yield) and selectively 
(C2-) functionalized. To showcase the late-stage functionalization utility of their developed 
protocol, the authors successfully functionalized camptothecin, an anti-cancer drug candidate, at 
the C7-position. Mechanistically, the authors propose single electron oxidation of the 
alkyltrifluoroborate reagent, which leads to generation of the desired alkyl radical intermediate 
and BF3. 
 
2.1.2. Radical Trifluoromethylation of (Hetero)arenes with 
Photoredox Catalysis 
 
In 2011, the MacMillan group developed the first reported method for the visible light-
driven radical trifluoromethylation of (hetero)arenes (Figure 2.8).16 In this report, reduction of 
trifluoromethanesulfonyl chloride by a ruthenium photocatalyst induced the loss of sulfur dioxide, 
affording the reactive trifluoromethyl radical species. This trifluoromethyl radical could be 
effectively trapped by several (hetero)arenes, resulting in C–H trifluoromethylation. This method 
demonstrated the applicability of photoredox catalysis in medicinal chemistry, as several 
trifluoromethylated pharmacophores could be easily accessed.  
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Figure 2.8. Photoredox catalysis for the radical trifluoromethylation of arenes and 
heteroarenes.  
 
 Trifluoromethyl iodide has been extensively utilized as a source for generating the 
trifluoromethyl radical and subsequently participating in π-bond functionalization, including atom 
transfer radical additions across aliphatic olefins.63-65 In 2012, Ye and Sanford reported an 
impressive advance wherein the generated trifluoromethyl radical can be intercepted with a Cu(III) 
catalyst to trifluoromethylate a diverse array of aryl boronic acids (Figure 2.9) with complete 
positional selectivity.66 In this example, the photoredox catalyst cycle of [Ru(bpy)3]Cl2 directly 
interacts with the copper-catalyzed cross-coupling reaction. The key intermediate of this method 
is the generation of a CuIII-CF3, which may participate in base-promoted transmetallation with an 
aryl boronic acid. The resultant intermediate can then undergo bond forming aryl-CF3 reductive 
elimination while regenerating the CuI catalyst. 
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Figure 2.9. Trifluoromethylation of boronic acids based on dual catalysis. 
 
2.1.3. Trifluoromethylation with TFAA and Pyridine N-Oxides 
 
The impressive number of reagents that have been developed for the synthesis of 
trifluoromethylated compounds speaks volumes to the importance of the CF3 group (Figure 2.10). 
Despite the undeniable value and utility of a wide library of trifluoromethylating reagents for 
discovery research, the use of many of these reagents in large-scale applications becomes less 
appealing when logistics such as reagent cost,67 environmental impact,68-69 and material sourcing 
are considered. Trifluoroacetic acid (TFA) and fluoroform (HCF3) are the most attractive CF3 
source materials in these respects because they are inexpensive and available in large quantities. 
In fact, many reagents for trifluoromethylation are prepared from these materials, and the 
environmental impact of the direct use of TFA or HCF3 is consequently minimal in comparison. 
For a scalable trifluoromethylation methodology, trifluoroacetic acid and its anhydride are most 
attractive in terms of cost and availability. 
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Figure 2.10. Library of commonly employed trifluoromethylating reagents.  
A particular challenge preventing the widespread use of TFA for trifluoromethylation 
chemistry is the large enathalpic barrier for decarboxylation, which can be accomplished thermally 
in a 2 e– pathway in the presence of copper salts at or above 140 ˚C (Figure 2.11).70 The 
decarboxylation of the reagent results in the chlorodifluoromethly anion, which is very short lived 
and undergoes ipso elimination to provide the dilfuorocarbene. Fluoride anion is essential to this 
process and adds to the carbene to form the trifluoromethyl anion, which is stabilized by 




Figure 2.11. Trifluoromethylation of aryl halides with methyl chlorodifluoroacetate. 
Decarboxylation of trifluoroacetate has thus far been shown to be incompatible with 
electron-rich and electron-neutral substrates, as the potentials required for this reactivity will 
oxidize many common organic solvents (F3CO2Na,  E1/2ox = >2.4 V vs. SCE in MeCN) (Figure 
2.12).71 The convergence of these factors has resulted in the use of TFA as a trifluoromethyl source 
only in very limited contexts of thermally72 or oxidatively73 stable substrates, such as benonitriles, 
often in the presence of stoichiometric or superstoichiometric metal promoters. 
 
Figure 2.12. Electrochemical trifluoromethylation through oxidation of TFA salts. 
(A) Electrochemical characteristics of TFA which makes it such as challenging reagent for 
trifluoromethylation. (B) An example of electrochemical activation of TFA/pyridine complex for 
trifluoromethylation of oxidatively stable substrates.  
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To address this challenge, our group envisioned that a mild decarboxylation of 
trifluoroacetic anhydride (TFAA) could be accomplished through appending a sacrificial redox 
auxiliary to alter the requisite electrochemical potentials (Figure 2.13A).49, 74 The use of an 
electron-rich auxiliary would enable the oxidation of the TFAA adduct at less-forcing potentials; 
however, because of electronic matching effects, the resultant electrophilic CF3 radical would be 
highly likely to recombine with the cleaved auxiliary. The alternative reduction of an electron-
deficient auxiliary presents a solution to this problem, as the use of an electron-deficient reagent 
would fail to out-compete more electron-rich substrates for CF3 radical addition.  
Pyrdine N-oxide (PNO) was identified as the reagent of choice for the formation of a 
reducible TFAA adduct (Figure 2.13B).49, 74 The strategic use of PNO: (1) nucleophilically 
activates the acid through acylation; (2) presents a weak N–O bond and low-lying LUMO for facile 
single-electron reduction; (3) produces pyridine as an endogenous base necessary to avoid acid 
buildup; and (4) avoids trifluoromethylation of the pyridine itself due to poor electronic matching 
with the electron-poor CF3 radical (Figure 4C). Mixing TFAA with one equivalent of PNO results 
in the formation of a putative adduct which undergoes reduction at mild potentials (Ered1/2 = –1.10 
V vs SCE in MeCN), forming the CF3 radical within the redox-window of Ru(bpy)32+. A proposed 
mechanism for this process is represented in Figure 2.14. 
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Figure 2.13. Our design strategy for trifluoromethylation with TFAA and pyridine N-oxide 
as a redox auxiliary.  
(A) Employing a redox auxiliary to TFAA to enable a mild decarboxylation within the redox 
window of Ru(bpy)32+. (B) Identifying pyridine N-oxide as a suitable redox auxuilary for TFAA 
and the generated pyridine is inert to CF3 radical functionalization.  
 
 
Figure 2.14. Proposed mechanism for the use of TFAA and pyridine N-oxide for the radical 
trifluoromethylation of (hetero)arenes. 
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The reagent combination is effective in equal stoichiometry with respect to the substrate 
and is sufficiently inexpensive for large-scale implementation (pyridine N-oxide $40–$70 per kg 
at 1,000 kg). Trifluoromethylation reactions may be performed in acetonitrile, with 1–2 
equivalents of pyridine N-oxide providing generally optimal results (Figure 2.15, yields in black 
font). Arenes containing both electron-donating and mildly electron-withdrawing groups were 
trifluoromethylated in moderate yields. A variety of functionalized heterocycles can also be 
functionalized; many of which would not be tolerant to highly forcing electrochemical conditions. 
In addition, trifluoromethylated pyrrolidines can be generated in excellent yield and 
diastereoselectivity by first trifluoromethylating substituted pyrroles followed by standard 
hydrogenation conditions.  
 
Figure 2.15. Scope of radical trifluoromethylation with TFAA and pyridine N-oxide. 
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Among the issues encountered in the activation of TFAA with PNO, we identified the 
reduction potential of the TFAA adduct (E1/2red = –1.10 V vs SCE) as potentially problematic, as 
the reducing power of photoexcited Ru(bpy)3Cl2 (Ered1/2 = –0.81 V vs SCE) is too positive for 
efficient reduction of this species. Of the wide array of pyridines available for investigation, 4-
phenylpyridine N-oxide (4-Ph-PNO) was expected to both stabilize the immediate product of 
reduction through additional conjugation, as well as present a lower LUMO due to the electron-
withdrawing nature of the phenyl substituent. Indeed, reduction of the 4-Ph-PNO/TFAA adduct is 
shifted 200 mV in the positive direction (Ered1/2 = –0.91 V vs SCE) as compared to the reduction 
of PNO/TFAA, suggesting that this alteration of N-oxide electronics can promote the 
decarboxylation of TFAA under even more mild conditions. Electron transfer from photoexcited 
Ru(bpy)3Cl2 (as indicated by fluorescence quenching) is accomplished roughly 7 times faster with 
the 4-Ph-PNO adduct. Significantly improved yields of trifluoromethylation products are obtained 
for an array of electron-rich substrates, many of which display significant further utility in the 
context of cross-coupling and unnatural amino acid synthesis (Figure 2.15, yields in blue font).  
 
2.1.4. Radical Approaches to Chlorodifluoromethylation of Arenes 
and Alkenes 
 
While the difluoromethyl radical exhibits nucleophilic behavior,75 the 
chlorodifluoromethyl radical may be characterized as an electrophilic radical (Figure 2.16A). We 
targeted the chlorodifluoromethyl radical as an attractive surrogate to the difluoromethyl radical 
to efficiently prepare electron-rich difluoromethyated (hetero)arenes and other high-value, 
fluorinated heterocycles. Herein, we report the direct chlorodifluoromethylation of (hetero)arenes 
with commercially available chlorodifluoroacetic anhydride (Figure 2.16B). The 
chlorodifluoromethyl group acts as a difluorinated linchpin, which readily participates in 
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postfunctionalization reactions, enabling the rapid generation of aryl esters, gem-difluoroenones, 
and β-keto-esters. Notably, the chlorodifluoromethyl group is shown to be a critical entryway to 
electron-rich difluoromethylated (hetero)arenes, which previous methods have been found 
challenging to prepare.  
 
Figure 2.16. The electronic advantage of employing chlorodifluoromethyl radicals. 
(A)  The electronic paradigm of fluorinated radicals. (B) This work: utilizing chlorodifluoromethyl 
radicals for (hetero)arene functionalization.  
 
 
Only a few precursors to the chlorodifluoromethyl radical have been reported (Figure 
2.17), including bromochlorodifluoromethane (Figure 2.17A),76-77 bis-
(chlorodifluoroacetyl)peroxide in the presence of Freon-113 (Figure 2.17B),78 and O-octadecyl-
S-chlorodifluoromethyl xanthate (Figure 2.17C), which requires an AIBN/(Me3Si)3SiH 
combination to reductively remove the xanthate group.79 We realized that these methods would 
not be suitable for practical or large-scale implementation.  
 45 
 
Figure 2.17. Reported methods for the generation of chlorodifluoromethyl radicals.  
(A) Chlorodifluoromethyl radicals from bromochlorodifluoromethane, (B) bis-
(chlorodifluoroacetyl)peroxide, and (C) O-octadecyl-S-chlorodifluoromethyl xanthate. 
 
 
2.2. Results and Discussion 
 
Recently, our group identified pyridine N-oxide as a suitable redox trigger for the reductive 
decarboxylation of trifluoroacetic anhydride for the intermolecular coupling of a range of vinyl, 
aryl, and heteroaryl substrates.49 This inexpensive reagent combination enables the direct 
generation of the CF3 radical. In addition, our group reported a complementary mode of reactivity 
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by altering the electronics of this redox-active system for the direct coupling of electron-deficient 
heterocyclic N-oxides with electron-rich alkyl radicals.80 This fragment coupling paradigm uses 
the heterocyclic N-oxide reagent as both a transient redox auxiliary as well as the (hetero)aryl 
coupling partner. Inspired by these reports, we envisioned the development of a mild reagent 
combination (chlorodifluoroacetic anhydride/pyridine N-oxide adduct E1/2red = −1.57 V vs SCE) 
for the generation of the chlorodifluoromethyl radical (•CF2Cl) (Figure 2.18).  
 
Figure 2.18. Radical chlorodifluoromethylation for (hetero)arene functionalization. 
 
 Benzene (2.1a) was the substrate of choice for our initial exploration of reaction conditions 
(Table 2.1). We were pleased to find that the combination of chlorodifluoroacetic anhydride, 
pyridine N-oxide, and 1 mol% Ru(bpy)3Cl2 furnished the desired chlorodifluoromethylated 
benzene (2.2a) in 78% yield (entry 1). Changing solvent from acetonitrile to dichloromethane or 
nitromethane gave comparable reaction efficiencies with only slight decreases in yield (entries 2-
3). Altering the identity of the N-oxide proved to have a dramatic effect on the yield. For example, 
changing the redox trigger from pyridine N-oxide to 4-Ph-pyridine N-oxide resulted in a minimal 
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decrease in product yield for this substrate (entry 4), whereas electron-poor N-oxides consistently 
led to reduced reaction efficiency (entries 5-8). Phenyl substitution at the 2-position of the N-oxide 
gave modest yield of 2.2a (entry 9). We were pleased to observe that the reaction proceeded just 
as smoothly with a reduced catalyst loading of 0.1 mol% Ru(bpy)3Cl2 (entry 10). Importantly, 
exclusion of light (entry 11) or photocatalyst (entry 12) from the reaction failed to give product. 




Entry x mol% N-Oxide Solvent Yield [%][b] 
1 1 pyridine N-oxide MeCN 78 
2 1 pyridine N-oxide CH2Cl2 68 
3 1 pyridine N-oxide MeNO2 66 
4 1 4-Ph-pyridine N-oxide MeCN 73 
5 1 4-Cl-pyridine N-oxide MeCN 24 
6 1 4-CO2Et-pyridine N-oxide MeCN 58 
7 1 4-CN-pyridine N-oxide MeCN 27 
8 1 4-tBu-pyridine N-oxide MeCN 41 
9 1 2-Ph-pyridine N-oxide MeCN 54 
10 0.1 pyridine N-oxide MeCN 74 
11[c] 1 pyridine N-oxide MeCN 0 
12 - pyridine N-oxide MeCN 0 
[a]Reactions run on a 0.8 mmol scale and with 5 equiv of benzene, and 2 mL of the indicated 
solvent. [b] Determined by 19F NMR spectroscopy with trifluorotoluene as the internal standard. [c] 
Reaction performed without blue LED irradiation. 
 
The scope of chlorodifluoromethylation was evaluated for a wide array of electron-rich and 
pharmaceutically relevant (hetero)aromatics (Figure 2.19). Several substrates exhibited good 
reactivity toward the radical fluoroalkylation protocol under the optimized reaction conditions, 
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while modest conversions for select substrates could be overcome by simply increasing the 
equivalents of pyridine N-oxide and anhydride or changing the redox trigger to 4-phenylpyridine 
N-oxide. The increase in yield can be rationalized by the in situ formation of an electron donor–
acceptor complex, providing an additional productive mechanistic pathway.74 Mesitylene (2.2b), 
pyrroles (2.2i, 2.2l, 2.2m, 2.2o), pyridones (2.2f, 2.2g, 2.2h, 2.2n), benzofuran (2.2d), furan (2.2k), 
xanthines (2.2p, 2.2q), aza-indoles (2.2e), anisole (2.2c), thiophene (2.2j), and quinoline (2.2s) all 
proved to be competent substrates. Subjection of 4-methylstyrene to the established conditions 
afforded the bis-substituted product (2.2r). This method was further shown to be tolerant of several 
sensitive functional groups, including esters, aryl halides, Boc-protected heterocycles, aryl methyl 
ethers, and MIDA boronates. In particular, the MIDA boronate products are appealing as potential 
fluorinated cross-coupling reagents and are frequently encountered in drug discovery efforts.81 
Moreover, in all reported examples, we observed a high preferential functionalization of the 
substrate over the concomitantly generated pyridine. Many products shown in Figure 2.19 are 
compounds with unreported synthetic preparations. While the title reaction is amenable to gram 
scale-up in batch (2.2p), successful implementation of a flow reactor manifold (1 mL internal 
reactor volume, 0.04 in. internal diameter PFA tubing, 0.2 mL/min flow rate, and residence time 




Figure 2.19. Scope of chlorodifluoromethylation of (hetero)arenes.  
[a]Isolated yields of reactions run on a 0.8 mmol scale with 2 mL of acetonitrile (0.4 M); 
[b]determined by 19F NMR spectroscopy using trifluorotoluene as the internal standard; [c]3 equiv 
pyridine N-oxide and 3.1 equiv anhydride used; [d]4-phenylpyridine N-oxide. 
 
With several classes of chlorodifluoromethylated (hetero)aromatic products prepared, we 
turned our attention toward exploring the reactivity of the chlorodifluoromethyl group and in 
particular to accessing the difluoromethyl group (CF2H). Notably, subjecting electron-rich 4-tBu-
anisole to the standard conditions with difluoroacetic anhydride or the known difluoromethylation 
reagent, zinc difluoromethanesulfinate (DFMS),15 failed to give radical CF2H addition (Figure 
2.20). Satisfyingly, under basic hydrogenolysis conditions, the electron-rich difluoromethylanisole 
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product (2.3c) was generated in excellent yield. These observations align with a literature 
precedent82-84 detailing the preferential addition of electron-rich difluoromethyl radicals to 
electron-deficient (hetero)aromatics. Sodium carbonate proved crucial for the success of this 
transformation and only trace amount of product was isolated in its absence, presumably due to 
deactivation of the palladium catalyst by in situ generated HCl.  
 
Figure 2.20. Electronic effects of fluoroalkyl radicals to functionalize 4-tBu-anisole. 
[a]no reaction as determined by TLC, GCMS, 1H NMR, and 19F NMR; DFMS = zinc 
difluoromethanesulfinate. 
 
A diverse set of (hetero)arene–CF2H products could be garnered in high yields (Figure 
2.21, 2.3a–e) and, in the case of 2.3e, excellent diastereoselectivity. Our two-step protocol stands 
as a robust synthetic equivalent to direct radical difluoromethylation and is an efficient solution to 
overcome the radical’s electronic limitations (Figure 2.21B). Chlorodifluoromethylation followed 
by hydrogenolysis of 2.3f provides the electronically mis-matched 5-difluomethylquinoline (2.3g). 
Notably, direct radical difluoromethylation of dihydroquinine is selective for the electrophilic 2-
position of the quinoline core, further supporting the synthetic value and the complementary nature 
of the CF2Cl motif. Additionally, exposing pyridone-CF2Cl products to methanolysis conditions 
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in either a one or two-pot sequence readily afforded the corresponding methyl esters in moderate 
to good yields (Figure 2.21C, 2.3h–2.3j). 
 
Figure 2.21. Synthetic utility of the chlorodifluoromethyl group. 
[a]reagents and conditions: 4-phenylpyridine N-oxide (1 equiv), Ru(bpy)3Cl2 (1 mol%), and 
chlorodifluoroacetic anhydride (1.1 equiv) [unless otherwise noted], MeCN, rt, 16 h, blue LEDs; 
yield in parenthesis is of direct methanolysis from the isolated chlorodifluoromethylated product. 
 
Subjection of internal aryl acetylenes to our standard conditions provided exclusive 
formation of gem-difluoroenones in excellent yields (Figure 2.22A, 2.4a, 2.4b). These 
difluorinated products are especially attractive synthetic building blocks.85-90 A plausible 
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mechanism for this transformation (Figure 2.22B) may involve vinylic radical oxidation and 
subsequent chloride elimination, which may lead to the observed gem-difluoroenone upon 
hydrolysis.91-93 Terminal and alkyl-substituted alkynes decomposed or failed to react under the 
same conditions. In an analogous reaction setup, as shown in Figure 2.22C, quenching the reaction 
with triethylamine and a primary alcohol furnished the corresponding β-keto esters in one reaction 
pot starting from simple aryl alkyne building blocks (2.4c–2.4e). 
 
Figure 2.22. Chlorodifluoromethylation and diversification of internal aryl alkynes. 
[a]reagents and conditions: 4-phenylpyridine N-oxide (1 equiv), Ru(bpy)3Cl2 (1 mol%), and 
chlorodifluoroacetic anhydride (1.1 equiv) [unless otherwise noted], MeCN, rt, 16 h, blue LEDs. 
 
2.3. Conclusions 
  In conclusion, we report a robust and efficient method for the decarboxylative radical 
chlorodifluoromethylation of medicinally valuable (hetero)arenes. Chlorodifluoromethylation 
with the corresponding acetic anhydride under visible light irradiation, in both batch and flow 
processing, proceeds with broad substrate scope compatibility, high regioselectivity, and 
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operational simplicity. The work herein demonstrates that the electrophilic chlorodifluoromethyl 
radical is a valuable synthetic precursor to prepare electron-rich difluoromethylated (hetero)arenes. 
Furthermore, the chlorodifluoromethyl group is shown to participate in a wide array of 




2.4. Experimental Procedures and Characterization of Compounds 
 
2.4.1. General Information, Procedures, and Mechanistic Studies 
 
General Information 
All chemicals were used as received and stored as recommended by the supplier. Reactions 
were monitored by thin layer chromatography (TLC) using glass-backed plates pre-coated with 
230–400 mesh silica gel (250 mm thickness) with fluorescent indicator F254, available from EMD 
Millipore (cat. #: 1.05715.0001). Plates were visualized with a dual short wave/long wave UV 
lamp. Column flash chromatography was performed using 230-400 mesh silica (SiliCycle cat. #: 
R12030B). gel or via automated column chromatography. Preparative TLC purifications were run 
on silica plates of 1000 µm thickness. NMR spectra were recorded on Varian MR400, Varian 
Inova 500, Varian Vnmrs 500, or Varian Vnmrs 700 spectrometers. Chemical shifts for 1H NMR 
were reported as δ, parts per million, relative to the signal of CHCl3 at 7.26 ppm. Chemical shifts 
for 13C NMR were reported as δ, parts per million, relative to the center line signal of the CDCl3 
triplet at 77.0 ppm. Chemical shifts for 19F NMR were reported as δ, parts per million, relative to 
the signal of a trifluorotoluene internal standard at -63.72 ppm. N-oxide screening experiments 
were quantitatively analyzed by 19F NMR with a relaxation delay of 1s, and all other internal 
standard yields were quantified by 19F NMR with a 1s relaxation delay. The abbreviations s, br. s, 
d, dd, br. d, ddd, t, q, br. q, qi, m, and br. m stand for the resonance multiplicity singlet, broad 
singlet, doublet, doublet of doublets, broad doublet, doublet of doublet of doublets, triplet, quartet, 
broad quartet, quintet, multiplet and broad multiplet, respectively. IR spectra were recorded on a 
Perkin-Elmer Spectrum BX FT-IR spectrometer fitted with an ATR accessory. Mass Spectra were 
recorded at the Mass Spectrometry Facility at the Department of Chemistry of the University of 
Michigan in Ann Arbor, MI on an Agilent Q-TOF HPCL-MS with ESI high resolution mass 
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spectrometer using electrospray ionization (ESI), positive ion mode, or electron impact ionization 
(EI). We thank Dr. James Windak and Dr. Paul Lennon at the University of Michigan Department 
of Chemistry instrumentation facility for conducting these experiments. UV-Vis measurements 
were obtained on a Shimadzu UV-1601 UV-Vis Spectrometer. LED lights and the requisite power 
box and cables were purchased from Creative Lighting Solutions 
(http://www.creativelightings.com) with the following item codes: CL-FRS5050-12WP-12V 
(4.4W blue LED light strip), CL-PS94670-25W (25 W power supply), CL-PC6FT-PCW (power 
cord), CL-TERMBL-5P (terminal block).  
Unless stated otherwise, all title reactions were run on a 0.8 mmol scale in a 2-dram vial 
equipped with stir bar and cap. The light apparatuses used to irradiate the reactions were 
constructed from test tube racks and wrapped with three 4.4 W LED strips.  Reactions were run 
only in slots marked by a black dot (right) in the picture below to keep a moderate distance from 















General Chlorodifluoromethylation Procedures 
 
 
General Procedure 1: 
To a 2-dram vial equipped with a stir bar was added pyridine N-oxide (76 mg, 0.80 mmol, 
1.0 equiv), Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 mol%), and substrate (0.80 mmol).1 The combined 
materials were then dissolved in MeCN (2.0 ml) and stirred to form a homogeneous solution. The 
reaction was sparged with nitrogen gas for 30 seconds with a glass pipette, followed by the addition 
of chlorodifluoroacetic anhydride (154 μl, 214 mg, 0.88 mmol, 1.1 equiv). The vial was equipped 
with a rubber-lined screw-on cap. Three 4.4 W LED light strips (positioned ~2.5 cm away) were 
turned on and the reaction was allowed to run for 12-16 hours before the light source was removed. 
Trifluorotoluene (98 μl, 0.80 mmol) was added as a stoichiometric internal standard. A sample of 
the reaction was removed and diluted with CDCl3 for NMR analysis. The trifluorotoluene signal 
was referenced to -63.72 ppm. Workup was performed by diluting the reaction with CH2Cl2 and 
washing with 1N HCl, followed by saturated NaHCO3 and then brine. The organic layer was dried 
over sodium sulfate before filtering and concentrating at 40 ˚C under reduced pressure. Yields are 
reported as duplicates of at least two runs.  
General Procedure 2 
General Procedure 2 is identical to Procedure 1 except 137 mg of 4-phenylpyridine N-oxide 
(0.8 mmol, 1.0 equiv) was used instead of pyridine N-oxide.    
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Voltammetry Measurements 
Cyclic voltammetry measurements of the pyridine N-oxide/chlorodifluoroacetic anhydride 
adduct were performed with a model 1000 series multi-potentiostat from CH Instruments.  
Measurements were performed with a glassy carbon working electrode, Pt auxiliary electrode, 
Ag/AgCl reference electrode, Bu4NPF6 electrolyte (0.1 M in MeCN), and analyte (pyridine N-
oxide:chlorodifluoroacetic anhydride, 1:1, 0.01 M) with a sweep rate of 10 mV s-1. A reproducible 
signal was obtained for an irreversible reduction (E1/2red = –1.57 vs SCE). Onset reduction is 
observable near –0.6 V vs SCE.  
 
Attempted Substrates 
The substrates listed below failed to provide chlorodifluoromethylated products in 




















General Procedure for Chlorodifluoromethylation in Flow 
Set-up of the flow reactor for chlorodifluoromethylation: 0.04 inch diameter PFA tubing, 
with a total internal volume exposed to visible light irradiation of 1 mL, was coiled around 2 x 25 
mL test tubes (Figure 2.23A). 2 x Luxeon Rebel high power LEDs- Royal Blue 447.5 nm (Item # 
SP-02-V4) where placed surrounding the tubing approximately 5 cm away from it in order to avoid 
overheating (Figure 2.23B). A syringe pump (Harvard Apparatus PHD 2000) was used in order 












Figure 2.23. Set-up of the flow reactor for radical chlorodifluoromethylation in flow. 
 




C. 2 x Luxeon 
Rebel high power 
LEDs- 447.5 nm 
flow in flow 
out 
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To a 4-dram vial was added 4-phenylpyridine N-oxide (137 mg, 0.80 mmol, 1.0 equiv), 
Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 mol%), and substrate (180 mg, 0.80 mmol). The combined 
materials were then dissolved in MeCN (4.0 ml) and stirred to form a homogeneous solution. The 
reaction was sparged with nitrogen gas for 30 seconds with a glass pipette, followed by the addition 
of chlorodifluoroacetic anhydride (154 μl, 214 mg, 0.88 mmol, 1.1 equiv). The solution was added 
to a 10 mL syringe which was connected to the flow reactor tubing and syringe pump. At this point 
the LEDs were turned on. A 0.2 mL/min flow (residence time of 10 min) was selected and the 
reaction was flowed. The temperature of the flow reactor system was measured by introducing a 
thermometer into one of the test tubes that supported the coiled tubing (see A). This temperature 
was measured and never exceeded 35 ˚C during the 10 min residence time. The collected mixture 
was diluted with CH2Cl2 and washed with 1N HCl, followed by saturated NaHCO3 and then brine. 
The organic layer was dried over sodium sulfate before filtering and concentrating at 40 ˚C under 
reduced pressure. The crude was purified by flash column chromatography to provide the title 









2.4.2. Preparation and Characterization of Substrates and 
Products 
 
Preparation and Data for Chlorodifluoromethylated (Hetero)Arenes 
(chlorodifluoromethyl)benzene (2.2a) 
General Procedure 1 (357 μL, 4.0 mmol, 5.0 equiv benzene): 78% 19F NMR yield  
The 1H and 19F NMR spectral data of the crude reaction mixture were identical to 
those of an authentic sample (Sigma-Aldrich item # 759309).  
1H NMR (CDCl3, 400 MHz): δ = 7.63 (m, 2H), 7.48 (br. m, 3H) ppm 




Modification of General Procedure 2 was followed. To a 2-dram vial 
equipped with a stir bar was added 4-Ph-pyridine N-oxide (136 mg, 0.8 
mmol, 1.0 equiv), Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 mol%), and mesitylene 
(96 mg, 0.8 mmol). The combined materials were then dissolved in MeCN (2.0 ml) and stirred to 
form a homogeneous solution. The reaction was sparged with N2 for 30 sec. Chlorodifluoroacetic 
anhydride (294 µl, 408 mg, 1.68 mmol, 2.1 equiv) was then added to the resulting solution. The 
vial was equipped with a screw-on cap for the duration of the reaction. Three 3 x 4.4 W LED light 
strips were turned on and the reaction was allowed to run for 14 h before the light source was 
removed. The crude reaction was filtered through silica, and the resulting filtrate was concentrated 
to yield a mixture of starting material (mesitylene) and product which proved challenging to 
seperate. Partial separation of the two can be accomplished with preparative TLC (100% hexanes). 
19F NMR yield = 72%.  
The 1H and 19F NMR spectral data of the isolated material (with trace mesitylene) are consistent 
with that reported for the corresponding trifluoromethylated mesitylene.49 
1H NMR (400 MHz, CDCl3): δ = 6.93 (s, 2H), 2.45 (d, J = 3.5 Hz, 3H), 2.32 (s, 3H) ppm 
19F NMR (CDCl3, 377 MHz): δ = -40.58 ppm 




General Procedure 2 was followed (131 mg, 0.8 mmol 4-tBu-anisole) and 
purification by flash column chromatography (SiO2, 100:0→98:2 
Hex:EtOAc) furnished the title anisole compound as a clear oil (82 mg, 
42%). 19F NMR yield = 59%. 
1H NMR (400 MHz, CDCl3): δ = 7.53 (d, J = 2.4 Hz, 1H), 7.47 (dd, J = 8.7, 2.4 Hz, 1H), 6.94 (d, 
J = 8.7 Hz, 1H), 3.91 (s, 3H), 1.31 (s, 9H) ppm 
13C NMR (176 MHz, CDCl3): δ = 154.4, 142.9, 129.6, 125.3, 122.5 (t, J = 286.8 Hz), 123.6 (t, J 
= 22.1 Hz), 122.4, 122.4, 112.0, 56.0, 34.2, 31.3 ppm 
19F NMR (CDCl3, 377 MHz): δ = -48.92 ppm 
IR (neat): 2963, 1616, 1505, 1274, 1048, 939, 897, 706 cm-1 




A modification of General Procedure 2 was followed (0.4 mmol scale). To 
a 2-dram vial equipped with a stir bar was added 4-phenylpyridine N-oxide 
(69 mg, 0.40 mmol, 1.0 equiv), Ru(bpy)3Cl2•6H2O (3.0 mg, 1.0 mol%), and 
3-methylbenzofuran (53 mg, 0.40 mmol). The combined materials were then dissolved in MeCN 
(2.0 ml) and stirred to form a homogeneous solution. The reaction was sparged with nitrogen gas 
for 30 seconds with a glass pipette, followed by the addition of chlorodifluoroacetic anhydride 
(140 μl, 194 mg, 0.80 mmol, 2.0 equiv). The vial was equipped with a rubber-lined screw-on cap. 
Three 4.4 W LED light strips (positioned ~2.5 cm away) were turned on and the reaction was 
allowed to run for 14 hours before the light source was removed. Trifluorotoluene (49 μl, 0.40 
mmol) was added as a stoichiometric internal standard. A sample of the reaction was removed and 
diluted with CDCl3 for NMR analysis. Workup was performed by diluting the reaction with 
CH2Cl2 and washing with 1N HCl, followed by saturated NaHCO3 and then brine. The organic 
layer was dried over sodium sulfate before filtering and concentrating at 40 ˚C under reduced 
pressure. Purification by flash column chromatography (SiO2, 100:0→97:3 Hex:EtOAc) furnished 
the title compound as a clear oil (62 mg, 71%). 19F NMR yield = 68%. 
1H NMR (400 MHz, CDCl3): δ = 7.59 (d, J = 7.8 Hz, 1H), 7.52 (d, J = 7.9 Hz, 1H), 7.43 (t, J = 
7.8 Hz, 1H), 7.32 (t, J = 7.5 Hz, 1H), 2.41 (t, J = 1.9 Hz, 3H) ppm 
13C NMR (176 MHz, CDCl3): δ = 153.8 (s), 142.3 (t, J = 34.3 Hz), 128.6 (s), 126.9 (s), 123.4 (s), 
120.7 (s), 122.0 (t, J = 302.9 Hz) 116.3 (s), 111.8 (s), 7.9 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -49.29 ppm 
IR (neat): 1615, 1454, 1372, 1392, 1263, 1129, 909, 788, 743 cm-1 




General Procedure 1 was followed (238 mg, 0.8 mmol N-Boc-5-
bromo-7-azaindole) and purification by flash column chromatography 
(SiO2, 100:0→95:5 Hex:EtOAc) furnished the title azaindole compound as a clear oil (121 mg, 
40%). 19F NMR yield = 50%. 
1H NMR (400 MHz, CDCl3): δ = 8.64 (d, J = 2.1 Hz, 1H), 8.10 (d, J = 2.2 Hz, 1H), 6.97 (s, 1H), 
1.69 (s, 9H) ppm 
13C NMR (176 MHz, CDCl3): δ = 148.5 (s), 146.7 (s), 133.1 (t, J = 34.1 Hz), 132.6 (s), 121.2 (t, 
J = 286.2 Hz), 120.3 (s), 115.2 (s), 107.0 (t, J = 5.9 Hz), 86.9 (s), 27.7 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -45.47 ppm 
IR (neat): 2987, 1775, 1759, 1541, 1366, 1134, 1102, 766 cm-1 





General Procedure 2 was followed (87 mg, 0.8 mmol N-methylpyridone) 
and purification by flash column chromatography (SiO2, 100:0→90:10 
DCM:MeOH) furnished the title pyridone as a tan solid (72 mg, 45%). 19F 
NMR yield = 48%. 
1H NMR (CDCl3, 400 MHz): δ = 7.71 (dd, J = 7.2, 2.0 Hz, 1H), 7.50 (dd, J = 6.7, 1.8 Hz, 1H), 
6.23 (t, J = 7.0 Hz, 1H), 3.62 (s, 3H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 158.4 (s), 141.8 (s), 136.8 (t, J = 6.7 Hz), 125.4 (t, J = 25.1 Hz), 
124.1 (t, J = 288.5 Hz), 103.9 (s), 37.9 (s) ppm  
19F NMR (CDCl3, 377 MHz): δ = -53.38 ppm 
IR (neat): 3070, 1729, 1627, 1582, 1560, 1484, 1455, 1410, 1301, 1282, 1068 cm-1 




General Procedure 1 was followed (5-bromo-1-methyl-pyridin-2-one, 150 
mg, 0.8 mmol) and purification by flash column chromatography (SiO2, 
95:5→70:30 Hex:EtOAc) furnished the title pyridone as a yellow/tan solid 
(86 mg, 40%). 19F NMR yield = 42%. 
1H NMR (CDCl3, 400 MHz): δ = 7.75 (d, J = 2.6 Hz, 1H), 7.64 (d, J = 2.5 Hz, 1H), 3.61 (s, 1H) 
ppm  
13C NMR (CDCl3, 126 MHz): δ = 156.9 (s), 141.9 (s), 139.9 (t, J = 7.0 Hz), 126.1 (t, J = 25.8 Hz), 
123.2 (t, J = 289.2 Hz), 95.5 (s), 38.1 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -54.09 ppm 
IR (neat): 2964, 1705, 1665, 1608, 1546, 1461, 1446, 1339, 1287, 1228, 1072, 984, 912 cm-1 




General Procedure 1 was followed (4-bromo-1-methyl-pyridin-2-one,150 
mg, 0.8 mmol) and purification by flash column chromatography (SiO2, 
100:0→95:5 DCM:MeOH) furnished the title pyridone as an off white/ tan 
solid (112 mg, 51%). 19F NMR yield = 68%. 
1H NMR (CDCl3, 400 MHz): δ = 7.24 (d, J = 7.2 Hz, 1H), 6.47 (d, J = 7.2 Hz, 1H), 3.55 (s, 3H) 
ppm 
13 C NMR (CDCl3, 176 MHz): δ = 157.7 (s), 139.3 (s), 133.8 (s), 124.6 (t, J = 22.5 Hz), 124.0 (t, 
J = 293.1 Hz), 111.6 (s), 37.9 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -48.50 ppm 
IR (neat): 3075, 1633, 1597, 1525, 1462, 1435, 1414, 1348, 1277, 1242, 1072 cm-1  
HRMS (ESI+) m/z calculated for C7H5BrClF2NO ([M+H]+) 271.9284, found 271.9280.  
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1-(tert-butyl) 2-methyl 5-(chlorodifluoromethyl)-1H-pyrrole-1,2-dicarboxylate (2.2i) 
General Procedure 2 was followed (1-tert-butyl 2-methyl pyrrole-1,2-
dicarboxylate,180 mg, 0.8 mmol) and purification by flash column 
chromatography (SiO2, 95:5→85:15 Hex:EtOAc) furnished the title pyrrole as a clear oil (170 mg, 
70%). 19F NMR yield = 72%. 
1H NMR (CDCl3, 400 MHz): δ = 6.80 (d, J = 3.9 Hz, 2H), 6.58 (d, J = 3.9 Hz, 2H), 3.87 (s, 3H), 
1.62 (s, 9H) ppm 
13 C NMR (CDCl3, 176 MHz): δ = 160.0 (s), 147.4 (s), 130.3 (t, J = 33.8 Hz), 127.4 (s), 120.9 (t, 
J = 285.6 Hz), 115.9 (s), 111.8 (t, J = 4.3 Hz), 86.9 (s), 52.1 (s), 27.1 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -44.69 ppm 
IR (neat): 2986, 1777, 1725, 1372, 1267, 1141, 991, 837 cm-1 
HRMS (ESI+) m/z calculated for C12H14ClF2NNaO4 ([M+Na]+) 332.0472, found 332.0475. 
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(5-(chlorodifluoromethyl)thiophen-2-yl)boronic acid MIDA ester (2.2j) 
A modification of General Procedure 2 was followed to ensure 
full consumption of starting material as it is challenging to isolate 
it away from the chlorodifluoromethylated product. To a 2-dram 
vial equipped with a stir bar was added 4-phenylpyridine N-oxide (548 mg, 3.2 mmol, 4.0 equiv), 
Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 mol%), and 2-thiopheneboronic acid MIDA ester (191 mg, 0.80 
mmol). The combined materials were then dissolved in MeCN (3.0 ml) and stirred to form a 
homogeneous solution. The reaction was sparged with nitrogen gas for 30 seconds with a glass 
pipette, followed by the addition of chlorodifluoroacetic anhydride (573 μL, 797 mg, 3.28 mmol, 
4.1 equiv). The vial was equipped with a rubber-lined screw-on cap. Three 4.4 W LED light strips 
(positioned ~2.5 cm away) were turned on and the reaction was allowed to run for 14 hours before 
the light source was removed. Trifluorotoluene (98 μL, 0.80 mmol) was added as a stoichiometric 
internal standard. A sample of the reaction was removed and diluted with CDCl3 for NMR analysis. 
Workup was performed by diluting the reaction with CH2Cl2 and washing with 1N HCl, followed 
by brine. The organic layer was dried over sodium sulfate before filtering and concentrating at 40 
˚C under reduced pressure. The residue was purified with flash column chromatography. Pyridine 
derivatives were flushed off the column with ~750 mL of 2% methanol in Et2O before the product 
was eluted with 10% MeCN in CH2Cl2. to provide the title thiophene as an amorphous, off-white 
solid (182 mg, 70%). 19F NMR yield = 87%. 
1H NMR (CDCl3, 400 MHz): δ = 7.48 (d, J = 3.6 Hz, 1H), 7.23 (d, J = 3.6 Hz, 1H), 3.94 (d, J = 
16.4 Hz, 2H), 3.83 (d, J = 16.3 Hz, 2H), 2.73 (s, 3H) ppm 
13 C NMR (CD3CN, 176 MHz): δ = 169.2 (s), 142.0 (t, J = 31.0 Hz), 134.7 (s), 131.4 (s), 125.5 (t, 
J = 284.0 Hz), 63.1 (s), 49.0 (s) ppm 
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19F NMR (CDCl3, 377 MHz): δ = -38.17 ppm 
IR (neat): 3006, 1765, 1245, 1142, 1008, 818, 660 cm-1 
HRMS (ESI+) m/z calculated for C10H9BClF2NO4S [M+H]+ 324.0075, found 324. 0064.  
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(5-(chlorodifluoromethyl)furan-2-yl)boronic acid MIDA ester (2.2k) 
A modification of General Procedure 2 was followed to ensure full 
consumption of starting material as it is challenging to isolate it 
away from the chlorodifluoromethylated product. To a 2-dram vial 
equipped with a stir bar was added 4-phenylpyridine N-oxide (274 mg, 1.6 mmol, 2.0 equiv), 
Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 mol%), and 2-furanylboronic acid MIDA ester (178 mg, 0.80 
mmol). The combined materials were then dissolved in MeCN (3.0 ml) and stirred to form a 
homogeneous solution. The reaction was sparged with nitrogen gas for 30 seconds with a glass 
pipette, followed by the addition of chlorodifluoroacetic anhydride (294 μL, 408 mg, 1.68 mmol, 
2.1 equiv). The vial was equipped with a rubber-lined screw-on cap. Three 4.4 W LED light strips 
(positioned ~2.5 cm away) were turned on and the reaction was allowed to run for 14 hours before 
the light source was removed. Trifluorotoluene (98 μL, 0.80 mmol) was added as a stoichiometric 
internal standard. A sample of the reaction was removed and diluted with CDCl3 for NMR analysis. 
Workup was performed by filtering the reaction through a small pad of silica and concentrating in 
vacuo. The residue was purified with flash column chromatography. Pyridine derivatives were 
flushed off the column with ~750 mL of 2% methanol in Et2O before the product was eluted with 
10% MeCN in CH2Cl2. to provide the title furan as an amorphous, off-white solid (151 mg, 62%). 
19F NMR yield = 56%. 
1H NMR (CDCl3, 400 MHz): δ = 6.83 (d, J = 3.4 Hz, 1H), 6.75 (d, J = 3.4 Hz, 1H), 3.93 (d, J = 
16.1 Hz, 2H), 3.86 (d, J = 16.2 Hz, 2H), 2.78 (s, 3H) ppm 
13 C NMR (CD3CN, 176 MHz): δ = 169.3 (s), 149.6 (t, J = 35.1 Hz), 136.6 (s), 122.0 (t, J = 282.0 
Hz), 120.6 (s), 112.9 (s), 63.1 (s), 48.7 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -49.95 ppm 
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IR (neat): 3015, 2968, 1764, 1468, 1286, 1070, 1009, 812 cm-1 
HRMS (ESI+) m/z calculated for C10H9BClF2NO5Na [M+Na]+ 330.0123, found 330.0131.  
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(tert-butyl 5-(chlorodifluoromethyl)-1H-pyrrole-1-carboxylate)boronic acid MIDA ester 
(2.2l) 
A modification of General Procedure 2 was followed to ensure full 
consumption of starting material as it is challenging to isolate it 
away from the chlorodifluoromethylated product. To a 2-dram vial equipped with a stir bar was 
added 4-phenylpyridine N-oxide (411 mg, 2.4 mmol, 3.0 equiv), Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 
mol%), and N-Boc-pyrroleboronic acid MIDA ester (258 mg, 0.80 mmol). The combined 
materials were then dissolved in MeCN (3.0 ml) and stirred to form a homogeneous solution. The 
reaction was sparged with nitrogen gas for 30 seconds with a glass pipette, followed by the addition 
of chlorodifluoroacetic anhydride (433 μL, 602 mg, 2.48 mmol, 3.1 equiv). The vial was equipped 
with a rubber-lined screw-on cap. Three 4.4 W LED light strips (positioned ~2.5 cm away) were 
turned on and the reaction was allowed to run for 14 hours before the light source was removed. 
Trifluorotoluene (98 μL, 0.80 mmol) was added as a stoichiometric internal standard. A sample of 
the reaction was removed and diluted with CDCl3 for NMR analysis. Workup was performed by 
filtering the reaction through a small pad of silica and concentrating in vacuo. The residue was 
purified with flash column chromatography. Pyridine derivatives were flushed off the column with 
~750 mL of 2% methanol in Et2O before the product was eluted with 10% MeCN in CH2Cl2. to 
provide the title pyrrole as an amorphous, off-white solid (185 mg, 57%, trace inseparable starting 
material observed in 1H and 13C NMR spectra). 19F NMR yield = 53%. 
1H NMR (CDCl3, 400 MHz): δ = 6.70 (d, J = 3.5 Hz, 1H), 6.65 (d, J = 3.6 Hz, 1H), 4.18 (d, J = 
16.8 Hz, 2H), 3.89 (d, J = 16.8 Hz, 2H), 3.01 (s, 3H), 1.59 (s, 9H) ppm 
13 C NMR (CDCl3, 176 MHz): δ = 168.4 (s), 150.4 (s), 130.0 (t, J = 33.0 Hz), 121.6 (t, J = 285.2 
Hz), 120.7 (s), 115.8 (s), 87.4 (s), 65.1 (s), 49.8 (s), 27.4 (s) ppm 
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19F NMR (CDCl3, 377 MHz): δ = -41.89 (broad) ppm 
IR (neat): 2988, 1772, 1736, 1316, 1210, 1027, 806 cm-1 
HRMS (ESI+) m/z calculated for C15H18BClF2N2O6 [M+NH4]+ 424.1253, found 424.1254.  
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tert-butyl 2-acetyl-5-(chlorodifluoromethyl)-1H-pyrrole-1-carboxylate (2.2m) 
General Procedure 1 was followed (tert-butyl 2-acetylpyrrole-1-
carboxylate, 167 mg, 0.8 mmol) and purification by flash column 
chromatography (SiO2, 100:0→97:3 Hex:EtOAc) furnished the title pyrrole as a pale yellow oil 
(163 mg, 69%). 19F NMR yield = 74%. 
1H NMR (CDCl3, 400 MHz): δ = 6.79 (d, J = 4.0 Hz, 1H), 6.58 (d, J = 4.0 Hz, 1H), 2.47 (s, 3H), 
1.62 (s, 9H) ppm 
13 C NMR (CDCl3, 176 MHz): δ = 187.7 (s), 147.9 (s), 134.8 (s), 131.2 (t, J = 33.6 Hz), 120.9 (t, 
J = 286.0 Hz), 116.0 (s), 111.4 (t, J = 4.1 Hz), 86.9 (s), 27.1 (s), 26.5 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -45.07 ppm 
IR (neat): 2984, 1775, 1676, 1540, 1370, 1273, 1235, 1149, 982 cm-1 
HRMS (ESI+) m/z calculated for C7H6ClF2NO ([M+]+[-Boc]) 193.0106, found 193.0111. 
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methyl 5-(chlorodifluoromethyl)-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate (2.2n) 
General Procedure 1 was followed (methyl 1-methyl-6-oxo-pyridine-3-
carboxylate, 134 mg, 0.8 mmol) and purification by flash column 
chromatography (SiO2, 90:10→60:40 Hex:EtOAc) furnished the title 
pyridone as a white solid (49 mg, 25%), 19F-NMR yield = 31%. 
1H NMR (CDCl3, 400 MHz): δ = 8.38 (d, J = 2.3 Hz, 1H), 8.25 (d, J = 2.2 Hz, 1H), 3.90 (s, 3H), 
3.68 (s, 3H) ppm 
13C NMR (CDCl3, 126 MHz): δ = 163.7 (s), 158.1 (s), 146.1 (s), 136.1 (s), 124.1 (t, J = 26.0 Hz), 
123.5 (t, J = 289.7 Hz), 107.7 (s), 52.4 (s), 38.5 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -53.87 ppm  
IR (neat): 3071, 1723, 1661, 1620, 1559, 1446, 1325, 1279, 1108, 957, 813, 711 cm-1 
HRMS (ESI+) m/z calculated for C9H8ClF2NO3 ([M+H]+) 252.0234, found 252.0236.  
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tert-butyl 2,5-bis(chlorodifluoromethyl)-1H-pyrrole-1-carboxylate (2.2o) 
Modification of General Procedure 1 was followed. To a 2-dram vial 
equipped with a stir bar was added pyridine N-oxide (76 mg, 0.80 mmol, 
3.0 equiv), Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 mol%), and N-Boc-pyrrole (0.80 mmol). The combined 
materials were then dissolved in MeCN (2.0 ml) and stirred to form a homogeneous solution. The 
reaction was sparged with nitrogen gas for 30 seconds with a glass pipette, followed by the addition 
of chlorodifluoroacetic anhydride (154 μl, 214 mg, 0.88 mmol, 3 equiv). The vial was equipped 
with a rubber-lined screw-on cap. Three 4.4 W LED light strips (positioned ~2.5 cm away) were 
turned on and the reaction was allowed to run for 14 hours before the light source was removed. 
Trifluorotoluene (98 μl, 0.80 mmol) was added as a stoichiometric internal standard. A sample of 
the reaction was removed and diluted with CDCl3 for NMR analysis. The trifluorotoluene signal 
was referenced to -63.72 ppm. Workup was performed by diluting the reaction with CH2Cl2 and 
washing with 1N HCl, followed by saturated NaHCO3 and then brine. The organic layer was dried 
over sodium sulfate before filtering and concentrating at 40 ˚C under reduced pressure to give the 
title bis-substituted pyrrole as a pale yellow oil (226 mg, 84%). 19F NMR yield = 78%. 
1H NMR (CDCl3, 500 MHz): δ = 6.64 (s, 1H), 1.64 (s, 6H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 146.5 (s), 130.5 (t, J = 34.5 Hz), 120.9 (t, J = 285.5 Hz), 112.7 
(t, J = 4.6 Hz), 88.1 (s), 27.2 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -43.94 ppm 
IR (neat): 2987, 1778, 1398, 1284, 1261, 1003, 972, 797 cm-1 




1-Gram Scale: To a flame dried 50 mL round bottom flask equipped 
with a stir bar was added pyridine N-oxide (490 mg, 5.2 mmol, 1.0 
equiv), Ru(bpy)3Cl2•6H2O (3.3 mg, 0.1 mol%), and caffeine (1.0 g, 5.2 
mmol). The combined materials were then dissolved in MeCN (26 mL) and stirred to form a 
homogeneous solution. The reaction was sparged with nitrogen gas for 30 seconds with a glass 
pipette, followed by the addition of chlorodifluoroacetic anhydride (986 μL, 1.37 g, 5.66 mmol, 
1.1 equiv). The flask was equipped with a septa then placed in a jacketed chilling beaker containing 
isopropanol, wrapped in three 4.4 W LED light strips and connected to a recirculating chiller set 
to 20 °C. The LED strips were turned on and the reaction was allowed to run for 14 hours before 
the light source was removed. Trifluorotoluene (63.2 μL, 0.52 mmol) was added as a 
stoichiometric internal standard. A sample of the reaction was removed and diluted with CDCl3 
for NMR analysis. Workup was performed by diluting the reaction with CH2Cl2 and washing with 
1N HCl, followed by saturated NaHCO3 and then brine. The organic layer was dried over sodium 
sulfate before filtering and concentrating at 40 ˚C under reduced pressure. Purification by flash 
column chromatography (SiO2, 100:0→90:10 CH2Cl2:EtOAc) furnished the title compound as a 
white solid (539 mg, 38%). 19F NMR yield = 42%. 
1H NMR (CDCl3, 400 MHz): δ = 4.17 (s, 3H), 3.59 (s, 3H), 3.42 (s, 3H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 155.4 (s), 151.2 (s), 146.2 (s), 142.4 (t, J = 33.0 Hz), 119.6 (t, 
J = 288.2 Hz), 109.5 (s), 33.4 (s), 29.8 (s), 28.1 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -51.02 ppm 
IR (neat): 2960, 1974, 1705, 1694, 1608, 1541, 1446, 1423, 1339, 1227, 1671, 984 cm-1 




General Procedure 2 was followed (223 mg, 0.8 
mmol pentoxifylline) and purification by flash column 
chromatography (SiO2, 70:30→30:70 Hex:EtOAc) furnished the title compound as a white solid 
(120 mg, 42%). 19F NMR yield = 44%. 
1H NMR (CDCl3, 400 MHz): δ = 4.16 (s, 3H), 4.02 (t, J = 6.7 Hz, 2H), 3.58 (s, 3H), 2.50 (t, J = 
6.7 Hz, 2H), 2.14 (s, 3H), 1.73 – 1.57 (m, 4H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 208.6 (s), 155.3 (s), 151.0 (s), 146.3 (s), 142.5 (t, J = 33.1 Hz), 
119.6 (t, J = 288.2 Hz), 109.6 (s), 43.1 (s), 41.1 (s), 33.4 (s), 29.9 (s), 29.8 (s), 27.3 (s), 20.9 (s) 
ppm 
19F NMR (CDCl3, 377 MHz): δ = -51.06 ppm 
IR (neat): 2956, 1705, 1662, 1544, 1319, 1129, 1089, 913, 738 cm-1 
HRMS (ESI+) m/z calculated for C14H17ClF2N4O3 ([M+H]+) 363.1030, found 363.1032. 
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3-chloro-3,3-difluoro-1-(p-tolyl)propyl 2-chloro-2,2-difluoroacetate (2.2r) 
General Procedure 2 was followed (95 mg, 0.8 mmol 4-methyl 
styrene) and workup by filtering through a pad of celite and 
concentrating to a light yellow oil. Purification by flash column 
chromatography (SiO2, 100:0→90:10 Hex:EtOAc) furnished the title 
compound as a clear oil (164 mg, 62%). 19F NMR yield = 68%. 
1H NMR (CDCl3, 400 MHz): δ = 7.28 (d, J = 8.3 Hz, 2H), 7.22 (d, J = 7.9 Hz, 2H), 6.22 (dd, J = 
9.3, 2.5 Hz, 1H), 3.18 (ddt, J = 22.6, 13.0, 9.4 Hz, 1H), 2.80 (qd, J = 13.7, 2.8 Hz, 1H), 2.36 (s, 
3H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 157.8 (t, J = 35.0 Hz), 139.7 (s), 133.3 (s), 129.8 (s), 127.0 (t, 
J = 292.9 Hz), 126.3 (s), 116.7 (t, J = 300.7 Hz), 74.6 (t, J = 2.9 Hz), 47.5 (t, J = 24.5 Hz), 21.2 
(s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -49.45 – -51.07 (m), -64.31 (d, J = 3.6 Hz) ppm 
IR (neat): 2927, 1781, 1299, 1169, 1103, 973, 815 cm-1 




Modification of General Procedure 1 was followed. To a 2-dram vial equipped 
with a stir bar was added pyridine N-oxide (231 mg, 2.40 mmol, 3.0 equiv), 
Ru(bpy)3Cl2•6H2O (6.0 mg, 1.0 mol%), and 6-methoxyquinoline (127 mg, 0.80 
mmol). The combined materials were then dissolved in MeCN (2.0 ml) and stirred to form a 
homogeneous solution. The reaction was sparged with nitrogen gas for 30 seconds with a glass 
pipette, followed by the addition of chlorodifluoroacetic anhydride (416 μl, 2.40 mmol, 3 equiv). 
The vial was equipped with a rubber-lined screw-on cap. Three 4.4 W LED light strips (positioned 
~2.5 cm away) were turned on and the reaction was allowed to run for 14 hours before the light 
source was removed. Workup was performed by diluting the reaction with CH2Cl2 and washing 
with 1N HCl, followed by saturated NaHCO3 and then brine. The organic layer was dried over 
sodium sulfate before filtering and concentrating at 40 ˚C under reduced pressure. Purification by 
flash column chromatography (SiO2, 95:5→85:15 Hex:EtOAc) furnished a 3:1 separable mixture 
of the title compound as an off white solid (60 mg, 33%) and the 7-(chlorodifluoromethyl)-6-
methoxyquinoline regioisomer as an off white solid (20 mg, 11%).  
1H NMR (CDCl3, 700 MHz): δ = 8.84 (dd, J = 4.0, 1.1 Hz, 1H), 8.65 (d, J = 8.9 Hz, 1H), 8.25 (d, 
J = 9.3 Hz, 1H), 7.55 (d, J = 9.4 Hz, 1H), 7.48 (dd, J = 8.9, 4.1 Hz, 1H), 4.07 (s, 3H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 155.6 (s), 148.4 (s), 143.5 (s), 135.5 (s), 132.4 (s), 126.3 (t, J = 
293.7 Hz), 125.4 (s), 122.3 (s), 117.2 (s), 116.3 (t, J = 23.4 Hz), 57.2 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -40.88 ppm 
IR (neat): 2959, 2927, 2838, 1629, 1597, 1497, 1455, 1347, 1277, 1198, 1034, 935, 875 cm-1 
HRMS (EI+) m/z calculated for C11H8ClF2NO ([M+H+]) 244.0335, found 244.0334.  
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7-(chlorodifluoromethyl)-6-methoxyquinoline (2.2s*) 
1H NMR (CDCl3, 700 MHz): δ = 8.82 (d, J = 3.9 Hz, 1H), 8.30 (s, 1H), 8.05 
(d, J = 8.3 Hz, 1H), 7.42 (dd, J = 8.2, 4.1 Hz, 1H), 7.16 (s, 1H), 4.02 (s, 3H) 
ppm 
13C NMR (CDCl3, 176 MHz): δ = 154.0 (s), 149.2 (s), 142.5 (s), 134.4 (s), 130.7 (s), 128.3 (t, J = 
25.4 Hz), 128.0 (t, J = 7.1 Hz), 124.3 (t, J = 290.2 Hz), 123.0 (s), 106.8 (s), 56.2 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -50.56 (s) ppm 
IR (neat): 2959, 2928, 2838, 1629, 1597, 1497, 1331, 1277, 1165, 1034, 976, 798 cm-1 
HRMS (EI+) m/z calculated for C11H8ClF2NO ([M+H+]) 244.0335, found 244.0335.  
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Preparation and Data for Difluoromethylated (Hetero)Arenes 
 
To a 10 mL RBF equipped with a stir bar was added palladium on activated carbon (10 wt%, 0.10 
equiv). The flask was evacuated and backfilled with N2 three times. Methanol (3 mL) was then 
added to the flask followed by the chlorodifluoromethylated (hetero)arene substrate (1 equiv) and 
sodium carbonate (1 equiv). The heterogeneous mixture was stirred under a H2 atmosphere (gas 
balloon) and monitored by TLC analysis.  Once the reaction was complete (under 1 h), the mixture 




The reaction was performed using 8-[chloro(difluoro)methyl]-1,3,7-
trimethyl-purine-2,6-dione (20 mg, 0.07 mmol, 1 equiv). Purification 
by flash column chromatography (SiO2, 100:0→50:50 Hex:EtOAc) 
furnished the title compound as a white solid (17.5 mg, 99%). 
1H NMR (CDCl3, 700 MHz): δ = 6.75 (t, J = 52.3 Hz, 1H), 4.16 (s, 3H), 3.57 (s, 3H), 3.42 (s, 2H) 
ppm 
13C NMR (CDCl3, 176 MHz): δ = 155.5 (s), 151.4 (s), 146.9 (s), 142.8 (s), 109.7 (t, J = 237.6 Hz), 
109.5 (s), 32.9 (s), 29.8 (s), 28.1 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -115.0 (d, J = 52.3 Hz) ppm 
IR (neat): 2925, 1706, 1665, 1604, 1549, 1459, 1090, 1036, 801 cm-1 




The reaction was performed using 3-(chlorodifluoromethyl)-1-
methylpyridin-2(1H)-one (38.7 mg, 0.20 mmol, 1 equiv). Purification by 
flash column chromatography (SiO2, 100:0→40:60 Hex:EtOAc) furnished 
the title compound as a tan solid (14.5 mg, 46%). 
1H NMR (CDCl3, 700 MHz): δ = 7.69 (d, J = 6.8 Hz, 1H), 7.42 (d, J = 6.6 Hz, 1H), 6.84 (t, J = 
55.3 Hz, 1H), 6.26 (t, J = 6.8 Hz, 1H), 3.59 (s, 3H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 160.7 (s), 140.4 (s), 137.1 (t, J = 5.9 Hz), 124.7 (s), 111.2 (t, J 
= 236.5 Hz), 105.0 (s), 37.6 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -118.8 (d, J = 55.3 Hz) ppm 
IR (neat): 3090, 2927, 1656, 1587, 1562, 1406, 1305, 1116, 1083, 999, 758 cm-1 




The reaction was performed using 4-tert-butyl-2-
[chloro(difluoro)methyl]-1-methoxy-benzene (50 mg, 0.2 mmol, 1 equiv). 
Purification by flash column chromatography (SiO2, 100:0→95:5 Hex:EtOAc) furnished the title 
compound as a clear oil (40 mg, 93%). 
1H NMR (CDCl3, 400 MHz): δ = 7.58 (s, 1H), 7.44 (d, J = 8.6 Hz, 1H), 6.95 (t, J = 55.8 Hz, 1H), 
6.87 (d, J = 8.8 Hz, 1H), 3.85 (s, 3H), 1.31 (s, 9H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 155.0 (s), 143.5 (s), 128.6 (s), 123.0 (t, J = 5.7 Hz), 121.9 (s), 
111.8 (t, J = 235.5 Hz), 110.5 (s), 55.7 (s), 34.2 (s), 31.4 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -114.94 (d, J = 55.8 Hz) ppm 
IR (neat): 2962, 1618, 1505, 1384, 1264, 1057, 1021, 817 cm-1 




The reaction was performed using 8-
[chloro(difluoro)methyl]-3,7-dimethyl-1-(5-
oxohexyl)purine-2,6-dione (50 mg, 0.14 mmol, 1 
equiv). Purification by flash column chromatography (SiO2, 100:0→80:20 Hex:EtOAc) furnished 
the title compound as a clear white solid (41 mg, 91% along with an inseparable trace impurity 
observed in the 1H and 13C NMR spectra). 
1H NMR (CDCl3, 400 MHz): δ = 6.74 (t, J = 52.3 Hz, 1H), 4.15 (s, 3H), 4.02 (t, J = 6.9 Hz, 2H), 
3.55 (s, 3H), 2.50 (t, J = 6.9 Hz, 2H), 2.14 (s, 3H), 1.68 – 1.62 (m, 4H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 208.6 (s), 155.4 (s), 151.1 (s), 146.9 (s), 142.7 (s), 109.7 (t, J = 
237.9 Hz), 109.5 (s), 43.1 (s), 40.9 (s), 32.9 (s), 29.9 (s), 29.7 (s), 27.3 (s), 20.9 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -115.0 (d, J = 52.2 Hz) ppm 
IR (neat): 2952, 1700, 1658, 1545, 1331, 1041, 750 cm-1 
HRMS (ESI+) m/z calculated for C14H18F2N4O3 ([M+H]+) 329.1420, found 329.1428. 
  
 88 
1-(tert-butyl) 2-methyl (2S,5R)-5-(difluoromethyl)pyrrolidine-1,2-dicarboxylate (2.3e) 
The reaction was performed using 1-(tert-butyl) 2-methyl 5-
(chlorodifluoromethyl)-1H-pyrrole-1,2-dicarboxylate (53 mg, 0.17 
mmol, 1 equiv). Purification by flash column chromatography (SiO2, 100% CH2Cl2) furnished the 
title cis-substituted compound as a clear oil (45 mg, 94%). 
The analogous cis-trifluoromethylated substituted pyrolidine has been previously reported.49 
1H NMR (d6-DMSO @ 60 °C, 400 MHz): δ = 6.05 (t, J = 56.4 Hz, 1H), 4.26 (t, J = 8.0 Hz, 1H), 
4.15 – 3.96 (m, 1H), 3.65 (s, 3H), 2.33 – 2.14 (m, 1H), 2.13 – 1.73 (m, 3H), 1.39 (s, 9H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 172.6 (s), 153.9 (s), 115.0 (t, J = 245.6 Hz), 114.4 ((t, J = 244.6 
Hz), 81.1 (s), 60.1 (s), 52.0 (s), 46.3 (s), 29.6 (d, J = 22.7 Hz), 28.2 (d, J = 24.5 Hz), 23.3 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -118.4 (dt, J = 104.1, 54.5 Hz), -124.5 (ddd, J = 77.4, 60.6, 21.5 
Hz), -126.0 (ddd, J = 79.5, 57.0, 21.2 Hz) ppm 
IR (neat): 2978, 1746, 1698, 1438, 1391, 1365, 1160, 1035 cm-1 




The reaction was performed using 5-[chloro(difluoro)methyl]-6-methoxy-
quinoline (30 mg, 0.12 mmol, 1 equiv), sodium carbonate (13 mg, 0.12 mmol), 
and ethyl acetate (3 mL) instead of methanol as an inseparable by-product was 
formed when methanol was used. Purification by flash column chromatography (SiO2, 
90:10→60:40, Hex:EtOAc) furnished the title compound as a white solid (20 mg, 78%).  
1H NMR (CD3CN, 700 MHz): δ = 8.83 (d, J = 3.0 Hz, 1H), 8.64 (d, J = 8.4 Hz, 1H), 8.21 (d, J = 
9.3 Hz, 1H), 7.66 (d, J = 9.3 Hz, 1H), 7.56 (t, J = 54.3 Hz, 1H), 7.51 (dd, J = 8.7, 4.0 Hz, 1H), 4.03 
(s, 3H) ppm 
13C NMR (CD3CN, 176 MHz): δ = 157.9 (s), 150.3 (s), 145.3 (s), 136.3 (s), 133.4 (t, J = 3.8 Hz), 
127.3 (s), 123.8 (s), 118.0 (s), 114.9 (t, J = 22.2 Hz), 114.5 (t, J = 231.8 Hz), 58.1 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -111.65 (d, J = 54.4 Hz) ppm 
IR (neat): 2959, 2927, 2837, 1629, 1597, 1497, 1470, 1347, 1276, 1198, 1103, 1034, 935, 848, 
798, 704 cm-1 
HRMS (ESI+) m/z calculated for C11H9F2NO ([M+H]+) 210.0725, found 210.0722. 
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Attempted Difluoromethylation with Difluoroacetic Anhydride and Zinc Difluoromethane-
sulfinate 
A. Difluoromethylation Attempt with Difluoroacetic Anhydride 
 
To a 2-dram vial equipped with a stir bar was added 4-Ph-pyridine N-oxide (136 mg, 0.8 mmol, 1 
equiv), Ru(bpy)3Cl2•6H2O (6 mg, 1 mol%), and 4-tBu-anisole (140 μL, 0.8 mmol, 1 equiv). The 
combined materials were then dissolved in MeCN (2.5 mL) and stirred to form a homogeneous 
solution. The reaction solution was then sparged with N2 for 30 sec. Difluoroacetic anhydride (109 
µL, 0.88 mmol, 1.1 equiv) was then added to the resulting solution. The vial was equipped with a 
screw-on cap for the duration of the reaction. Three 4.4 W blue LED light strips were turned on 
and the reaction was allowed to run overnight (16 h) before the light source was removed. Workup 
was performed by diluting the reaction with CH2Cl2 and washing with 1N HCl, followed by 
saturated NaHCO3 and then brine. The organic layer was dried over sodium sulfate, filtered, 
concentrated, and analyzed by 1H NMR, 19F NMR, TLC, and GCMS to reveal recovered starting 
4-tBu-anisole. 
n.r. = no detectable trace of difluoromethylated product (TLC, GCMS, 1H NMR, 19F NMR) was 
observed during the course of the reaction or upon reaction workup.  
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B. Difluoromethylation Attempt with Zinc Difluoromethanesulfinate 
 
To a 2 dram vial equipped with a stir bar was prepared a solution of 4-tBu-anisole (41 mg, 0.25 
mmol, 1 equiv) and zinc difluoromethanesulfinate (DFMS) (200 mg, 0.66 mmol, 2.7 equiv) in 
dichloromethane (1 mL) and water (0.4 mL). At rt, trifluoroacetic acid (20 µL, 0.25 mmol, 1 equiv) 
was added to the solution followed by slow addition of tBu-hydroperoxide (70% solution in water, 
0.17 mL, 1.25 mmol, 5 equiv). The reaction was capped, stirred, and monitored by thin layer 
chromatography (5% EtOAc in Hex). After 22 h, the reaction was partitioned between CH2Cl2 
(2mL) and saturated NaHCO3 (2 mL). The organic layer was separated, and the aqueous layer was 
extracted with CH2Cl2 (3 X 2 mL). The organic layers were dried over sodium sulfate, 
concentrated, and analyzed by 1H NMR, 19F NMR, TLC, and GCMS to reveal recovered starting 
4-tBu-anisole.  
n.r. = no detectable trace of difluoromethylated product (TLC, GCMS, 1H NMR, 19F NMR) was 
observed during the course of the reaction or upon reaction workup.  
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Preparation and Data for Methylester Pyridones 
 
One-Pot Sequence: General Procedure 1 was followed running the reaction with pyridone (0.8 
mmol, 1 equiv). After 14-24 h of stir time, the light source was turned off and 2 mL of dried MeOH 
and (1-2 equiv) of sodium acetate was added to the dark reaction mixture. The whole was heated 
to 50 °C and allowed to stir for 4-6 h. Workup was performed by diluting the reaction with 4 mL 
CH2Cl2 and 3 mL of dH2O. The aqueous layer was washed with CH2Cl2 (3 x 5 mL), and the 
organic layers combined, washed with brine, dried over sodium sulfate, filtered and concentrated 
at 40 ˚C under reduced pressure. 
 
From CF2Cl-pyridone: To a 2-dram vial was added CF2Cl-pyridone (1 equiv), sodium acetate (1 
equiv) and methanol (2 mL). The whole was heated to 50 °C and allowed to stir for 4-6 hours. 
Workup was performed by diluting the reaction mixture with CH2Cl2 and extracting with de-
ionized water followed by washing with brine. The organic layer was dried over sodium sulfate 
before filtering and concentrating at 40 ˚C under reduced pressure. 
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methyl 1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate (2.3h) 
One-Pot Sequence: General Procedure 1 was followed running the 
reaction with 1-methyl-pyridin-2-one (87 mg, 0.8 mmol, 1 equiv). After 24 
h of stir time, the light source was turned off and 2 mL of dried MeOH and 66 mg (0.80 mmol, 1 
equiv) of sodium acetate was added to the dark reaction mixture. The whole was heated to 50 °C 
and allowed to stir for 6 h. Workup was performed by diluting the reaction with 4 mL CH2Cl2 and 
3 mL of dH2O. The aqueous layer was washed with CH2Cl2 (3 x 5 mL), and the organic layers 
combined, washed with brine, dried over sodium sulfate, filtered and concentrated under reduced 
pressure to give a crude dark brown oil. Purification by flash column chromatography (SiO2, 
100:0→90:10 CH2Cl2:MeOH) furnished the title pyridone as a tan solid (76 mg, 57%). 
From 3-[chloro(difluoro)methyl]-1-methyl-pyridin-2-one: To a 2-dram vial was added 3-
[chloro(difluoro)methyl]-1-methyl-pyridin-2-one (19 mg, 0.1 mmol, 1 equiv), 1 mL dried MeOH, 
and sodium acetate (8 mg, 0.1 mmol, 1 equiv). The whole was allowed to stir for 6 h at 50 °C. 
Workup was performed by diluting the reaction with 4 mL CH2Cl2 and 3 mL of dH2O. The 
aqueous layer was washed with CH2Cl2 (3 x 5 mL), and the organic layers combined, washed with 
brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to give a crude 
dark brown oil. Purification by flash column chromatography (SiO2, 100:0→90:10 
CH2Cl2:MeOH) furnished the title pyridone as a tan solid (15 mg, 91%). 
1H NMR (CDCl3, 400 MHz): δ 8.16 (d, J = 7.2 Hz, 1H), 7.54 (d, J = 6.5 Hz, 1H), 6.23 (t, J = 6.8 
Hz, 1H), 3.91 (s, 3H), 3.60 (s, 3H) ppm 
13C NMR (CDCl3, 126 MHz): δ 165.8 (s), 159.8 (s), 144.8 (s), 143.1 (s), 120.5 (s), 104.5 (s), 52.3 
(s), 38.3 (s) ppm 
IR (neat): 2936, 1717, 1648, 1590, 1435, 1376, 1272, 1102, 772 cm-1 
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HRMS (ESI+) m/z calculated for C8H9NO3 ([M+Na]+) 190.0475, found 190.0475.  
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methyl 5-bromo-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate (2.3i) 
One-Pot Sequence: General Procedure 1 was followed running the reaction 
with 5-bromo-1-methyl-pyridin-2-one (150 mg, 0.8 mmol, 1 equiv). After 16 
h of stir time, the light source was turned off and 2 mL of dried MeOH 
and 131 mg (1.6 mmol, 2 equiv) of sodium acetate was added to the dark reaction mixture. The 
whole was heated to 50 °C and allowed to stir for 6 h. Workup was performed by diluting the 
reaction with 4 mL of CH2Cl2 and 3 mL of dH2O. The aqueous layer was washed with CH2Cl2 (3 
x 5 mL), and the organic layers combined, washed with brine, dried over sodium sulfate, filtered 
and concentrated under reduced pressure to give a crude dark brown oil. Purification by flash 
column chromatography (SiO2, 100:0→90:10 CH2Cl2:MeOH) furnished the title pyridone as a 
light yellow solid (85 mg, 44% along with trace inseparable starting material observed in the 1H 
NMR spectra). 
1H NMR (CDCl3, 400 MHz): δ 8.18 (d, J = 2.8 Hz, 1H), 7.66 (d, J = 2.8 Hz, 1H), 3.91 (s, 3H), 
3.58 (s, 3H) ppm 
13C NMR (CDCl3, 175 MHz): δ 164.5 (s), 158.2 (s), 147.2 (s), 142.9 (s), 121.4 (s), 95.9 (s), 52.6 
(s), 38.5 (s) ppm 
IR (neat): 2960, 2362, 1734, 1700, 1634, 1540, 1457, 1430, 1297, 1101 cm-1 
HRMS (ESI+) m/z calculated for C8H8BrNO3 ([M+Na]+) 267.9580, found 267.9582.  
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methyl 4-bromo-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate (2.3j) 
One-Pot Sequence: General Procedure 1 was followed running the 
reaction with 4-bromo-1-methyl-pyridin-2-one (150 mg, 0.8 mmol, 1 equiv). 
After 16 h of stir time, the light source was turned off and 2 mL of dried 
MeOH and 66 mg (0.80 mmol, 1 equiv) of sodium acetate was added to the dark reaction mixture. 
The whole was heated to 50 °C and allowed to stir for 4 h. Workup was performed by diluting the 
reaction with 4 mL CH2Cl2 and 3 mL of dH2O. The aqueous layer was washed with CH2Cl2 (3 x 
5 mL), and the organic layers combined, washed with brine, dried over sodium sulfate, filtered and 
concentrated under reduced pressure to give a crude dark brown oil. Purification by flash column 
chromatography (SiO2, 100:0→90:10 CH2Cl2:MeOH) furnished the title pyridone as an off white 
solid (107 mg, 54%). 
1H NMR (CDCl3, 400 MHz): δ 7.19 (d, J = 7.2 Hz, 1H), 6.39 (d, J = 7.2 Hz, 1H), 3.94 (s, 3H), 
3.52 (s, 3H) ppm 
13C NMR (CDCl3, 126 MHz): δ 165.1 (s), 158.7 (s), 138.5 (s), 133.1 (s), 127.4 (s), 110.1 (s), 52.9 
(s), 37.7 (s) ppm 
IR (neat): 2955, 1705, 1660, 1608, 1545, 1445, 1425, 1339, 1228, 1072, 912, 741 cm-1 




The substrates listed below failed to provide methyl carboxylate products in sufficient quantities 




Preparation and Data for gem-Difluoroenones 
 
 
General Procedure 2 was followed then after 16 h the mixture was filtered through a silica plug 
and concentrated under reduced pressure. The crude was purified via flash column 
chromatography using a 0 to 3% ethyl acetate in hexanes elution gradient. 
3,3-difluoro-2-methyl-1-phenylprop-2-en-1-one (2.4a) 
The reaction was performed using 1-phenyl-1-propyne (0.10 mL, 0.8 mmol, 
1 equiv). The title compound was furnished as a light yellow oil (132 mg, 
91%). 19F NMR yield = 95%. 
1H NMR (CDCl3, 400 MHz): δ = 7.49 – 7.34 (m, 5H), 2.02 (s, 3H) ppm 
13C NMR (CDCl3, 176 MHz): δ = 155.9 (t, J = 35.8 Hz), 131.8 (s), 130.3 (s), 129.1 (s), 128.2 (s), 
125.2 (t, J = 291.9 Hz), 116.4 (t, J = 300.8 Hz), 12.4 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -48.88, -64.18 ppm 
IR (neat): 2362, 1751, 1696, 1669, 1490, 1277, 1102 cm-1 





The reaction was performed using 1-phenyl-1-butyne (0.11 mL, 0.8 mmol, 
1 equiv). The title compound was furnished as a clear oil (140 mg, 89%). 
19F NMR yield = 95%. 
1H NMR (CDCl3, 400 MHz): δ = 7.51 – 7.36 (m, 5H), 2.40 (q, J = 7.15 Hz, 2H), 1.24 (td, J = 7.5, 
3.5 Hz, 1H) ppm 
13C NMR (CDCl3, 176 MHz): δ =156.2 (t, J = 35.6 Hz), 131.9 (s), 130.2 (s), 129.2 (s), 128.1 (s), 
125.4 (t, J = 292.6 Hz), 116.3 (t, J = 300.8 Hz), 20.9 (s), 13.0 (s) ppm 
19F NMR (CDCl3, 377 MHz): δ = -47.69, -64.38 ppm 
IR (neat): 2980, 1795, 1491, 1286, 1172, 1105, 958, 829 cm-1 





The substrates listed below failed to provide gem-difluoroenone products in sufficient quantities 




Preparation and Data for β-keto esters 
 
General Procedure 2 was followed then after 16 h, the reaction was diluted with R1OH (1 mL) 
and triethylamine (0.12 mL, 1 equiv) then the whole was let stir for 1 h.  The mixture was filtered 
through a silica plug and concentrated under reduced pressure. The crude was purified via flash 
column chromatography using a 0 to 5% ethyl acetate in hexanes elution gradient.  
methyl 2-methyl-3-oxo-3-phenylpropanoate (2.4c) 
General Procedure 2 was followed using 1-phenyl-1-propyne (93 mg, 
0.8 mmol, 1 equiv) then the reaction was quenched with 1 mL of 
methanol. The title compound was isolated as a clear oil (65 mg, 42%).  
The 1H NMR data and HRMS is identical to that reported in the literature.  
1H NMR (CDCl3, 400 MHz): δ 7.98 (d, J = 7.3 Hz, 2H), 7.59 (t, J = 7.4 Hz, 1H), 7.48 (t, J = 7.7 
Hz, 2H), 4.41 (q, J = 7.1 Hz, 1H), 3.69 (s, 3H), 1.50 (d, J = 7.1 Hz, 3H) ppm 
HRMS (EI+) m/z calculated for C11H12O3 (M+) 192.0786, found 192.0795.  
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methyl 2-benzoylbutanoate (2.4d) 
General Procedure 2 was followed using 1-phenyl-1-ethyne (104 mg, 
0.8 mmol, 1 equiv) then the reaction was quenched with 1 mL of 
methanol. The title compound was isolated as a clear oil (60 mg, 36%).  
The 1H-NMR data and HRMS is identical to that reported in the literature. 
1H NMR (CDCl3, 400 MHz): δ 7.99 (d, J = 7.4 Hz, 2H), 7.59 (t, J = 7.5 Hz, 1H), 7.48 (t, J = 7.7 
Hz, 2H), 4.25 (t, J = 7.2 Hz, 1H), 3.69 (s, 3H), 2.05 (pd,  J = 7.29, 2.04 Hz, 2H), 0.99 (t, J = 7.4 
Hz, 3H) ppm 
HRMS (EI+) m/z calculated for C12H14O3 (M+) 207.1016, found 207.1016.  
  
 103 
ethyl 2-benzoylbutanoate (2.4e) 
General Procedure 2 was followed using 1-phenyl-1-ethyne (104 mg, 0.8 
mmol, 1 equiv) then the reaction was quenched with 1 mL of ethanol. The 
title compound was isolated as a clear oil (34 mg, 20%).  
The 1H-NMR data and HRMS is identical to that reported in the literature. 
1H NMR (CDCl3, 400 MHz): δ 7.99 (dd, J = 5.3, 3.2 Hz, 2H), 7.58 (t, J = 7.3 Hz, 1H), 7.48 (t, J 
= 7.7 Hz, 2H), 4.21 (t, J = 7.2 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 2.04 (p, J = 7.31 Hz, 2H), 1.17 (t, 
J = 7.1 Hz, 3H), 1.00 (t, J = 7.4 Hz, 3H) ppm 
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Arylsulfonylacetamides as Bifunctional Reagents for Alkene 
Aminoarylation 
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3.1. Introduction 
 
3.1.1. Significance of Alkene Difunctionalization Reactions and 
Arylethylamine Scaffolds 
  
Alkenes are fundamental building blocks in organic chemistry and are essential in natural 
product synthesis, pharmaceutical development, and material sciences. Alkene difunctionalization 
reactions offer unique advantages by allowing for the formation of two chemical bonds in a single 
operation, potentially simplifying synthetic plans and leading directly to biologically desirable 
pharmacaphores (Figure 3.1A). Pharmaceutical synthesis often requires the formation of adjacent 
carbon-carbon and carbon-nitrogen bonds and thus methods to forge these new bonds in a single 
operation are particularly desirable.  
Alkene aminoarylation (a subclass of alkene difunctionalization reactions) allows direct 
access to the biologically active arylethylamine pharmacaphore. The arylethylamine motif is 
conserved in dopamine, serotonin, and many opioid receptor drugs responsible for modulating 
pain sensation and treating neurobehavioral disorders (Figure 3.1B).1-2 In light of the opioid 
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epidemic, it is also noteworthy that frontline medications treating opioid addiction also contain 
such arylethylamine substructures (Figure 3.1C).3-4 With this rationale, continued drug 
development in the arylethylamine chemical space is necessary for general hit-to-lead exploration 
and the discovery of new and safer pain-management medicines. Conventional methods to 
synthesize arylethylamines use multistep homologation and reductive amination sequences 
(Figure 3.1D). Alternatively, alkene aminoarylation, particularly of anethole and other biomass-
derived alkenes, allows for direct access to this medicinally desirable functionality. The 
development of methodologies to rapidly construct two new bonds (C–C and C–N) in a single 
operation from feedstock chemicals can improve and expedite the discovery of new 
arylethylamine-based small-molecule therapeutics. 
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Figure 3.1. The importance of alkene difunctionalization reactions and the arylethylamine 
pharmacaphore.  
(A) A general representation of alkene difunctionalization reactions. (B) The importance of the 
arylethylamine motifs in medicines. (C) The arylethylamine motif at the center of the opioid 
epidemic. (D) Conventional methods to synthesize arylethylamines.  
 
3.1.2. Transition-Metal Catalyzed Aminoarylation Reactions 
 
Alkene aminoarylation has been demonstrated with palladium,5-6 copper,7-9 nickel,10-11 and 
gold,12 in which alkenes are activated by the transition metal to facilitate a stereoselective amine 
cyclization, followed by a two-electron metal-mediated arylation event (Figure 3.2). The metals 
used in these aminoarylation platforms control stereoselectivity and activate the alkene for 
reactivity while suppressing protodemetallation or β-hydride elimination pathways that hinder 
desired C–C bond formation. Amides and amines are more nucleophilic than the alkene coupling 
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partner; thus, elevated temperatures are often necessary to facilitate ligand substitution to unite the 
reactants in the initial amination event.13 Despite robust investigation, these methods are generally 
limited by the need for directing groups and intramolecular reaction designs that restrict the 
products to pyrrolidine and piperidine products.  
 
Figure 3.2. General representation of transition-metal mediated alkene aminoarylation 
reactions.  
 
Recently, transformations effecting intermolecular aminoarylation and carboamination 
have been accomplished in which the alkene is decoupled from the arylation and amination 
reagents. In one case, Lin and Liu demonstrated an enantioselective copper(I)-catalyzed 
aminoarylation of vinyl arenes relying upon preoxidized sulfonamide reactants (N-fluoro-N-
methylbenzenesulfonamide) as both the copper oxidant and nitrogen nucleophile (Figure 3.3).8 
Only vinyl arenes are presented in their substrate scope, potentially suggesting the allylic 
functionality is not compatible with the developed conditions. 
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Figure 3.3. Enantioselective copper-catalyzed alkene aminoarylation reaction.  
Separately, Rovis and Piou demonstrated an intermolecular carboamination using N-
enoxyphthalimides and Rh(I-III) catalysis in a diastereoselective fashion (Figure 3.4).14 This 
approach allows for both nitrogen and carbon containing functionalities to be delivered from the 
same, easily prepared reagent. While this approach allows for the incorporation of a wide array of 
arenes, it is limited to fumarate and maleate esters as the reactive alkene component. 
 
Figure 3.4. Intermolecular carboamination reaction using a bifunctional reagent. 
3.1.3. Visible Light-Mediated Carboamination Reactions 
 
Photocatalysis and radical-based chemistry have proven similarly influential in alkene 
difunctionalization. The simplest strategy is Meerwein aminoarylation, a Markovnikov-selective 
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reaction that begins with the reductive generation of a radical from a suitable precursor (arene 
diazonium salt or diaryliodonium salt) followed by radical-polar crossover and Ritter trapping with 
acetonitrile solvent and hydrolysis (Figure 3.5).15 These reactions are regioselective but are devoid 
of stereoselectivity. 
 
Figure 3.5. Markovnikov-selective Meerwein aminoarylation enabled by phoptoredeox 
catalysis. 
 
Photocatalytic anti-Markovnikov–selective alkene hydro- and carboamination reactions 
were recently demonstrated by Knowles16-20 and Nicewicz.21-23 These approaches represent 
contrasting C–N bond formation strategies while using a common catalytic cycle (see also Chapter 
1). Knowles and co-workers have demonstrated both aminium radical cation (Figure 3.6A) and 
amidyl radical (Figure 3.6B) generation for the addition to olefins. In both cases, nitrogen-
centered radicals couple with π-systems to generate β-amino radicals that are rapidly trapped with 
an H-atom transfer reagent or an appropriate acceptor for a C−C bond forming event. Successful 
H-atom transfer reagents are minimally nucleophilic to prevent thiol-ene reactivity. Nitrogen 
radical–based chemistry is particularly challenging because both alkene addition and allylic H-
atom abstraction are kinetically competitive processes;24 thus, success often requires excesses of 
the alkene component or intramolecular amino-cyclization. Importantly, this proton-coupled 
electron transfer strategy allows for native functionalities (N−H bonds of amines and amides) to 
become directly activated without the need for N-pre-functionalization (such as N-chloroamines 
 118 
or elaborate fragmentable redox-auxiliaries). This system operates with a highly oxidizing 
photocatalyst in combination with a weak base to initiate a homolytic N−H bond fragmentation. 
The resultant N-centered radicals then chemoselectively react with alkenes in both intra- and 
intermolecular fashions. It should be noted that amine and amide oxidation generate a more 
reactive, but not a more nucleophilic, nitrogen atom. 
 
Figure 3.6. Activation of native N−H bonds (amines and amides) for hydro- and 
carboamination of alkenes.  
(A) Amine activation to aminium radical cation for alkene hydroamination. (B) PCET activation 
of aryl amides for alkene carboamination.  
 
In contrast to the developed PCET activation of nitrogenous nucleophiles for hydro- and 
carboamination methods, Nicewicz and co-workers have targeted alkene single-electron oxidation, 
a process approximately as rapid as amide or amine oxidation. This approach benefits from 
converting the alkene to a more electrophilic species in solution, necessitating lower equivalents 
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of the nitrogen nucleophile to conduct alkene difunctionalization. Mechanistically, these reactions 
operate via oxidation of the aliphatic olefin with a potent photoexcited acridinium catalyst (Figure 
3.7A). The resultant radical cation is poised for nucleophilic trapping from either a nitrogen or 
oxygen-based nucleophile. The resultant carbon-centered radical can be trapped by a suitable H-
atom transfer agent (Figure 3.7B) or a radical acceptor reagent (Figure 3.7C) for C−C bond 
formation. 
 
Figure 3.7. Alkene oxidation for hydro- and carboamination of alkenes.  
(A) Potent acridinium photocatalysts from the excited state. (B) Alkene oxidation for alkene 
hydroamination. (C) Alkene oxidation for alkene carboamination. 
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3.1.4. Photochemical Smiles Rearrangements – The Potential for 
Alkene Aminoarylation 
 
To contrast the widely investigated field of transition metal–mediated aminoarylation and 
build on the successes of photocatalytic alkene difunctionalization chemistry, we were inspired by 
the possibility of a radical Smiles rearrangement to provide alkene aminoarylation products in a 
diastereoselective fashion. The classic Smiles rearrangement is an intramolecular nucleophilic 
aromatic substitution reaction that interchanges one biaryl-heteroatom linker for another (Figure 
3.8A). This process is largely controlled by the relative acidities of the two interchangeable 
heteroatomic nucleophiles. Traditionally, the Truce variant of the Smiles rearrangement is a 
nucleophilic aromatic substitution effected by benzylic lithiation of o-tolyl-arylsulfones (Figure 
3.8B).25 The rearrangement is more broadly applicable to ipso-substitution reactions with aryl 
sulfides, sulfoxides, sulfones, and amides. Pennell and Motherwell furthered the utility of this 
transformation by demonstrating that aryl radicals are also capable of the same arene transposition 




Figure 3.8. Classic aryl transfer strategies. 
(A) The classic anionic Smiles rearrangement. (B) The Truce modification of the Smiles 
rearrangement extending the reaction to C-nucleophiles. (C) The Motherwell and Pennel 
modification of the Smiles rearrangement extending to C-centered radicals.  
 
In the past, our group, in collaboration with Eli Lilly developed a method toward preparing 
gem-difluorobenzyl motifs via a radical Smiles-Truce rearrangement.27-28 Prior to this 
collaboration, Lilly had been using a non-sustainable sequence to produce a thiophene-based 
intermediate (Figure 3.9A) that required excess of AIBN, Deoxo-Fluor, and several 
chromatographic purifications. Our solution instead allowed for the simple coupling of the 
corresponding sulfonyl chloride and a readily-available alcohol (one step from commercial) 
followed by single-electron reduction to initiate a radical Smiles-Truce rearrangement sequence, 
generating the difluorinated alcohol substrate after loss of SO2 (Figure 3.9B). Multiple 
(hetero)aryl substrates were amenable to this chemistry (Figure 3.9C), with the energy of 
dearomatization during the ipso attack providing the major enthalpic barrier (elevated temperatures 
generally recovered any loss in efficiency due to this factor).  
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Figure 3.9. Employing a photochemical Smiles rearrangement for the synthesis of gem-
difluoroaryl ethanol motifs.  
(A) The inspiration for the developed photochemical Smiles rearrangement. (B) The design 
strategy and proposed key intermediate for the photochemical Smiles rearrangement. (C) Select 
substrate scope for the developed method.  
 
Although there are numerous intramolecular examples of radical Smiles-Truce reactions,27, 
29-32 many of these reactions use net reductive conditions, generate a stoichiometric amount of 
waste, and rely on a substrate design that tethers the radical precursor to the aryl-sulfonate 
derivative. Realizing that this intramolecular tether can be formed via in situ oxidation of an alkene 
and subsequent nucleophilic trapping with an arylsulfonylacetamide,33 we sought to design a 
photocatalyzed radical Smiles-Truce reaction that showcases the utility of arylsulfonylacetamides 




Figure 3.10. General design strategy for the reported alkene aminoarylation employing 
arylsulfonylacetamides as bifunctional reagents.   
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3.2. Results and Discussion 
 
A general catalytic cycle was postulated to begin with an oxidation event between a 
photoexcited catalyst (*IrIII) and an alkene (I) (Figure 3.11A).22-23 Single-electron oxidation of 
the alkene would enable nucleophilic addition of an arylsulfonylacetamide (II) to afford the desired 
β-aminoalkyl radical intermediate (III).34-36 This radical is poised for regioselective cyclization 
onto the ipso-position of the appended arene to generate IV.37 Lastly, an entropically favored 
desulfonylation can proceed via two plausible pathways to generate the aminoarylation product, 
VII: (i) rapid radical desulfonylation from IV to generate nitrogen-centered radical V followed by 
catalyst turnover, or (ii) homolytic fragmentation of the CAr–S bond to furnish VI, which can turn 
over the catalyst and undergo desulfonylation to VII. Exploiting both the electronic activation of 
the sulfonylated arene unit and the tunable nucleophilicity of the nitrogen motif allows for this 





Figure 3.11. Proposed reaction design for aminoarylation with arylsulfonylacetamides. 
(A) Proposed reaction mechanism. (B) Initial reaction discovery.  
 
To realize the proposed aminoarylation reactivity, we first conducted reaction optimization 
with vinyl anisole (3.1) [Ep/2 = 1.6 V versus saturated calomel electrode (SCE)]38 and 1- 
naphthylsulfonylacetamide (3.2). A potent photooxidant, [Ir(dF(CF3ppy)2)(5,5′-CF3-bpy)]PF6 
(3.3) (IrIII*/II = 1.68 V versus SCE in MeCN)39 was initially selected for alkene radical cation 
formation (Figure 3.11B). Early optimization experiments lent evidence to the chemoselectivity 
of this reaction; excess loading of arylsulfonylacetamide and base were unnecessary. Nearly 
equivalent stoichiometry between 3.1 and 3.2 afforded the highest yield for the optimization 
product 3.4. A base screen revealed potassium acetate, benzoate, and tribasic phosphate as superior 
bases to the less basic potassium trifluoroacetate and potassium phosphate (mono- or dibasic). The 
reaction was incompatible with pyridine or with stronger alkoxide bases, as photocatalyst 
decomposition was observed. Reaction dilution past 0.1 M slowed the rate of product formation, 
whereas reaction concentrations greater than 0.1 M inhibited product formation. Further 
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optimization proved that less oxidizing photocatalysts such as [Ru(bpy)3]Cl2 (RuII*/I = 0.77 V 
versus SCE in MeCN), [Ir(dF(CF3ppy)2)(dtbbpy)] PF6 (IrIII*/II = 0.89 V versus SCE in MeCN), 
[Ir(ppy)2(dtbbpy)]PF6 (IrIII*/II = 0.31 V versus SCE in MeCN),40 were unable to catalyze this 
transformation. Use of Fukuzumi’s catalyst (PC*/PC• = 1.88 V versus SCE in MeCN)41 did 
produce 3.4 in 13% yield. Finally, H-atom donor additives such as 1,4-cyclohexadiene and 
isopropanol did not improve on the established conditions for the optimization product 3.4. 
Exclusion of either light or photocatalyst failed to promote aminoarylation. With the proof of 
concept established, we identified the acyl group, among a range of amides and carbamates, as the 
optimal activating group for the sulfonamide reagent in this transformation (Figure 3.12A, 3.4–
3.7). We reasoned that the acidity and the steric encumbrance of the sulfonamide activating group 
control the nucleophilicity of the arylsulfonylacetamide. 
A substantial increase in aminoarylation was observed when using 1,2-disubstituted p-
methoxyphenyl alkenes in comparison to 3.1 (Figure 3.12A). This substitution allowed us to 
realize the aryl transfer of several groups including 1-naphthyl (3.4–3.6, 3.8–3.10, 3.21, 3.22), 2-
napthyl (3.11), 3-thiophenyl (3.12, 3.13), 2-thiophenyl (3.14, 3.15, 3.18), 2-furanyl (3.16), 8-
quinolino (3.17), 2-benzothiazole (3.19), and β-styrene (3.20) all in greater than 20:1 
diastereoselectivity. X-ray crystallographic analysis of 3.15 was found to show a syn-configuration 
between the 5-bromothiophene and the acetamide groups supporting the stereochemical 
assignment. Use of cyclic (E)-alkenes allowed for the synthesis of cyclic arylethylamines (3.23–
3.26) containing two contiguous stereocenters, one of which is quaternary (Figure 3.12B). 
Furthermore, the cis-diastereomer 3.27 can be formed when a cyclic (Z)-alkene is used as the 
oxidizable alkene substrate partner (Figure 3.13C). Preparation of arylethylamine 3.21 containing 
an N-tosyl amide showcases the chemoselective nature of this aminoarylation, and the successful 
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isolation of 3.22 suggests that nucleophiles tethered to the alkene are well tolerated under the 
reaction conditions.  
 
Figure 3.12. Exploration of substrate scope.  
All yields are isolated yields. Relative configurations of products were assigned by analogy to 3.15 
and 3.23. (A) Evaluation of scope of aryl group. (B) Scope of cyclic trans-PMP alkenes. (C) Scope 
of a compatible cyclic cis-PMP alkene. *2:1 mixture of E/Z alkene diastereomers. 
 
To provide mechanistic insight, we carried out several studies to understand the efficiency 
and high diastereoselectivity of this transformation. We hypothesized that both acyclic (Z)- and 
(E)-alkenes would convert to the same trans-aminoarylation diastereomer as a result of bond 
rotation outcompeting cyclization of intermediate III. Notably, performing the title aminoarylation 
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with (Z)-anethole afforded a nearly identical yield of 3.9 (72%), in comparison to (E)-anethole 
(82%), whereas diastereomer 3.9′ was not observed (Figure 3.13A). Reaction progress analysis 
by 1H-nuclear magnetic resonance spectroscopy of (Z)-anethole aminoarylation revealed that (E)-
anethole is generated during the reaction (Figure 3.13B). On the basis of this observation, we 
examined the rates of isomerization for each anethole isomer to the photostationary state (Figure 
3.13C). This revealed a photostationary state of 1.4:1 (Z:E), with the initial rate of (Z)-anethole 
isomerization being much faster than (E)-anethole isomerization.42 Furthermore, initial rate 
analysis of aminoarylation shows alkene consumption to be slower than (Z)-anethole 
isomerization. These data suggest that the diastereoselectivity arises from either (i) a kinetically 
favored generation of (E)-anethole radical cation and subsequent aminoarylation, or (ii) a 
thermodynamic preference of radical intermediate III to adopt an anti-periplanar conformation 
between the paramethoxyphenyl (PMP) and methyl substituents prior to cyclization (Figure 
3.13D). One other competing possibility is that the (E)-anethole radical cation reacts with 3.2 faster 
than does the (Z)-anethole radical cation. Overall, these mechanistic details describe how the 
combination of a Smiles-Truce aryl transfer and radical cation chemistry can be combined into a 
highly diastereoconvergent alkene aminoarylation reaction platform. 
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Figure 3.13. Experiments to probe reaction mechanism. 
(A) Aminoarylation with (Z)-anethole (3.28). (B) Tracking reaction progress for aminoarylation 
with (Z)-anethole (3.28) (▲ = 2, ■ = (Z)-anethole, ♦ = 3.9, ■ = (E)-anethole). (C) Determination 
of the photostationary state for anethole isomers catalyzed by 3.3. (D) Favored and disfavored 




In conclusion, given the current availability of sulfonamide building blocks along with the 
ubiquity of alkenes as feedstock substrates, we view the method to be a highly enabling platform 
for research efforts synthesizing the arylethylamine pharmacophore diastereoselectively in a single 
operation. We believe that because this process is driven by visible light and uses readily available 
chemical reagents it is well suited to immediately impact a variety of chemical disciplines, 
including simplifying the synthesis of drug-like molecules we encounter in our everyday lives. 
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3.4. Experimental Procedures and Characterization of Compounds 
 




All chemicals were used as received and stored as recommended by the supplier. Reactions 
were monitored by thin layer chromatography (TLC) using glass-backed plates pre-coated with 
230–400 mesh silica gel (250 mm thickness) with fluorescent indicator F254, available from EMD 
Millipore (cat. #: 1.05715.0001). Plates were visualized with a dual short wave/long wave UV 
lamp. Column flash chromatography was performed using 230-400 mesh silica (SiliCycle cat. #: 
R12030B) gel or via automated column chromatography. NMR spectra were recorded on Varian 
MR400, Varian Inova 500, Varian Vnmrs 500, or Varian Vnmrs 700 spectrometers. Chemical 
shifts for 1H NMR were reported as δ, parts per million, relative to the signal of CHCl3 at 7.26 
ppm and for DMSO 2.50. Chemical shifts for 13C NMR were reported as δ, parts per million, 
relative to the center line signal of the CDCl3 triplet at 77.0 ppm and for DMSO 39.52 for center 
of septet. 19F NMR chemical shifts were reported as δ, parts per million, relative to CFCl3 at 0.0 
ppm. The abbreviations s, br. s, d, dd, br. d, ddd, t, q, br. q, qi, m, and br. m stand for the resonance 
multiplicity singlet, broad singlet, doublet, doublet of doublets, broad doublet, doublet of doublet 
of doublets, triplet, quartet, broad quartet, quintet, multiplet and broad multiplet, respectively. IR 
spectra were recorded on a Perkin-Elmer Spectrum BX FT-IR spectrometer fitted with an ATR 
accessory. Melting points were obtained using a Mel-Temp 3.0 (model no. 1401). Mass Spectra 
were recorded at the Mass Spectrometry Facility at the Department of Chemistry of the University 
of Michigan in Ann Arbor, MI on an Agilent Q-TOF HPCL-MS with ESI high resolution mass 
spectrometer using electrospray ionization (ESI), positive ion mode, or electron impact ionization 
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(EI). Fluorescence quenching was recorded using a Horiba Scientific Fluoromax 2 using DataMax 
software. We thank Dr. James Windak and Dr. Paul Lennon at the University of Michigan 
Department of Chemistry instrumentation facility for conducting these experiments. X-Ray 
Crystallography work was done by Dr. Jeff. W. Kampf. UV-Vis measurements were obtained on 
a Shimadzu UV-1601 UV-Vis Spectrometer. Electrochemical data was collected on a CHI600E 
potentiostat with the accompanying CH Instruments software. H150 Blue grow lights from Kessil 
were used as the visible light irradiation source.  
General Reaction Set-up 
 
Unless stated otherwise, all reactions were run on a 0.3 mmol scale in a 2-dram vial 
equipped with an oval shaped stir bar. 1 x H150 Blue Kessil lamp sufficiently irradiated 1-3 
reaction vials at one time, about 5 cm away (A, side view). At this distance, with a fan dissipating 
the standing atmosphere (B, top view), the air temperature surrounding the reactions did not exceed 
25 ˚C. 
  
General reaction set-up for radical aminoarylation 
 
  
A  B  
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General Procedure A: Radical Aminoarylation of Alkenes (0.3 mmol scale) 
 
Unless otherwise noted, to a flame dried 2-dram vial, equipped with a teflon coated oval 
shaped stir bar, was added (aryl-sulfonyl)acetamide (1 equiv, 0.3 mmol), potassium benzoate (14.4 
mg, 30 mol%), and Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (3 mg, 1 mol%). The vial contents were 
then dissolved in anhydrous DMF (3 mL, 0.1 M). Finally, the alkene (1.2 equiv) was added to the 
reaction vial. The reaction was sparged under argon for 15 min, quickly capped and sealed with 
parafilm. Reactions were irradiated with 1 x blue H150 Kessil LED light and stirred (500 to 550 
rpm) for 12 to 16 h at room temperature.  
Reaction workup was performed by diluting the reaction with 15 mL dH2O and extracting 
the aqueous layer with EtOAc (3 x 10 mL). The organic layers were combined, washed with 5 
wt% LiCl (3 x 10 mL), brine (15 mL), dried over sodium sulfate, filtered and concentrated to 
provide the crude residue, which was purified by flash column chromatography.  
Step-by-step Reaction Set-up Pictures 
  
Step 1: Flame dried 2-dram vial 
and stir bar 




Step 3: Solid reagents diluted in DMF (0.1 
M) 
Step 4: Sparge degassing technique with argon 






Step 5: Vial-cap juncture wrapped in 
parafilm immediately after argon sparging 
Step 6: Blue light irradiation with 1 x H150 








Reaction Optimization Studies 
 
Entry B equiv Base Base equiv. Catalyst Solvent [M] C (% yield) 
1 3 KOAc 3 None DMF [0.1] M 0 
2 3 KOAc 3 [Ir-1] (no light) DMF [0.1] M 0 
3 3 KOAc 3 [Ir-1] DMF [0.1 M] 46 
4 3 NaOAc 3 [Ir-1] DMF [0.1 M] 42 
5 3 K2HPO4 3 [Ir-1] DMF [0.1 M] 23 
6 3 K2CO3 3 [Ir-1] DMF [0.1 M] 11 
7 3 K3PO4 3 [Ir-1] DMF [0.1 M] 41 
8 3 Pyridine 3 [Ir-1] DMF [0.1 M] 9 
9 1 KOAc 0.3 [Ir-1] DMF [0.1 M] 32 
10 1 PhCO2K 0.3 [Ir-1] DMF [0.1 M] 41 
11 1 CF3CO2K 0.3 [Ir-1] DMF [0.1 M] 10 
12 1 K3PO4 0.3 [Ir-1] DMF [0.1 M] 30 
13 1 Pyridine 0.3 [Ir-1] DMF [0.1 M] 0 
14 1 PhCO2K 0.3 [Ir-1] DMF [0.2 M] 7 
15 1 PhCO2K 0.3 [Ir-1] DMF [0.4 M] <5 
16 1 K3PO4 0.3 [Ir-1] DMSO [0.1 M] 10 
17 1 K3PO4 0.3 [Ir-1] MeCN [0.1 M] 11 
18 1 K3PO4 0.3 [Ir-1] THF [0.1 M] 0 
19 1 PhCO2K 0.3 [Ir-1] 
THF:DMF 
[0.1 M] 30 
20 1 K3PO4 0.3 [Ir]-2 DMF [0.1 M] 0 
21 1 K3PO4 0.3 [Ir]-2 DMF [0.1 M] 0 
22 1 K3PO4 0.3 [Ru]-1 DMF [0.1 M] 0 
23 1 K3PO4 0.3 [Ru]-2 DMF [0.1 M] 0 
24 1 Pyridine 0.3 AcrMe DMF [0.1 M] 13 
25 1 K3PO4 + iPrOH 0.3 + 10 [Ir-1] DMF [0.1 M] 34 
26 1 DABCO 0.3 [Ir-1] DMF [0.1 M] <10 
27 1 Et3N 0.3 [Ir-1] DMF [0.1 M] <10 
28 1 PhMe2SiH 1 [Ir-1] DMF [0.1 M] <10 
29 1 (EtO)3SiH 1 [Ir-1] DMF [0.1 M] <10 
30 1 1,4-CHD 0.6 [Ir-1] DMF [0.1 M] 30 
 




Photocatalyst Redox Potentials 
 
Photocatalyst Reference M+/M* M*/M– M+/M M/M– 
[Ir]-1 38 +1.68 V –0.43 V +1.94 V –0.69 V 
[Ir]-2 43 –1.21 V +0.89 V +1.69 V –1.37 V 
[Ir]-3 39 –1.73 V +0.31 V +0.77 V –2.19 V 
Acr-Me+ClO4– 41 -- +1.88 V -- –0.49 V 
[Ru]-1 39 –0.81 V +0.77 V +1.29 V –1.33 V 
[Ru]-2 39 –0.26 V +1.45 V +1.86 V –0.80 V 
Electrochemical potentials reported vs. SCE reference electrode in MeCN Solvent. 
 















Unreactive Substrates in the Aminoarylation Reaction38 
 
 




3.4.2. Reaction Profiling and Mechanism Elucidation Experiments 
 
Stern-Volmer Luminescent Quenching Experiment 
Fluorescence quenching of [Ir]-1 was recorded with a Horiba Scientific Fluoromax 2 using 
DataMax software. Samples consisting of the noted concentrations were prepared and degassed 
by sparging with argon for 3 minutes prior to each measurement. The solutions were irradiated at 
420 nm and luminescence was measured at 593 nm. I0/I values were generated from the average 
of three scans taken per quencher concentration. The quenching studies were repeated three times. 
Potassium benzoate was not sufficiently soluble in DMF in order to run this analysis. 
Conclusion: This quenching study supports the hypothesis of alkene activation over sulfonamide 
activation as the sulfonamide is not shown to quench the photocatalyst. 
Constant [Ir]-1, variable E-anethole 
 
Run # [Q] (mM) scan 1 scan 2 scan 3 average I0/I 
1 0 1279652 1279595 1277671 1278973 1  
0.5 1239028 1240121 1237808 1238986 1.032274  
1 1198883 1201995 1197508 1199462 1.066289  
2 1139567 1136768 1134669 1137001 1.124865  
4 966005 967975 966423 966801 1.322891  
5 915329 913206 913369 913968 1.399363 
2 0 1338796 1335993 1333927 1336239 1  
0.5 1299050 1296895 1293265 1296403 1.030728  
1 1189198 1187756 1186116 1187690 1.125074  
2 1112948 1111220 1111004 1111724 1.201952  
4 1035308 1033016 1030568 1032964 1.293597  
5 941187 939153 936440 938926.7 1.423156 
3 0 1323583 1322346 1318529 1321486 1  
0.5 1297235 1296530 1291170 1294978 1.02047  
1 1235964 1233167 1231129 1233420 1.0714  
2 1150680 1148221 1146468 1148456 1.150663  
4 1026073 1023204 1019673 1022983 1.291796  
5 936491 932451 930715 933219 1.416051 
 138 
 
Constant [Ir]-1, variable Z-anethole 
 
Run # [Q] (mM) scan 1 scan 2 scan 3 average I0/I 
1 0 1563299 1568831 1563814 1565315 1  
0.0005 1506480 1502415 1505346 1504747 1.040251  
0.001 1612968 1610825 1609429 1611074 0.971597  
0.002 1277113 1278729 1279468 1278437 1.224398  
0.004 1293512 1292485 1291087 1292361 1.211205  
0.008 1132608 1130304 1125737 1129550 1.385786 
2 0 1500716 1503267 1498616 1500866 1  
0.0005 1460206 1460267 1459212 1459895 1.028065  
0.001 1353200 1352411 1350893 1352168 1.10997  
0.002 1362804 1362675 1361090 1362190 1.101804  
0.004 1296812 1295625 1290413 1294283 1.159612  
0.008 1090574 1083777 1082080 1085477 1.382679 
3 0 1452602 1453180 1450419 1452067 1  
0.0005 1513751 1509306 1513027 1512028 0.960344  
0.001 1435001 1433724 1429664 1432796 1.01345  
0.002 1361539 1356950 1352472 1356987 1.070067  
0.004 1218421 1214864 1212004 1215096 1.195022  
0.008 1110932 1102370 1099683 1104328 1.314887 
 
 



















Constant [Ir]-1, variable sulfonylacetamide 
 
Run # [Q] (mM) scan 1 scan 2 scan 3 average  I0/I 
1 0 1379545 1379215 1379257 1379339 1  
0.5 1407231 1408755 1404343 1406776 0.980496  
1 1421023 1419515 1420010 1420183 0.971241  
2 1241674 1242138 1238751 1240854 1.111604  
4 1369068 1368141 1369533 1368914 1.007616  
8 1345129 1344560 1346924 1345538 1.025121 
2 0 1315329 1314718 1314642 1314896 1  
0.5 1365594 1362761 1365947 1364767 0.963458  
1 1358677 1357730 1356903 1357770 0.968423  
2 1311015 1312800 1314739 1312851 1.001558  
4 1358471 1359711 1361332 1359838 0.966951  
8 1368996 1366131 1365807 1366978 0.9619 
3 0 1285963 1286332 1284033 1285443 1  
0.5 1426932 1427614 1425122 1426556 0.901081  
1 123400 1423014 1422116 989510 1.29907  
2 1349385 1348451 1345525 1347787 0.953743  
4 1370793 1367963 1372327 1370361 0.938032  
5 1363714 1366155 1361547 1363805 0.942541 
 





































Reaction Profile and Initial Rates for Aminoaryation with vinyl-Anisole 
To a flame dried 2-dram vial, equipped with a teflon coated oval shaped stir bar, was added 
vinyl-anisole (20.1 mg, 0.15 mmol), N-(1-naphthylsulfonyl)acetamide (37.4 mg, 0.15 mmol), 
potassium benzoate (7.21 mg, 30 mol%), and Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (1.5 mg, 1 
mol%). The vial contents were then dissolved in anhydrous d7-DMF (1.5 mL, 0.1 M) followed by 
addition of trimethyl(phenyl)silane (8.52 μL, 0.05 mmol) as an internal standrad. The reaction was 
sparged under argon for 15 min before the 1.5 mL solution volume was equally seperated between 
3 argon sparged NMR tubes (0.5 mL each). The tubes were quickly capped and sealed with 
parafilm. Time zero (t0) 1H-NMR measurements were taken of all three samples prior to 
irradiation. Then, the 3 NMR tubes were irradiated with 1 x blue H150 Kessil LED light (~2 cm) 
and cooled by one overhead fan. After the alloted time (i.e. 5, 10, 15, 20... min), the light was 
turned off and reaction solution analyzed by 1H-NMR. 
Analysis: The concentrations and yields for the aminoarylation substrates and product were 
plotted against time in minutes. The slope through five points for the first ~20% reaction 
conversion was utilized to calculate the initial rates of reaction. The procedure was repeated in 
triplicate (3 1H-NMR measurements) and the average of these three trials was determined. 
Calculated values are tabulated below. 
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Aminoarylation Reaction Profile with vinyl-anisole 
([M] vs. time) 
  







0 0.0000 0.12633 0.10133 
5 0.0020 0.12433 0.09967 
10 0.0027 0.12267 0.09933 
15 0.0030 0.12133 0.09867 
30 0.0087 0.11733 0.09433 
45 0.0144 0.10567 0.08467 
60 0.0214 0.09767 0.07800 
90 0.0328 0.08833 0.06567 
180 0.0455 0.02500 0.05233 
240 0.0488 0.01733 0.04933 
300 0.0501 0.01200 0.04667 
360 0.0495 0.00500 0.04700 
 
Plotted Aminoarylation Reaction Profile with vinyl-anisole  
 





























Plotted Aminoarylation Reaction Profile with vinyl-anisole  























Alkene continues to 
be consumed 
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Plotted Initial Rates for Aminoarylation with vinyl-anisole  















([M] • min-1) 0.0003 -0.0003 -0.0002 
R2 0.9563 0.9920 0.9666 
 
  
y = 0.0003x - 3E-05
R² = 0.9563
y = -0.0003x + 0.1259
R² = 0.992


























Reaction Profile and Initial Rates for Aminoaryation with trans-Anethole 
 
To a flame dried 2-dram vial, equipped with a teflon coated oval shaped stir bar, was added 
trans-anethole (54 μL, 0.36 mmol), N-(1-naphthylsulfonyl)acetamide (75 mg, 0.3 mmol), 
potassium benzoate (14.4 mg, 30 mol%), and Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (3 mg, 1 mol%). 
The vial contents were then dissolved in anhydrous DMF (3 mL, 0.1 M) followed by addition of 
trimethyl(phenyl)silane (17 μL, 0.1 mmol) as an internal standrad. The reaction was sparged under 
argon for 15 min before the 3 mL solution volume was equally seperated between 3 argon sparged 
NMR tubes (1 mL each). The tubes were quickly capped and sealed with parafilm. Time zero (t0) 
1H-NMR measurements were taken of all three samples prior to irradiation. Then, the 3 NMR 
tubes were irradiated with 1 x blue H150 Kessil LED light (~2 cm) and cooled by one overhead 
fan. After the alloted time (i.e. 5, 10, 15, 20... min), the light was turned off and reaction solution 
analyzed by 1H-NMR. 
Analysis: The concentrations and yields for the aminoarylation substrates and product were 
plotted against time in minutes. The slope through five points for the first ~20% reaction 
conversion was utilized to calculate the initial rates of reaction. The procedure was repeated in 
triplicate (3 1H-NMR measurements) and the average of these three trials was determined. 
Calculated values are tabulated below. 
  
 146 
Aminoarylation Reaction Profile with trans-Anethole  
([M] vs. time) 
  







0 0.0000 0.1170 0.1027 
5 0.0060 0.0990 0.0880 
10 0.0151 0.0950 0.0860 
15 0.0205 0.0827 0.0767 
30 0.0373 0.0607 0.0603 
45 0.0497 0.0510 0.0500 
60 0.0571 0.0413 0.0407 
120 0.0644 0.0240 0.0183 
180 0.0725 0.0240 0.0147 
240 0.0745 0.0167 0.0083 
300 0.0795 0.0100 0.0050 
360 0.0812 0.0050 0.0050 
 
Plotted Aminoarylation Reaction Profile with trans-Anethole  



























Plotted Aminoarylation Reaction Profile with trans-Anethole 




Plotted Initial Rates for Aminoarylation with trans-Anethole  
([M] vs. time) 
 
  








([M] • min-1) 
0.0012 -0.0018 -0.0013 



















y = 0.0012x + 0.0008
R² = 0.9917
y = -0.0018x + 0.1123
R² = 0.9694

























Reaction Profile and Initial Rates for Aminoaryation with cis-Anethole 
 
To a flame dried 2-dram vial, equipped with a teflon coated oval shaped stir bar, was added 
cis-anethole (35.6 mg, 0.24 mmol), N-(1-naphthylsulfonyl)acetamide (49.9 mg, 0.2 mmol), 
potassium benzoate (9.61 mg, 30 mol%), and Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (2 mg, 1 mol%). 
The vial contents were then dissolved in anhydrous d7-DMF (2 mL, 0.1 M) followed by addition 
of trimethyl(phenyl)silane (11.4 μL, 0.066 mmol) as an internal standrad. The reaction was sparged 
under argon for 15 min before the 2 mL solution volume was equally seperated between 3 argon 
sparged NMR tubes (0.67 mL each). The tubes were quickly capped and sealed with parafilm. 
Time zero (t0) 1H-NMR measurements were taken of all three samples prior to irradiation. Then, 
the 3 NMR tubes were irradiated with 1 x blue H150 Kessil LED light (~2 cm) and cooled by one 
overhead fan. After the alloted time (i.e. 5, 10, 15, 20... min), the light was turned off and reaction 
solution analyzed by 1H-NMR. 
Analysis: The concentrations and yields for the aminoarylation substrates and product were 
plotted against time in minutes. The slope through five points for the first ~20% reaction 
conversion was utilized to calculate the initial rates of reaction. The procedure was repeated in 
triplicate (3 1H-NMR measurements) and the average of these three trials was determined. 
Calculated values are tabulated below. 
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Aminoarylation Reaction Profile with cis-Anethole 
([M] vs. time) 
  










0 0.0000 0.0617 0.0743 0.0000 
5 0.0070 0.0527 0.0703 0.0113 
10 0.0123 0.0463 0.0633 0.0170 
15 0.0160 0.0400 0.0590 0.0193 
20 0.0200 0.0360 0.0533 0.0220 
30 0.0260 0.0290 0.0477 0.0240 
45 0.0333 0.0220 0.0383 0.0247 
60 0.0377 0.0173 0.0337 0.0247 
120 0.0460 0.0103 0.0233 0.0220 
180 0.0484 0.0077 0.0207 0.0197 
240 0.0510 0.0060 0.0120 0.0153 
300 0.0540 0.0000 0.0067 0.0137 
 
Plotted Aminoarylation Reaction Profile with cis-Anethole  






























Plotted Aminoarylation Reaction Profile with cis-Anethole  




Plotted Initial Rates for Aminoarylation with cis-Anethole 

























y = 0.001x + 0.0013
R² = 0.981
y = -0.0013x + 0.0601
R² = 0.982
y = -0.0011x + 0.0747
R² = 0.9943







































([M] • min-1) 0.0010 -0.0013 -0.0011 -0.0010 




Reaction Profile and Initial Rates for Alkene Isomerization with trans-Anethole 
 
 
To a flame dried 2-dram vial, equipped with a teflon coated oval shaped stir bar, was added 
trans-anethole (14.8 mg, 0.1 mmol) and Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (1 mg, 1 mol%). The 
vial contents were then dissolved in anhydrous d7-DMF (1 mL, 0.1 M) followed by addition of 
trimethyl(phenyl)silane (5.68 μL, 0.033 mmol) as an internal standrad. The reaction was sparged 
under argon for 15 min before the 1 mL solution volume was equally seperated between 2 argon 
sparged NMR tubes (0.5 mL each). The tubes were quickly capped and sealed with parafilm. Time 
zero (t0) 1H-NMR measurements were taken of both samples prior to irradiation. Then, the 2 NMR 
tubes were irradiated with 1 x blue H150 Kessil LED light (~2 cm) and cooled by one overhead 
fan. After the alloted time (i.e.10, 15, 20... min), the light was turned off and reaction solution 
analyzed by 1H-NMR. 
Analysis: The alkene yields for the isomerization were plotted against time in minutes. The slope 
through five points for the first ~20% reaction conversion was utilized to calculate the initial rate 
of isomerization. The procedure was repeated and the average of these two trials was determined. 









Average of 2 trials 
min % trans-anethole % cis-anethole 
0 100.00 0.00 
10 96.86 6.73 
15 89.69 12.56 
20 82.96 16.14 
30 76.68 30.04 
45 63.23 38.12 
60 53.81 44.39 
120 40.36 51.12 
180 40.81 50.67 
 
Plotted Isomerization Reaction Profile with cis-Anethole  


































Plotted Initial Rates for Isomerization with cis-Anethole  
([M] vs. time) 
 
 Avg. of 2 trials 
 cis-Anethole Formation trans-Anethole Consumption 
Initial rate 
([M] • min-1) 0.0009 -0.0009 
R2 0.9883 0.8874 
 
  
y = -0.0009x + 0.1135
R² = 0.8874





















Reaction Profile for Alkene Isomerization with cis-Anethole 
 
To a flame dried 2-dram vial, equipped with a teflon coated oval shaped stir bar, was added 
cis-anethole (14.8 mg, 0.1 mmol) and Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (1 mg, 1 mol%). The 
vial contents were then dissolved in anhydrous d7-DMF (1 mL, 0.1 M) followed by addition of 
trimethyl(phenyl)silane (5.68 μL, 0.033 mmol) as an internal standrad. The reaction was sparged 
under argon for 15 min before the 1 mL solution volume was equally seperated between 2 argon 
sparged NMR tubes (0.5 mL each). The tubes were quickly capped and sealed with parafilm. Time 
zero (t0) 1H-NMR measurements were taken of both samples prior to irradiation. Then, the 2 NMR 
tubes were irradiated with 1 x blue H150 Kessil LED light (~2 cm) and cooled by one overhead 
fan. After the alloted time (i.e. 10, 15, 20... min), the light was turned off and reaction solution 
analyzed by 1H-NMR. 
Analysis: The alkene yields for the isomerization were plotted against time in minutes. Because 
the isomerization of cis-trans anethole is so rapid, initial rates could not be determined. 




Plotted Isomerization Reaction Profile with trans-Anethole  
(yield vs. time) 
 
 
Average of 2 trials 
min % cis % trans 
0 100.00 0.00 
10 45.11 64.67 
15 44.02 66.30 
20 45.65 60.87 
30 47.83 59.24 
45 52.72 51.09 
60 54.89 47.28 
120 58.70 39.13 























Plotted Isomerization Reaction Profile for 10 min with trans-Anethole  
(yield vs. time) 
 
 Average of 2 trials 
min % cis % trans 
0 100.00 0.00 
1 67.86 41.67 
2 59.52 49.40 
3 56.55 56.55 
4 50.60 58.93 
5 47.02 62.50 























Determination of Photostationary State Between cis-Anethole and trans-Anethole 
 
The following isomeric ratios were extrapolated from the above alkene isomerization 
experiments. The cis:trans ratios were taken from tfinal (180 min) once the equilibrium state 
between the two isomers had been observed.  
 
From trans to cis From cis to trans 
Time (minutes) % cis % trans % cis % trans 
180 50.67 40.81 59.24 38.04 
Normalized 
yields 
55.39 44.61 60.90 39.10 
 
Photostationary State between cis-Anethole and trans-Anethole 
min % cis % trans 







Aminoarylation Product Stability Assay 
 
In order to validate the stability of the aminoarylation product and to be sure that it is not 
decomposing under the title reaction conditions over time, a stability assay analysis was 
performed.  
To a flame dried 2-dram vial, equipped with a teflon coated oval shaped stir bar, was added 
the aminoaryylation product (33.3 mg, 0.1 mmol), potassium benzoate (4.81 mg, 30 mol%), 
Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (1 mg, 1 mol%), and in the case of trial B trans-anethole (2.97 
μL, 0.02 mmol, 20 mol%). No trans-anethole was added for trial A. The vial contents were then 
dissolved in anhydrous DMF (1 mL, 0.1 M) followed by addition of trimethyl(phenyl)silane (5.7 
μL, 0.033 mmol) as an internal standrad. The reaction was sparged under argon for 15 min before 
the 1 mL solution volume was added to an argon sparged NMR tube. The tube was quickly capped 
and sealed with parafilm. Time zero (t0) 1H-NMR measurements were taken prior to irradiation. 
Then, the NMR tubes were irradiated with 1 x blue H150 Kessil LED light (~2 cm) and cooled by 
one overhead fan. After the alloted time (i.e. 5, 10, 15, 20... min), the light was turned off and 
reaction solution analyzed by 1H-NMR. 
Analysis: The concentration of the aminoarylation product was plotted against time in minutes. 
As the plots below suggest, no noticable degradation of the aminoarylation product occurs either 
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in the presence or absence of trans-anethole. These results suggest the aminoarylation product is 














































3.4.3. Synthesis and Characterization of Reagents, Starting 
Materials, and Aminoarylation Products 
 
Preparation of Ir(dF(CF3)ppy)2(5,5'd(CF3)bpy)PF6 (3)/[Ir]-1 
 
 
The following procedure has been adopted from a two-step, one-pot literature procedure 
from our laboratory disclosing the synthesis of heteroleptic-Ir(I) complexes through microwave 
irradiation.43 
To an oven dried 20 mL microwave vial was charged a magnetic stirring bar, IrCl3-xH2O 
(507 mg, 1.6 mmol, 1 equiv), and 2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine (1.04 g, 4.0 
mmol, 2.5 equiv). The vial contents were dissolved in ethylene glycol (15 mL) and then the 
microwave vial capped. Then the reaction was sonicated for 3 minutes to increase homogeneity 
(picture A). The reaction was heated in a microwave reactor at 200 °C for 50 min with a 5 min 
pre-stir period. After the reaction had cooled to room temperature (picture B), 5-(trifluoromethyl)-
2-[5-(trifluoromethyl)-2-pyridyl]pyridine (617 mg, 2.1 mmol, 2 equiv) was added, the vial re-
capped, and the reaction was heated to 200 °C for 30 min with a 5 min pre-stir period. 
After the reaction had cooled to room temperature (picture C), the solution was dissolved 
in dH2O (50 mL) and extracted with CH2Cl2 (3 x 20 mL). The organic layers were combined and 
concentrated down, followed by the addition of NH4PF6 (10 g in ~50 mL dH2O). The whole was 
placed in the freezer overnight to allow for maximum crystal formation. The yellow/orange 
 162 
crystals were filtered and washed with cold Et2O. Re-crystallization was performed with pentane 
and acetone (insoluble in pentane) to provide the title complex as a free-flowing yellow powder 
(1.08 g, 59%). 
1H and 19F NMR characterization data is identical to that reported in the literature.39 
1H NMR (500 MHz, d6-Acetone) δ = 9.32 (d, J = 8.6 Hz, 1H), 8.83 (d, J = 8.5 Hz, 1H), 8.61 (d, J 
= 8.7 Hz, 1H), 8.56 (s, 1H), 8.40 (d, J = 8.9 Hz, 1H), 8.19 (s, 1H), 6.91 (t, J = 11.7 Hz, 1H), 5.98 
(dd, J = 8.4, 2.2 Hz, 1H) ppm 
 
19F NMR (471 MHz, d6-Acetone) δ = -62.66 (d, J = 107.9 Hz), -71.75(d, JP-F = 707.4 Hz), -
103.14(dd, J = 20.1, 9.3 Hz), -106.81(t, J = 12.2 Hz) ppm 
 










(Step 1): To a dry 250 mL round bottom flask equipped with a sizable oval shaped stir bar, 
a 3:1 mixture of Ether:Acetone was prepared (100 mL total). To this the solid naphthalene-1-
sulfonyl chloride (10.0 g, 44.1 mmol), added into the flask. The solution is homogeneous at this 
point. Then by dropwise addition, saturated NH4OH ((5809 µl) 44.1 mmol, 1 equiv) was added at 
0 °C. The reaction was checked by TLC (4:6 EtOAc:Hexanes). If the reaction was not complete 
in 1 hour, an additional 1 equiv of NH4OH was added to ensure full conversion.  
The reaction was then neutralized to a pH of 6-7. Caution should be taken to not inhale the 
off gassing excess ammonia from the solution, and this will process faster if the reaction is under 
a continuous flush of nitrogen gas. Dilute the reaction in an equal volume of water and extract 2x 
with an equal amount of ethyl acetate. Combine the organic portions and dry over sodium sulfate, 
with a final concentration in vacuo to reveal a white powder.  
(Step 2A): To a dry 250 mL round bottom flask equipped with a sizeable oval shaped stir 
bar, KOH (4426 mg, 78.9 mmol – crushed fine powder) and naphthalene-1-sulfonamide (5.45 g, 
26.3 mmol) were added. The flask was evacuated and backfilled with nitrogen 3 times, after which 
the contents were diluted in dichloromethane solvent (50 mL). After stirring for a few minutes, 
acetyl chloride (2244 µL, 31.6 mmol) was added dropwise at room temperature. During this 
addition, the reaction very noticeably goes heterogeneous, then homogeneous and then back to 
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heterogeneous. After 2 hours this reaction is complete but is stable if left under nitrogen for up to 
24 hours. At this point the reaction was diluted with 100 mL of water and acidified past neutrality. 
These contents were then transferred to a 500 mL separatory funnel and the aqueous layer was 
extracted 2x times with 75 mL of CH2Cl2. The CH2Cl2 extracts were combined, and concentrated, 
and the product was recrystallized in methanol to yield dense white crystals.  
Alternatively, the product can be separated from the starting material by first combining 
the CH2Cl2 extraction and concentrating in vacuo to take back up in a minimal amount of EtOAc 
(60 mL). This was then extracted 5x times with 60 mL of 5 % NaHCO3 aq solution. These 
combined aqueous extracts were then acidified using 4 M HCl beyond neutrality (product becomes 
insoluble in solution. Finally, the desired product can be extracted from the acidic aqueous layer 
using EtOAc or CH2Cl2. Combination and drying over Na2SO4 and concentration in vacuo yields 
the desired product. The product can be further purified by recrystallization in MeOH. Non-
recystallized material is lighter in density, and more difficult to handle.    
(Step 2B): To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar 
was added naphthalene-1-sulfonamide (1 g, 4.83 mmol), DMAP (6 mg, 1 mol%), CH2Cl2 (35 mL), 
and THF (6 mL). The reaction mixture at this point appears mostly heterogeneous. Then the 
reaction was cooled to 0 °C and via syringe was added pyridine (777 µL, 9.65 mmol, 2 equiv) 
followed by acetic anhydride (1.82 mL, 19.3 mmol, 4 equiv). The whole slowly became more 
homogeneous over a few minutes. The reaction was slowly allowed to warm to rt while stirring 
overnight (12 h). Upon completion of the reaction as judged by TLC analysis (40% EtOAc in 
Hex), the reaction was diluted in 20 mL dH2O, layers separated, and the aqueous layer washed 
with 20 mL CH2Cl2. The organic layers were combined and rinsed with 1 N HCl (2 x 20 mL), 
brine, dried over sodium sulfate, filtered and concentrated in vacuo to provide white, compact 
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crystals. The product may be further purified via flash column chromatography (0-40% EtOAc in 
Hex elution gradient). 
1H NMR (700 MHz, CDCl3): δ = 8.68 (bs, 1H), 8.59 (d, J = 8.5 Hz, 1H), 8.51 (d, J = 7.2 Hz, 1H), 
8.16 (d, J = 8.1 Hz, 1H), 7.99 (d, J = 8.1 Hz, 1H), 7.70 (t, J = 7.6 Hz, 1H), 7.63 (dd, J = 12.5, 7.3 
Hz, 2H), 2.03 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.1, 135.8, 134.2, 133.0, 132.1, 129.4, 128.9, 128.0, 127.1, 
124.2, 123.6, 23.4 ppm 
 
Rf (4:6 – EtOAc:Hex) = 0.3 
 
IR (neat): 3246, 1730, 1441, 1410, 1372, 1328, 1215, 1127, 760, 734 cm-1 
 
HRMS (ESI+) m/z calculated for C12H11NO3S [M+H]+ 250.0532, found 250.0529 
 




ethyl (naphthalen-1-ylsulfonyl)carbamate (3.S1) 
 
To a 100 mL round bottom flask charged with a magnetic stir bar was added naphthalene-
1-sulfonamide (1 g, 4.83 mmol), DMAP (29.5 mg, 0.24 mmol), CH2Cl2 (30 mL), and ethyl 
chloroformate (0.59 mL, 6.27 mmol). The whole was cooled to 0 °C then triethylamine (0.74 mL, 
5.31 mmol) was added dropwise via syringe. The reaction slowly went from a white, 
heterogeneous mixture to a clear colorless, homogenous solution. The reaction was gradually 
warmed to rt and monitored by TLC (50% EtOAc in Hex). After 2 h, the reaction was concentrated 
under reduced pressure to give a light yellow oil. This crude mixture was diluted with EtOAc (30 
mL) then washed 3 x with 1 N HCl (10 mL). The organic layer was washed with brine, dried over 
sodium sulfate, and filtered to give a white solid. Purification by flash column chromatography 
(10 to 40% EtOAc in Hex elution gradient) provided the title substrate as a compact white solid 
(782 mg, 59%). 
1H NMR (700 MHz, CDCl3): δ = 8.60 (d, J = 8.6 Hz, 1H), 8.49 (d, J = 7.4 Hz, 1H), 8.15 (d, J = 
8.2 Hz, 1H), 7.98 (d, J = 8.1 Hz, 1H), 7.80 (s, 1H), 7.70 (t, J = 7.7 Hz, 1H), 7.62 (dt, J = 12.1, 7.5 
Hz, 2H), 4.04 (q, J = 7.1 Hz, 2H), 1.11 (t, J = 7.1 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 150.2, 135.7, 134.1, 132.8, 132.4, 129.3, 128.8, 128.0, 127.0, 
124.1, 123.9, 63.1, 13.9 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.5 
 
IR (neat): 3081, 1712, 1507, 1476, 1352, 1309, 1167, 1139, 917, 802, 766 cm-1 
 
HRMS (ESI+) m/z calculated for C13H13NO4S [M+H]+ 280.00638, found 280.0634.  
 
MP: 137–140 °C 
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tert-butyl (naphthalen-1-ylsulfonyl)carbamate (3.S2) 
 
To a 50 mL round bottom flask charged with a magnetic stir bar was added naphthalene-
1-sulfonamide (1 g, 4.83 mmol), DMAP (58.9 mg, 0.483 mmol), CH2Cl2 (30 mL), and Boc 
anhydride (1.22 mL, 5.31 mmol). The whole was cooled to 0 °C then triethylamine (0.74 mL, 5.31 
mmol) was added dropwise via syringe. The reaction slowly went from a cloudy white color to 
clear. The whole was slowly warmed to rt and monitored by TLC (50% EtOAc in Hex). After 2 h, 
the reaction was concentrated under reduced pressure to give a light yellow oil. This crude mixture 
was diluted with EtOAc (30 mL) then washed 3 x with 1 N HCl (10 mL). The organic layer was 
washed with brine, dried over sodium sulfate, and filtered to give a white solid. Purification by 
flash column chromatography (10 to 40% EtOAc in Hex elution gradient) provided the title 
substrate as a compact white solid (1.02 g, 69%). 
1H NMR (700 MHz, CDCl3): δ = 8.58 (d, J = 8.6 Hz, 1H), 8.45 (d, J = 7.2 Hz, 1H), 8.15 (d, J = 
8.2 Hz, 1H), 7.97 (d, J = 8.1 Hz, 1H), 7.69 (t, J = 7.5 Hz, 1H), 7.63  ̶  7.59 (m, 3H), 1.27 (s, 9H) 
ppm 
 
13C NMR (176 MHz, CDCl3): δ = 149.0, 135.4, 134.1, 133.2, 132.1, 129.2, 128.7, 128.0, 126.9, 
124.0, 123.9, 84.3, 27.7 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.5 
 
IR (neat): 3073, 2982, 1701, 1354, 1332, 1134, 804, 777 cm-1 
 
HRMS (ESI+) m/z calculated for C15H17NO4S [M+H]+ 308.0951, found 308.0947. 
 








To a 100 mL round bottom flask charged with a magnetic stir bar was added naphthalene-
1-sulfonamide (1 g, 4.83 mmol), DMAP (58.9 mg, 0.483 mmol), CH2Cl2 (40 mL), and TFAA 
(0.783 mL, 5.31 mmol). The whole was cooled to 0 °C then triethylamine (0.74 mL, 5.31 mmol) 
was added dropwise via syringe. The reaction slowly went from a cloudy white color to clear. The 
whole was slowly warmed to rt and monitored by TLC (50% EtOAc in Hex). After 4 h, the reaction 
was concentrated under reduced pressure to give a light yellow oil. This crude mixture was diluted 
with EtOAc (30 mL) then washed 3 x with 1 N HCl (10 mL). The organic layer was washed with 
brine, dried over sodium sulfate, and filtered to give a white solid. Purification by flash column 
chromatography (10 to 40% EtOAc in Hex elution gradient) provided the title substrate as a 
compact white solid (1.28 g, 88%). 
1H NMR (400 MHz, DMSO-d6): δ = 11.06 (bs, 1H), 8.68 (d, J = 8.0 Hz, 1H), 8.14 – 8.01 (m, 2H), 
7.98 (d, J = 7.4 Hz, 1H), 7.72 – 7.40 (m, 3H) ppm 
 
13C NMR (176 MHz, DMSO-d6): δ = 159.9 (q, J = 32.9 Hz), 139.9, 133.6, 131.7, 128.3, 128.3, 
127.4, 126.6, 126.1, 124.3, 117.6 (q, J = 291.4 Hz)  
 
19F NMR (377 MHz, DMSO-d6) = δ -74.1 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.3 
 
IR (neat): 3209, 1762, 1508, 1452, 1362, 1201, 1108, 988, 765 cm-1 
 
HRMS (ESI+) m/z calculated for C12H8F3NO3S [M+H]+ 326.0069, found 326.0066.  
 








To a flame dried 250 mL round bottom flask charged with a magnetic stir bar was 
added thiophene-2-sulfonamide (3 g, 18.4 mmol), DMAP (22.5 mg, 0.184 mmol), CH2Cl2 (50 
mL), and THF (10 mL). The reaction appears mostly heterogeneous. Then the reaction was 
cooled to 0 °C then via syringe was added pyridine (4.44 mL, 55.1 mmol) followed by acetic 
anhydride (6.95 mL, 73.5 mmol). The reaction was allowed to warm to rt and monitored by TLC 
(50% EtOAc in Hex). After 3 h, the reaction was concentrated under reduced pressure to give a 
light yellow oil. This crude mixture was diluted with EtOAc (30 mL) then washed 3 x with 1 N 
HCl (10 mL). The organic layer was washed with brine, dried over sodium sulfate, and filtered to 
give a white solid. Purification by flash column chromatography (10 to 50% EtOAc in Hex elution 
gradient) provided the title substrate as a compact white solid (2.57 g, 68%). 
1H NMR (700 MHz, CDCl3): δ = 8.71 (s, 1H), 7.90 (dd, J = 3.8, 1.2 Hz, 1H), 7.71 (dd, J = 5.0, 
1.2 Hz, 1H), 7.14 (dd, J = 4.9, 3.9 Hz, 1H), 2.13 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.1, 138.6, 135.2, 134.2, 127.5, 23.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.4 
 
IR (neat): 3105, 1688, 1446, 1421, 1368, 1351, 1017, 999, 728 cm-1 
 
HRMS (EI) m/z calculated for C6H7NO3S2 [M+] 204.9867, found 204.9871. 
 








To a flame dried 100 mL round bottom flask charged with a magnetic stir bar was added 
methyl 3-sulfamoylthiophene-2-carboxylate (500 mg, 2.26 mmol), DMAP (2.76 mg, 0.0226 
mmol), CH2Cl2 (35.0 mL), and THF (5.00 mL). The reaction appears mostly heterogeneous. The 
whole was cooled to 0 °C then via syringe was added pyridine (0.546 mL, 6.78 mmol) and acetic 
anhydride (0.854 mL, 9.04 mmol). The reaction was allowed to warm to rt and monitored by TLC 
(50% EtOAc in Hex). After 12 h, the reaction was concentrated under reduced pressure to give a 
light yellow oil. This crude mixture was diluted with EtOAc (30 mL) then washed 3 x with 1 N 
HCl (10 mL). The organic layer was washed with brine, dried over sodium sulfate, and filtered to 
give a white solid. Purification by flash column chromatography (10 to 50% EtOAc in Hex elution 
gradient) provided the title substrate as a compact white solid (512 mg, 86%). 
1H NMR (700 MHz, CDCl3): δ = 8.92 (s, 1H), 7.72 (d, J = 5.2 Hz, 1H), 7.58 (d, J = 5.2 Hz, 1H), 
3.95 (s, 3H), 2.15 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.5, 160.3, 142.9, 132.6, 131.5, 130.4, 53.3, 23.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.2 
 
IR (neat): 3131, 1719, 1701, 1435, 1358, 1265, 1173, 1144, 898, 772 cm-1 
 
HRMS (ESI+) m/z calculated for C8H9NO5S2Na [M+Na]+ 285.9814, found 285.9818.  
 








To a flame dried 250 mL round bottom flask charged with a magnetic stir bar was added 
quinoline-8-sulfonamide (1000 mg, 4.80 mmol), DMAP (5.87 mg, 0.0480 mmol), CH2Cl2 (35.0 
mL), and THF (5.00 mL). The reaction appears mostly heterogeneous. The whole was cooled to 0 
°C then via syringe was added pyridine (0.387 mL, 4.80 mmol) followed by acetic anhydride (1.82 
mL, 19.2 mmol). The reaction was allowed to warm to rt and monitored by TLC (50% EtOAc in 
Hex). After 12 h, the reaction was diluted in 100 mL dH2O. The white crystalline solid were 
filtered off and washed with cold acetone to provide the title substrate as a compact white solid 
(1.03 g, 86%). 
1H NMR (700 MHz, DMSO-d3): δ = 12.32 (s, 1H), 9.10 (m, 1H), 8.57 (d, J = 8.1 Hz, 1H), 8.46 
(d, J = 8.1 Hz, 1H), 8.35 (d, J = 8.1 Hz, 1H), 7.80 (t, J = 7.7 Hz, 1H), 7.72 (dd, J = 8.2, 4.1 Hz, 
1H), 1.88 (s, 3H) ppm 
 
13C NMR (176 MHz, DMSO-d3): δ = 169.0, 151.5, 142.8, 137.1, 135.2, 134.7, 133.1, 128.5, 125.6, 
122.6, 23.1 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.3 
 
IR (neat): 3003, 2818, 1713, 1499, 1457, 1330, 1166, 1139, 995, 973 cm-1 
 
HRMS (ESI+) m/z calculated for C11H10N2O3S [M+H]+ 251.0485, found 251.0484.  
 








To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added naphthalene-1-sulfonamide (1 g, 4.83 mmol), DMAP (6 mg, 1 mol%), CH2Cl2 (35 mL), 
and THF (6 mL). The reaction mixture at this point appears mostly heterogeneous. Then the 
reaction was cooled to 0 °C and via syringe was added pyridine (777 uL, 9.65 mmol, 2 equiv) 
followed by acetic anhydride (1.82 mL, 19.3 mmol, 4 equiv). The whole slowly became more 
homogeneous over a few minutes. The reaction was slowly allowed to warm to rt while stirring 
overnight (12 h). Upon completion of the reaction as judged by TLC analysis (40% EtOAc in 
Hex), the reaction was diluted in 20 mL dH2O, layers separated, and the aqueous layer was 
extracted with 20 mL CH2Cl2. The organic layers were combined and rinsed with 1 N HCl (2 x 20 
mL), brine, dried over sodium sulfate, filtered and concentrated in vacuo to provide a white 
powder. The material may be further purified via flash column chromatography (0 to 40% EtOAc 
in Hex elution gradient) to provide the title substrate as a compact white solid (848 mg, 78%). 
1H NMR (700 MHz, CDCl3): δ = 8.67 (bm, 2H), 8.02 (d, J = 8.2 Hz, 1H), 7.99 (s, 2H), 7.93 (d, J 
= 8.2 Hz, 1H), 7.68 (t, J = 7.5 Hz, 1H), 7.63 (t, J = 7.5 Hz, 1H), 2.09 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.0, 135.5, 135.1, 131.9, 130.5, 129.6, 129.5, 129.4, 127.9, 
127.8, 122.5, 23.5 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.3 
 
IR (neat): 3274, 1719, 1436, 1412, 1328, 1150, 1126, 994, 877, 747 cm-1 
 
HRMS (ESI+) m/z calculated for C12H11NO3S [M+H]+ 272.0352, found 272.0353.  
 








To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added methyl 5-sulfamoylfuran-2-carboxylate (184 mg, 0.897 mmol), DMAP (1.10 mg, 0.00897 
mmol), CH2Cl2 (20.0 mL), and THF (5.00 mL). The reaction mixture at this point appears 
mostly heterogeneous. Then the reaction was cooled to 0 °C and via syringe was added pyridine 
(0.217 mL, 2.69 mmol) followed by acetic anhydride (0.339 mL, 3.59 mmol). The whole slowly 
became more homogeneous over a few minutes. The reaction was slowly allowed to warm to rt 
while stirring for 3 h. Upon completion of the reaction as judged by TLC analysis (50% EtOAc in 
Hex), the reaction was concentrated under reduced pressure to give a light yellow oil. This crude 
mixture was diluted with CH2Cl2 (15 mL) then washed 3 x with 1 N HCl (10 mL). The organic 
layer was washed with brine, dried over sodium sulfate, and filtered to give a white solid. 
Purification by flash column chromatography (10 to 50% EtOAc in Hex elution gradient) provided 
the title substrate as a compact white solid (172 mg, 78%). 
1H NMR (700 MHz, CDCl3): δ = 8.89 (s, 1H), 7.38 (d, J = 3.6 Hz, 1H), 7.24 (d, J = 3.6 Hz, 1H), 
3.93 (s, 3H), 2.17 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.0, 158.0, 148.9, 147.3, 120.3, 118.0, 52.8, 23.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.2 
 
IR (neat): 3303, 3159, 1732, 1574, 1431, 1355, 1040, 917 cm-1 
 
HRMS (ESI+) m/z calculated for C8H9NO6S [M+H]+ 265.0489, found 265.0488.  
 








To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added thiophene-3-sulfonamide (1000 mg, 6.13 mmol), DMAP (7.48 mg, 0.0613 mmol), CH2Cl2 
(35.0 mL), and THF (5.0 mL). The reaction mixture at this point appears mostly heterogeneous. 
Then the reaction was cooled to 0 °C and via syringe was added pyridine (1.48 mL, 18.4 mmol) 
followed by acetic anhydride (2.32 mL, 24.5 mmol). The whole slowly became more 
homogeneous over a few minutes. The reaction was slowly allowed to warm to rt while stirring 
for 12 h. Upon completion of the reaction as judged by TLC analysis (50% EtOAc in Hex), the 
reaction was concentrated under reduced pressure to give a light yellow oil. This crude mixture 
was diluted with CH2Cl2 (25 mL) then washed 3 x with 1 N HCl (20 mL). The organic layer was 
washed with brine, dried over sodium sulfate, and filtered to give a white solid. Purification by 
flash column chromatography (10 to 50% EtOAc in Hex elution gradient) provided the title 
substrate as a compact white solid (1.12 g, 89%). 
1H NMR (700 MHz, CDCl3): δ = 8.78 (s, 1H), 8.32 – 8.20 (m, 1H), 7.60 – 7.48 (m, 1H), 7.44 (dd, 
J = 5.1, 3.1 Hz, 1H), 2.11 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.3, 138.0, 133.7, 127.8, 126.1, 23.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.3 
 
IR (neat): 3070, 2867, 1691, 1460, 1417, 1346, 1235, 1157, 788 cm-1 
 
HRMS (ESI+) m/z calculated for C6H7NO3S2Na [M+Na]+ 227.9760, found 227.9757.  
 








To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar was added 
5-chlorothiophene-2-sulfonamide (500 mg, 2.53 mmol), DMAP (3.09 mg, 0.0253 mmol), CH2Cl2 
(35.0 mL), and THF (5.00 mL). Then the reaction was cooled to 0 °C and via syringe was added 
pyridine (0.611 mL, 7.59 mmol) followed by acetic anhydride (0.956 mL, 10.1 mmol). The whole 
slowly became more homogeneous over a few minutes. The reaction was slowly allowed to warm 
to rt while stirring for 12 h. Upon completion of the reaction as judged by TLC analysis (50% 
EtOAc in Hex), the reaction was concentrated under reduced pressure to give a light yellow oil. 
This crude mixture was diluted with CH2Cl2 (25 mL) then washed 3x with 1 N HCl (20 mL). The 
organic layer was washed with brine, dried over sodium sulfate, and filtered to give a white solid. 
Purification by flash column chromatography (10 to 50% EtOAc in Hex elution gradient) provided 
the title substrate as a compact white powder (486 mg, 77%). 
1H NMR (700 MHz, CDCl3): δ = 8.69 (s, 1H), 7.69 (d, J = 4.1 Hz, 1H), 6.97 (d, J = 4.1 Hz, 1H), 
2.14 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.1, 140.0, 136.0, 134.7, 126.8, 23.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.4 
 
IR (neat): 3076, 2874, 1689, 1463, 1409, 1357, 1235, 1162, 1004, 990 cm-1 
 
HRMS (ESI+) m/z calculated for C6H6ClNO3S2 [M+H]+ 239.9550, found 239.9548.  
 








To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar was added 
5-bromothiophene-2-sulfonamide (1000 mg, 4.13 mmol), DMAP (5.05 mg, 0.0413 mmol), 
CH2Cl2 (35.0 mL), and THF (5.0 mL). Then the reaction was cooled to 0 °C and via syringe was 
added pyridine (1.0 mL, 12.4 mmol) followed by acetic anhydride (1.56 mL, 16.5 mmol). The 
whole slowly became more homogeneous over a few minutes. The reaction was slowly allowed to 
warm to rt while stirring for 12 h. Upon completion of the reaction as judged by TLC analysis 
(50% EtOAc in Hex), the reaction was concentrated under reduced pressure to give a light yellow 
oil. This crude mixture was diluted with CH2Cl2 (25 mL) then washed 3 x with 1 N HCl (20 mL). 
The organic layer was washed with brine, dried over sodium sulfate, and filtered to give a white 
solid. Purification by flash column chromatography (10 to 50% EtOAc in Hex elution gradient) 
provided the title substrate as a compact white powder (1.07 g, 91%). 
1H NMR (700 MHz, CDCl3): δ = 8.62 (s, 1H), 7.64 (d, J = 4.1 Hz, 1H), 7.11 (d, J = 4.1 Hz, 1H), 
2.13 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.0, 138.9, 135.4, 130.4, 122.7, 23.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.3 
 
IR (neat): 3301, 1713, 1412, 1395, 1209, 1155, 1025, 799, 678 cm-1 
 
HRMS (ESI+) m/z calculated for C6H6BrNO3S2 [M+Na]+ 305.8865, found 305.8869.  
 








To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar was added 
1,3-benzothiazole-2-sulfonamide (294 mg, 1.37 mmol), DMAP (1.68 mg, 0.0137 mmol), CH2Cl2 
(35.0 mL), and THF (5.0 mL). Then the reaction was cooled to 0 °C and via syringe was added 
pyridine (0.322 mL, 4.12 mmol) followed by acetic anhydride (0.519 mL, 5.49 mmol). The whole 
slowly became more homogeneous over a few minutes. The reaction was slowly allowed to warm 
to rt while stirring for 12 h. Upon completion of the reaction as judged by TLC analysis (50% 
EtOAc in Hex), the reaction was concentrated under reduced pressure to give a light yellow oil. 
This crude mixture was diluted with CH2Cl2 (25 mL) then washed 3 x with 1 N HCl (20 mL). The 
organic layer was washed with brine, dried over sodium sulfate, and filtered to give a white solid. 
Purification by flash column chromatography (10 to 50% EtOAc in Hex elution gradient) provided 
the title substrate as a compact white solid (443 mg, 99%). 
1H NMR (700 MHz, DMSO-d6): δ = 13.06 (s, 1H), 8.31 (d, J = 7.8 Hz, 1H), 8.23 (d, J = 7.9 Hz, 
1H), 7.75 – 7.61 (m, 2H), 2.04 (s, 3H) ppm 
 
13C NMR (176 MHz, DMSO-d6): δ = 169.7, 165.4, 151.4, 136.3, 128.1, 127.9, 124.7, 123.3, 23.4 
ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3022, 2855, 1726, 1484, 1358, 1162, 1132, 1094, 994 cm-1 
 
HRMS (ESI+) m/z calculated for C9H8N2O3S2 [M+H]+ 257.0049, found 257.0052.  
 








A 25 mL flame dried round bottom flask charged with a magnetic stir bar was added KOH 
(91.9 mg, 1.64 mmol) and (E)-2-phenylethenesulfonamide (100 mg, 0.546 mmol). The flask was 
septa capped and put under nitrogen, before diluting in CH2Cl2 [0.2 M]. This reaction was then 
cooled to 0 °C followed by dropwise addition of AcCl (58.2 μL, 1.5 equiv) to the reaction. Over 
2.5 hours, the reaction was allowed to warm to room temperature. The reaction was quenched by 
adding 4 M HCl at 0 °C to equal the mmol of KOH added. This was then diluted in water and 
extracted 3x with CH2Cl2. The CH2Cl2 layers were combined dried over sodium sulfate, filtered 
and concentrated to provide the crude residue which was purified by column chromatography (4:6 
EtOAc to Hexanes) to afford the desired acetamide (52 mg, 42%). 
1H NMR (400 MHz, DMSO-d6) δ = 11.84 (s, 1H), 7.75 (d, J = 6.3 Hz, 2H), 7.60 – 7.35 (m, 5H), 
1.97 (s, 3H) ppm 
 
13C NMR (126 MHz, DMSO-d6) δ = 169.1, 142.6, 132.3, 131.1, 129.1, 128.9, 125.9, 23.4 ppm 
 
Rf (1:1 – EtOAc:Hex) = 0.4 
 
IR (neat): 3243, 3049, 1714, 1615, 1417, 1369, 1326, 1213, 1199, 1142, 1039, 991, 968, 944, 
869, 824, 805, 744, 687, 651, 631, 609 cm-1 
 
HRMS (ESI+) m/z calculated for [M+H]+ 226.0532, found 226.0532. 
 








To a dry round bottom flask hexanoic acid (420 mg, 3.62 mmol) was added and diluted 
into 6 mL of DCM and 100 μL of DMF. This solution was cooled to 0°C and oxyalyl chloride was 
added neat and dropwise over the course of 3 minutes. The reaction was stirred at 0°C for 30 
minutes. Then the reaction was warmed to room temperature and concentrated in vacuo to a thick 
yellow oil. The reaction was then taken back up into a fresh supply of 6 mL of DCM, followed by 
naphthalene-1-sulfonamide (500 mg, 2.41 mmol) in one portion. Slow addition of pyridine (389 
μL, 2 equiv) and DMAP (14.7 mg, 0.05 eq), occurred with considerable exotherm. The reaction 
was then stirred for 15 hours and stopped by the addition of 10 mL of water. The whole was 
transferred to a separatory funnel and extracted three times with 15 mL of ethyl acetate. The 
combine organic layer was then washed with saturated sodium bicarbonate followed by saturated 
soidum chloride solutions. Drying over magnesium sulfate and concentration in vacuo afforded an 
orange oil that was purified on column (0-50% EtOAc in Hexanes) to afford N-(1-
naphthylsulfonyl) hexanamide (382 mg, 1.25 mmol, yield: 52%) 
1H NMR (700 MHz, DMSO-d6) δ 12.40 (s, 1H), 8.61 (d, J = 8.6 Hz, 1H), 8.33 (d, J = 7.4 Hz, 2H), 
8.16 (m, 1H), 7.79 (t, J = 7.0 Hz, 1H), 7.76 – 7.69 (m, 2H), 1.36 – 1.28 (m, 2H), 1.04 (m, 2H), 
0.90 (m, 2H), 0.66 (dt, J = 7.2, 5.3 Hz, 3H) ppm 
 
13C NMR (176 MHz, DMSO-d6) δ = 172.4, 135.9, 134.8, 134.5, 132.1, 130.1, 129.2, 128.2, 127.8, 
125.3, 124.5,  36.3, 31.1, 24.7, 22.5, 14.5 ppm 
 
Rf =  0.5 in 1:1 Hexanes:EtOAc 
 
IR (neat): 3301, 2958, 2926, 2869, 1713, 1506, 1472, 1442, 1411, 1364, 1324, 1271, 1221, 1204, 
1177, 1160, 1144, 1131, 1085, 1057, 1035, 975, 945, 864, 807.3, 797.5, 776.3, 741, cm-1 
 







Vinyl-anisole was purchased from Sigma Aldrich (97%, item # 141003) and was distilled 
under hi-vac (~ 13 mbar), at 60 °C. It was then stored in the dark, under argon in a 4 dram vial for 







trans-Anethole was purchased from AK Scientific (98%, item # X8716) and was used as 







Z-anethole preparation was repeated based on the procedure detailed by Yoon and co-
workers.44-45 (Step 1): To a dry round bottom flask, 1-ethynyl-4-methoxy-benzene (1000 mg, 7.57 
mmol) was added as a clear liquid and diluted into solution with 20 mL of THF. The solution was 
cooled to -78°C for 30 minutes and then the starting material was deprotonated with the dropwise 
addition of LiHMDS (8.323 μL, 1.1 equiv) over the course of 10 minutes. The solution was 
allowed to stir and deprotonate for 30 minutes. Following this time, MeI (565 μL, 1.2 equiv) was 
added dropwise, and the reaction was allowed to stir another 30 minutes before warming to room 
temperature. The reaction was quenchinged wit 4 mL of saturated aqueous ammonium chloride 
solution, and diluted in 30 mL of water. The whole was transferred to a separatory funnel where 
20 mL of diethyl ether was added and the layers were separated. The aqueous layer was then 
extracted twice more with 30 mL of diethylether each time. The combined organic layer was then 
washed with saturated sodium chloride solution and dried over magnesium sulfate. Concentration 
in vacuo produced an orange oil that was then purified by a short column (0-5% EtOAc in 
Hexanes) to afford 1-methoxy-4-prop-1-ynyl-benzene which was taken directly onto the next step.  
(Step 2): To a flame dried flask, a solution of cyclohexene (15.2 mmol, 2.11 equiv, 1601 
μL) was diluted in 8 mL of THF. The solution was cooled to 0°C and then a 2.0 M solution of 
BH3•DMS complex in toluene was added (749 μm 1.1 equiv). After 10 minutes the reaction 
becomes heterogeneous, and this was allowed to stir for another twenty minutes. After this time, 
1-methoxy-4-prop-1-ynyl-benzene was added as a 1 M solution in THF, to the reaction at 0°C. 
This was allowed to stir for 45 minutes, followed by quenching with 1 mL of glacial acetic acid. 
The acid quench was allowed to stir for 45 minutes and warm up to room temperature. The reaction 
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solution was transferred to a separatory funnel and diluted in 30 mL of water. The layers were 
separated and the aqueous layer was extracted twice more with 30 mL of diethyl ether each time. 
The combined organic layer was washed with saturated sodium bicarbonate followed by saturated 
aqueous sodium chloride solution. Drying over magnesium sulfate followed by concentration in 
vacuo afforded an oil that was purified by silica chromatography (0-5% EtOAc in Hexanes). The 
spectral data of 1-methoxy-4-[(Z)-prop-1-enyl]benzene (512 mg, 49% yield) was consistent with 







The following procedure was followed according to that reported in the literature for the 
preparation of the title substrate.46 
CeCl3·7H2O (2218 mg, 9.00 mmol) was quickly ground to a fine powder in a mortar, 
placed in a three-neck 250 mL round bottom flask and dried at 140 °C for 2 h. At rt, nitrogen gas 
was introduced, and anhydrous THF (25 mL) was added with vigorous stirring. The suspension 
was stirred for 1.5 h at rt. To a cold (-78 °C) and stirred solution of 4-bromoanisole (0.828 mL, 
6.60 mmol) in anhydrous THF (25 mL) was added 1.6 M nBuLi in hexanes (4.50 mL, 7.20 mmol). 
This solution was stirred at -78 °C for 1.5 h then added to the cold (-78 °C) suspension of CeCl3  
in THF. The resulting solution was stirred at -78 °C for 1 h. Cyclopentanone (0.531 mL) 6.00 
mmol) dissolved in anhydrous THF (5 mL) was added to the corresponding organocerium reagent. 
The resulting mixture was stirred at -78 °C for 1h then at rt for 1 h. At -30 °C, after dilution with 
anhydrous THF (20 mL), DBU (2.32 mL, 10.5 mmol, 3 equiv) then MsCl (1.39 mL, 10.5 mmol, 
3 equiv) were added dropwise. The reaction mixture was then allowed to warm to rt and stirred 
overnight. At 0 °C, aqueous HCl 1 M (15 mL) was added and the solution was stirred for 1 h. The 
aqueous layer was extracted with Et2O (3 x 30 mL). The resulting organic layers were washed with 
aqueous NaOH 2 M (10 mL), water (10 mL), brine (10 mL), dried over sodium sulfate and the 
solvent evaporated to provide a light yellow oil. The residue was purified by flash column 
chromatography on silica gel using a 0 to 1% EtOAc in Hex elution gradient to provide the desired 
olefin as a white fluffy powder (616 mg, 59%). 
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All analytical data matches that reported in the literature.46 
 
1H NMR (700 MHz, CDCl3): δ = 7.38 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 6.08 – 5.99 
(m, 1H), 3.81 (s, 3H), 2.68 (td, J = 7.8, 2.1 Hz, 2H), 2.52 (td, J = 7.7, 2.3 Hz, 2H), 2.08 – 1.95 (m, 
2H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 158.5, 141.8, 129.7, 126.7, 123.9, 113.6, 55.3, 33.3, 33.2, 23.4 
ppm 
 
Rf (1:9 – EtOAc:Hex) = 0.6 
 
IR (neat): 2951, 2894, 2841, 1601, 1510, 1309, 1252, 1180, 1030 cm-1 
 






The following procedure was followed according to that reported in the literature for the 




CeCl3·7H2O (2218 mg, 9.00 mmol) was quickly ground to a fine powder in a mortar, 
placed in a three-neck 250 mL round bottom flask and dried at 140 °C for 2 h. At rt, nitrogen gas 
was introduced, and anhydrous THF (25 mL) was added with vigorous stirring. The suspension 
was stirred for 1.5 h at rt. To a cold (-78 °C) and stirred solution of 4-bromoanisole (0.828 mL, 
6.60 mmol) in anhydrous THF (25 mL) was added 1.6 M nBuLi in hexanes (4.50 mL, 7.20 mmol). 
This solution was stirred at -78 °C for 1.5 h then added to the cold (-78 °C) suspension of CeCl3  
in THF. The resulting solution was stirred at -78 °C for 1 h. Cycloheptanone (0.709 mL, 6.00 
mmol) dissolved in anhydrous THF (5 mL) was added to the corresponding organocerium reagent. 
The resulting mixture was stirred at -78 °C for 1 h then at rt for 1 h. At -30 °C, after dilution with 
anhydrous THF (20 mL), DBU (2.32 mL, 10.5 mmol, 3 equiv) then MsCl (1.39 mL, 10.5 mmol, 
3 equiv) were added dropwise. The reaction mixture was then allowed to warm to rt and stirred 
overnight. At 0 °C, aqueous HCl 1 M (15 mL) was added and the solution was stirred for 1 h. The 
aqueous layer was extracted with Et2O (3 x 30 mL). The resulting organic layers were washed with 
aqueous NaOH 2 M (10 mL), water (10 mL), brine (10 mL), dried over sodium sulfate and the 
solvent evaporated to provide a light yellow oil. The residue was purified by flash column 
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chromatography on silica gel using a 0 to 1% EtOAc in Hex elution gradient to provide the desired 
olefin as a colorless oil (655 mg, 54%). 
All analytical data matches that reported in the literature.46 
 
1H NMR (700 MHz, CDCl3): δ = 7.27 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.03 (t, J = 
6.7 Hz, 1H), 3.81 (s, 3H), 2.64 – 2.54 (m, 2H), 2.28 (dd, J = 11.0, 6.5 Hz, 2H), 1.84 (dt, J = 11.8, 
6.0 Hz, 2H), 1.64 (dt, J = 11.3, 5.8 Hz, 2H), 1.56 (dt, J = 11.3, 5.9 Hz, 2H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 158.2, 144.3, 137.5, 128.8, 126.7, 113.4, 55.3, 32.8, 32.7, 28.8, 
26.9, 26.8 ppm 
 
Rf (1:9 – EtOAc:Hex) = 0.8 
 
IR (neat): 2916, 2834, 1606, 1509, 1489, 1286, 1242, 1177, 1032 cm-1 
 







To a flame dried 50 mL round bottom flask charged with a magentic stir bar was added N-
allyl-4-methyl-benzenesulfonamide (637 mg, 3.01 mmol, 1.2 equiv) 5 mL of DMF. To this, NaH 
(60%, 86.6 mg, 2.26 mmol, 0.9 equiv) was added portion-wise to the flask and the sulfonamide 
was allowed to react at 0 °C for 30 minutes. After this time, 2-bromo-1-phenyl-ethanone (500 mg, 
2.51 mmol, 1 equiv), was diluted separately in 6 mL of DMF and transferred to the reaction via 
syringe at 0 °C. The reaction was slowly allowed to warm to room temperature over 1 h, and then 
quenched with 7 mL of aqueous 5% citric acid and 7 mL of 10% sodium thiosulfate at 0 °C. The 
mixture was then transferred to a separatory funnel and extracted 3 times with 50 mL of diethyl 
ether. The combined ether extracts were washed with saturated sodium bicarbonate solution, 
followed by 5% LiCl wash (equal volume). The combined organic fractions were dried over 
sodium sulfate and then concentrated in vacuo to provide a crude dark oil which was purified by 
silica gel chromatography (30% EtOAc in Hexanes). N-allyl-4-methyl-N-phenacyl-
benzenesulfonamide isolated in 47% yield (396 mg) and corresponded to literature 
characterization.47   
To a flame dried 25 mL round bottom flask charged with a magnetic stir bar was added N-
allyl-4-methyl-N-phenacyl-benzenesulfonamide (100 mg, 0.304 mmol), 6 mL of dry CH2Cl2, 
followed by 1-methoxy-4-vinyl-benzene (202 µL, 1.52 mmol, 5 equiv). The reaction was sparged 
by an argon line for 5 minutes. Then Hoveyda-Grubbs II (CAS No. 301224-40-8) (4.76 mg, 
0.00759 mmol, 2.5 mol %) was added, the flask was flushed with argon and then the reaction was 
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capped and allowed to stir for 12 hours. Following this time, the crude mixture was pushed through 
a celite plug and concentrated to provide the crude residue. The material was purified by silica gel 
chromatography (3:7 ethyl acetate/Hexanes), and the stilbene impurity was triturated out with cold 
ether, after concentrating to yield 29 mg of the title substrate (22% yield).  
1H NMR (700 MHz, CDCl3) δ =  7.89 (d, J = 8.0 Hz, 2H), 7.79 (d, J = 8.1 Hz, 2H), 7.58 (t, J = 7.4 
Hz, 1H), 7.45 (t, J = 7.6 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 7.17 (d, J = 8.6 Hz, 2H), 6.33 (d, J = 
15.8 Hz, 1H), 6.33 (d, J = 15.8 Hz, 1H), 5.88 (dt, J = 14.6, 7.0 Hz, 1H), 5.88 (dt, J = 14.6, 7.0 Hz, 
1H), 4.76 (s, 2H), 4.05 (d, J = 7.0 Hz, 2H), 3.80 (s, 3H), 2.45 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3) δ = 194.2, 159.5, 143.4, 136.9, 134.9, 134.4, 133.7, 129.6, 128.7, 
128.7, 128.0, 127.7, 127.5, 121.0, 113.9, 55.3, 51.9, 50.5, 21.6 ppm 
 
Rf (3:7 – EtOAc:Hex) = 0.3 
 
IR (neat): 2932, 2836, 2254, 1699, 1606, 1579, 1510, 1448, 1420, 1334, 1304, 1249, 1224, 1174, 
1154, 1092, 1059, 1032, 1001, 971, 906, 856, 839, 812, 729, 689, 668, 607 cm-1 
 








To a solution of (E)-3-(4-methoxyphenyl)prop-2-en-1-ol (200 mg, 1.22 mmol) in CH2Cl2 
(15 mL) and THF (5 mL) was added DMAP (14.9 mg, 0.122 mmol). Then the reaction was 
cooled to 0 °C and via syringe was added pyridine (0.294 mL, 3.65 mmol) followed by acetic 
anhydride (0.345 mL, 3.65 mmol). The reaction was slowly allowed to warm to rt while stirring 
for 12 h. Upon completion of the reaction as judged by TLC analysis (10% EtOAc in Hex), the 
reaction was concentrated under reduced pressure to give a light yellow oil. This crude mixture 
was diluted with EtOAc (25 mL) then washed 3 x with 1 N HCl (20 mL). The organic layer was 
washed with brine, dried over sodium sulfate, and filtered to give a crude, colorless oil. Purification 
by flash column chromatography (0 to 5% EtOAc in Hex elution gradient) provided the title 
substrate as a clear, colorless oil (219 mg 87%). 
1H NMR (400 MHz, CDCl3): δ = 7.33 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 6.60 (d, J = 
15.9 Hz, 1H), 6.15 (dt, J = 15.8, 6.6 Hz, 1H), 4.70 (d, J = 6.6 Hz, 2H), 3.81 (s, 3H), 2.09 (s, 3H) 
ppm 
 
13C NMR (176 MHz, CDCl3) δ = 170.9, 159.5, 134.0, 128.9, 127.8, 120.8, 113.9, 65.3, 55.3, 21.0 
ppm 
 
Rf (1:10 – EtOAc:Hex) = 0.7 
 
IR (neat): 2938, 1733, 1607, 1362, 1222, 1174, 1023, 958, 842 cm-1 
 






A solution of 6-methoxytetralin-1-one (1000 mg, 5.67 mmol) in diethyl ether (17 mL) was 
added to a suspension of LiAlH4 (108 mg, 2.84 mmol) in diethyl ether (8.5 mL). The temperature 
of the reaction as kept below 5 °C during this addition. The addition process took, 30 minutes, and 
the reaction was allowed to stir for 30 more minutes to reach completion. The reaction was 
quenched by the addition of 220 μL of a 3M NaOH solution at 0 °C, followed by 600 μL of water. 
The solution was then gravity filtered to remove the aluminum salts, and then washed with 30 mL 
of water, followed by 30 mL of saturated sodium chloride solution. Drying over magnesium sulfate 
and concentration yielded a clear liquid.  
The crude alcohol was dissolved in toluene (30 mL, 0.2 M), and 4-methylbenzenesulfonic 
acid;hydrate (6.75 mg, 0.0355 mmol) was added. The reaction was heated to reflux for no longer 
than 30 minutes, and then cooled to room temperature. The mixture was washed with 30 mL of 
water followed by 30 mL of saturated sodium chloride solution, followed by drying over 
magnesium sulfate. Vacuum filtration with additional washing with ethyl acetate removed the 
dessicant, while azeotropic distillation of the toluene with ethyl acetate afforded a brown oil free 
of toluene. The brown oil was distilled to yield under vacuum at 0.2 mbar/80 °C afforded 7-
methoxy-1,2-dihydronaphthalene (275 mg, 1.72 mmol, yield: 30%). Spectral data of the product 






The General Procedure A was followed performing the reaction with N-(1-
naphthylsulfonyl)acetamide (75 mg, 0.3 mmol) and 1-methoxy-4-vinyl-benzene (48 μL, 0.36 
mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to 
furnish the title compound as a white foam (39 mg, 41%). 
1H NMR (700 MHz, CDCl3): δ = 8.13 (d, J = 8.1 Hz, 1H), 7.88 – 7.81 (m, 1H), 7.77 (d, J = 8.1 
Hz, 1H), 7.51 – 7.43 (m, 3H), 7.39 (d, J = 7.1 Hz, 1H), 7.19 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.6 
Hz, 2H), 5.53 (bs, 1H), 4.96 (t, J = 7.7 Hz, 2H), 4.03 (ddd, J = 13.6, 7.5, 6.0 Hz, 1H), 3.97 – 3.86 
(m, 1H), 3.76 (s, 3H), 1.88 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 170.1, 158.3, 137.5, 134.1, 133.9, 131.9, 129.1, 128.8, 127.6, 
126.3, 125.7, 125.3, 124.2, 123.7, 114.1, 55.2, 45.1, 44.1, 23.3 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2929, 1648, 1547, 1510, 1260, 1240, 1140, 1025, 781 cm-1 
 






The General Procedure A was followed performing the reaction with ethyl-N-(1-
naphthylsulfonyl)carbamate (251 mg, 0.9 mmol) and 1-methoxy-4-vinyl-benzene (40 μL, 0.3 
mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to 
furnish the title compound as a light yellow foam (38 mg, 36%). 
1H NMR (500 MHz, CDCl3): δ = 8.12 (d, J = 6.9 Hz, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.76 (d, J = 
8.1 Hz, 1H), 7.46 (m, 3H), 7.38 (d, J = 7.0 Hz, 1H), 7.19 (d, J = 8.5 Hz, 2H), 6.83 (d, J = 8.6 Hz, 
2H), 4.95 (bs, 1H), 4.73 (bs, 1H), 4.09 (m, 2H), 3.96 (dd, J = 13.4, 6.3 Hz, 1H), 3.90 – 3.79 (m, 
1H), 1.19 (t, J = 6.5 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 158.3, 156.5, 137.5, 134.1, 133.9, 131.9, 129.2, 128.8, 127.6, 
126.3, 125.6, 125.3, 124.1, 123.7, 114.1, 60.8, 55.2, 45.7, 45.5, 14.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2931, 1693, 1609, 1509, 1244, 1177, 1032, 799, 729 cm-1 
 






The General Procedure A was followed performing the reaction with t-butyl-N-(1-
naphthylsulfonyl)carbamate (277 mg, 0.9 mmol) and 1-methoxy-4-vinyl-benzene (40 μL, 0.3 
mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to 
furnish the title compound as a white foam (30 mg, 27%). 
1H NMR (700 MHz, CDCl3): δ = 8.10 (d, J = 7.9 Hz, 1H), 7.84 (d, J = 8.0 Hz, 1H), 7.77 (d, J = 
8.1 Hz, 1H), 7.50 – 7.44 (m, 3H), 7.42 (d, J = 6.6 Hz, 1H), 7.18 (d, J = 8.6 Hz, 2H), 6.82 (d, J = 
8.3 Hz, 2H), 4.93 (t, J = 7.0 Hz, 1H), 4.62 (s, 1H), 3.89 (dd, J = 13.3, 6.3 Hz, 1H), 3.84 (dd, J = 
12.9, 6.2 Hz, 1H), 3.76 (s, 3H), 1.41 (s, 9H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 158.2, 155.8, 137.6, 134.1, 132.1, 129.2, 128.8, 127.5, 126.2, 
125.6, 125.3, 124.1, 123.7, 114.0, 79.3, 55.2, 45.7, 45.2, 29.7, 28.4 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2975, 1696, 1508, 1365, 1245, 1161, 1035, 799, 780 cm-1 
 






The General Procedure A was followed performing the reaction with t-butyl- N-(1-
naphthylsulfonyl)carbamate (277 mg, 0.9 mmol) and trans-anethole (45 μL, 0.3 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a white foam (43 mg, 37%). 
1H NMR (700 MHz, CDCl3): δ =  8.13 (d, J = 8.3 Hz, 1H), 7.82 (d, J = 7.9 Hz, 1H), 7.72 (d, J = 
7.8 Hz, 2H), 7.50 (t, J = 7.6 Hz, 1H), 7.46 (t, J = 7.4 Hz, 1H), 7.42 (t, J = 7.3 Hz, 1H), 7.26 (d, J 
= 7.6 Hz, 2H), 6.78 (d, J = 8.2 Hz, 2H), 4.61 (s, 1H), 4.56 (d, J = 9.9 Hz, 1H), 4.33 (s, 1H), 3.72 
(s, 3H), 1.33 (s, 9H), 1.18 (d, J = 5.7 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 158.1, 155.3, 137.5, 134.1, 132.0, 129.4, 128.9, 127.1, 125.9, 
125.5, 125.2, 124.4, 123.3, 114.3, 113.9, 79.1, 55.1, 52.2, 49.3, 28.3, 21.1 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2974, 2831, 1689, 1609 1509, 1452, 1365, 1247, 1162, 929, 782 cm-1 
 






With trans-Anethole: The General Procedure A was followed performing the reaction 
with N-(1-naphthylsulfonyl)acetamide (75 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) 
and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the 
title compound as a light yellow foam (82 mg, 82%). 
With cis-Anethole: The General Procedure A was followed performing the reaction with 
N-(1-naphthylsulfonyl)acetamide (75 mg, 0.3 mmol) and cis-anethole (54 μL, 0.36 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a light yellow foam (72 mg, 72%). 
1H NMR (700 MHz, CDCl3): δ =  8.14 (d, J = 8.5 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.73 (d, J = 
8.2 Hz, 1H), 7.66 (d, J = 7.2 Hz, 1H), 7.50 (t, J = 7.7 Hz, 1H), 7.47 (td, J = 8.1, 7.1 Hz, 1H), 7.43 
(t, J = 7.4 Hz, 1H), 7.25 (d, J = 8.5 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 5.22 (d, J = 7.8 Hz, 1H), 
5.01 – 4.87 (m, 1H), 4.58 (d, J = 10.4 Hz, 1H), 3.72 (s, 3H), 1.74 (s, 3H), 1.17 (d, J = 6.3 Hz, 3H) 
ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.4, 158.2, 137.1, 134.1, 133.7, 131.9, 129.5, 129.1, 127.3, 
126.0, 125.6, 125.3, 124.2, 123.2, 113.9, 55.1, 51.9, 48.1, 23.4, 20.7 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3089, 2929, 1637, 1509, 1370, 1302, 1249, 1177, 1031 cm-1 
 





The General Procedure A was followed performing the reaction on 0.2 mmol scale with 
N-(1-naphthylsulfonyl)hexanamide and trans-anethole (59.3 mg, 0.400 mmol). Purification by 
flash column chromatography (SiO2, 90:10 to 60:40 Hex:EtOAc) to furnish the title compound as 
a light yellow foam (45%). Further removal of residual N-(1-naphthylsulfonyl)hexanamide 
(~10%) was done by washing with 1 N NaOH and extracting into Et2O. Reconcentration of the 
purified product provided a light yellow foam (20.7 mg, 25%).  
1H NMR (400 mHz, CDCl3) = δ 8.16 (d, J = 8.3 Hz, 1H), 7.83 (d, J = 8.0 Hz, 1H), 7.73 (d, J = 
8.2 Hz, 1H), 7.66 (d, J = 7.2 Hz, 1H), 7.49 (t, J = 7.7 Hz, 2H), 7.46 – 7.38 (t,  8.0 Hz, 1H), 7.28 (d, 
J = 8.0 Hz, 2H), 6.79 (d, J = 8.5 Hz, 2H), 5.20 (d, J = 8.6 Hz, 1H), 4.95 (m, 1H), 4.60 (d, J = 10.5 
Hz, 1H), 3.73 (s, 3H), 1.90 (dtd, J = 29.3, 14.5, 7.5 Hz, 2H), 1.47 – 0.86 (m, 9H), 0.78 (t, J = 7.2 
Hz, 2H) ppm 
 
13C NMR (100 mHz, CDCl3) = 172.4, 158.2, 137.3, 134.1, 133.8, 131.9, 129.5, 129.1, 127.3, 
126.0, 125.6, 125.2, 124.5, 123.1, 113.9, 55.1, 51.9, 48.0, 36.9, 31.2, 25.3, 22.3, 20.8, 13.8 ppm 
 
Rf (4:6 – EtOAc:Hex) = 0.5 
 
IR (neat) = 2996, 2932, 2253, 1641, 1510, 1252, 905, 784, 729, 649 cm-1 
 





The General Procedure A was followed performing the reaction with N-(2-
naphthylsulfonyl)acetamide (75 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a light yellow foam (78 mg, 78%). 
1H NMR (700 MHz, CDCl3): δ = 7.79 (d, J = 8.0 Hz, 1H), 7.77 (d, J = 7.9 Hz, 1H), 7.75 (d, J = 
8.6 Hz, 1H), 7.73 (m, 1H), 7.45 (td, J = 11.0, 3.9 Hz, 1H), 7.42 (t, J = 6.9 Hz, 1H), 7.38 (dd, J = 
8.5, 1.2 Hz, 1H), 7.23 (d, J = 8.6 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 5.22 (d, J = 8.4 Hz, 1H), 5.01 
– 4.87 (m, 1H), 3.97 (d, J = 9.7 Hz, 1H), 3.76 (s, 3H), 1.77 (s, 3H), 1.17 (d, J = 6.4 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.3, 158.3, 139.6, 134.2, 133.4, 132.2, 129.3, 128.3, 127.8, 
127.5, 126.5, 126.4, 126.1, 125.6, 114.1, 57.2, 55.2, 47.5, 23.5, 20.3 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3268, 2971, 1636, 1509, 1371, 1247, 1178, 1032, 915 cm-1 
 






The General Procedure A was followed performing the reaction with N-(3-
thienylsulfonyl)acetamide (62 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a light yellow foam (26 mg, 30%). 
1H NMR (700 MHz, CDCl3): δ = 7.24 – 7.21 (m, 1H), 7.14 (d, J = 8.4 Hz, 2H), 7.09 (s, 1H), 6.93 
(d, J = 4.8 Hz, 1H), 6.83 (d, J = 8.4 Hz, 2H), 5.20 (d, J = 8.1 Hz, 1H), 4.83 – 4.66 (m, 1H), 3.94 
(d, J = 8.7 Hz, 1H), 3.78 (s, 3H), 1.87 (s, 3H), 1.07 (d, J = 6.5 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.2, 158.4, 142.8, 133.4, 129.5, 127.8, 125.6, 120.9, 113.9, 
55.2, 52.2, 48.2, 23.6, 19.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3325, 3000, 1628, 1511, 1373, 1251, 1032, 849, 796, 708 cm-1 
 






The General Procedure A was followed performing the reaction with methyl 3-
(acetylsulfamoyl)thiophene-2-carboxylate (79 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 
mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to 
furnish the title compound as a light yellow foam (92 mg, 89%). 
1H NMR (700 MHz, CDCl3): δ = 7.36 (d, J = 5.2 Hz, 1H), 7.27 (d, J = 8.7 Hz, 2H), 7.15 (d, J = 
5.2 Hz, 1H), 6.83 (d, J = 8.6 Hz, 2H), 5.86 (d, J = 9.0 Hz, 1H), 4.93 (d, J = 11.5 Hz, 1H), 4.86 – 
4.65 (m, 1H), 3.89 (s, 3H), 3.77 (s, 3H), 1.75 (s, 3H), 1.12 (d, J = 6.4 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.1, 163.9, 158.4, 151.8, 133.1, 130.9, 129.5, 129.0, 126.2, 
114.0, 55.2, 52.0, 49.6, 49.1, 23.3, 20.7 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3289, 2941, 1718, 1639, 1585, 1512, 1445, 1226, 1104, 1075, 829 cm-1 
 






The General Procedure A was followed performing the reaction with N-(2-
thienylsulfonyl)acetamide (62 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a light yellow foam (69 mg, 69%). 
1H NMR (700 MHz, CDCl3): δ = 7.21 (d, J = 8.6 Hz, 2H), 7.15 (d, J = 4.9 Hz, 1H), 6.93 – 6.91 
(m, 2H), 6.85 (d, J = 8.6 Hz, 2H), 5.31 (d, J = 8.3 Hz, 1H), 4.73 – 4.67 (m, 1H), 4.15 (d, J = 8.1 
Hz, 1H), 3.79 (s, 3H), 1.89 (s, 3H), 1.11 (d, J = 6.6 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.3, 158.6, 145.6, 133.2, 129.5, 126.7, 124.9, 124.1, 113.9, 
55.2, 51.6, 49.1, 23.5, 19.5 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2987, 2983, 1638, 1538, 1512, 1373, 1282, 1030 cm-1 
 






The General Procedure A was followed performing the reaction with N-[(5-bromo-2-
thienyl)sulfonyl]acetamide (85 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a light yellow foam (49 mg, 45%). 
1H NMR (700 MHz, CDCl3): δ = 7.17 (d, J = 8.5 Hz, 2H), 6.86 – 6.85 (m, 3H), 6.67 (d, J = 3.6 
Hz, 1H), 5.27 (d, J = 7.4 Hz, 1H), 4.77 – 4.55 (m, 1H), 4.06 (d, J = 8.1 Hz, 1H), 3.79 (s, 3H), 1.92 
(s, 3H), 1.09 (d, J = 6.6 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.3, 158.8, 147.5, 132.4, 129.5, 129.4, 125.2, 114.1, 110.5, 
55.3, 51.9, 48.7, 23.6, 19.3 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3313, 2930, 1627, 1511, 1446, 1372, 1281, 1222, 1175, 801 cm-1 
 






The General Procedure A was followed performing the reaction with methyl 5-
(acetylsulfamoyl)furan-2-carboxylate (74 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) 
and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the 
title compound as a white foam (79 mg, 80%). 
1H NMR (700 MHz, CDCl3): δ = 7.19 (d, J = 8.7 Hz, 2H), 7.09 (d, J = 3.5 Hz, 1H), 6.86 (d, J = 
8.7 Hz, 2H), 6.29 (d, J = 3.4 Hz, 1H), 5.53 (d, J = 9.3 Hz, 1H), 4.77 – 4.60 (m, 1H), 4.05 (d, J = 
8.2 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 1.89 (s, 3H), 1.07 (d, J = 6.7 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.3, 160.4, 159.1, 158.9, 143.5, 130.1, 129.5, 119.1, 114.1, 
109.3, 55.2, 51.8, 50.4, 48.2, 23.5, 19.5 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3294, 2989, 1721, 1634, 1628, 1515, 1308, 1251, 1126, 1031, 826 cm-1 
 






The General Procedure A was followed performing the reaction with methyl N-(8-
quinolylsulfonyl)acetamide (62 mg, 0.25 mmol) and trans-anethole (44 μL, 0.3 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a light yellow foam (47 mg, 58%). 
1H NMR (700 MHz, CDCl3): δ = 8.95 (d, J = 2.7 Hz, 1H), 8.16 (d, J = 8.1 Hz, 1H), 7.67 (d, J = 
7.3 Hz, 1H), 7.65 (d, J = 8.0 Hz, 1H), 7.47 (t, J = 7.7 Hz, 1H), 7.42 (dd, J = 8.2, 4.1 Hz, 1H), 7.35 
(d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 6.44 (s, 1H), 5.45 (d, J = 11.1 Hz, 1H), 4.89 – 4.76 
(m, 1H), 3.76 (s, 3H), 1.48 (s, 3H), 1.25 (d, J = 6.3 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.1, 158.1, 149.2, 146.6, 141.1, 136.9, 134.2, 129.8, 128.8, 
128.4, 126.8, 126.5, 120.8, 113.8, 55.2, 49.6, 48.9, 23.1, 21.0 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3259, 2965, 1664, 1638, 1495, 1369, 1302, 1230, 1031, 930 cm-1 
 






The General Procedure A was followed performing the reaction with N-[(5-chloro-2-
thienyl)sulfonyl]acetamide (72 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) and 
purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the title 
compound as a light yellow foam (67 mg, 79%). 
1H NMR (700 MHz, CDCl3): δ = 7.17 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 6.71 (d, J = 
3.8 Hz, 1H), 6.68 (d, J = 3.6 Hz, 1H), 5.30 (d, J = 8.5 Hz, 1H), 4.71 – 4.58 (m, 1H), 4.03 (d, J = 
8.2 Hz, 1H), 3.79 (s, 3H), 1.92 (s, 3H), 1.09 (d, J = 6.6 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.3, 158.8, 144.6, 132.4, 129.5, 128.3, 125.6, 124.2, 114.1, 
55.2, 51.9, 48.7, 23.6, 19.3 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3275, 2985, 1652, 1585, 1511, 1484, 1249, 1034 cm-1 
 






The General Procedure A was followed performing the reaction with N-(1,3-
benzothiazol-2-ylsulfonyl)acetamide (77 mg, 0.3 mmol) and trans-anethole (54 μL, 0.36 mmol) 
and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) to furnish the 
title compound as a light yellow foam (43 mg, 42%). 
1H NMR (700 MHz, CDCl3): δ = 8.03 (d, J = 8.2 Hz, 1H), 7.83 (d, J = 8.0 Hz, 1H), 7.49 (t, J = 
7.7 Hz, 1H), 7.38 (t, J = 7.6 Hz, 1H), 7.27 (d, J = 8.7 Hz, 2H), 6.90 (d, J = 8.3 Hz, 1H), 6.85 (d, J 
= 8.6 Hz, 2H), 4.76 (dq, J = 13.0, 6.4 Hz, 1H), 4.48 (d, J = 5.9 Hz, 1H), 3.78 (s, 3H), 1.91 (s, 3H), 
1.27 (d, J = 6.7 Hz, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 171.9, 169.4, 159.0, 152.9, 134.9, 130.9, 129.4, 126.1, 125.1, 
122.9, 121.6, 114.1, 55.2, 53.8, 49.7, 23.6, 20.1 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3309, 2924, 1639, 1531, 1515, 1247, 1183, 1038, 832, 757 cm-1 
 







The General Procedure A was followed performing the reaction with N-[(E)-
styryl]sulfonylacetamide (20.1 mg, 0.0894 mmol) and trans-anethole (13.3 mg, 0.0894 mmol) and 
purification by flash column chromatography (SiO2, 30:70 Hex:EtOAc) to furnish the title 
compound (23 mg, 83%). 
Major Diastereomer:  
1H NMR (700 MHz, CDCl3) δ 1.94 (s, 3H), 1.06 (d, J=6.6 Hz, 3H), 3.39 (t, J= 8.2 Hz, 3H), 3.80 
(s, 3H), 4.43-4.36 (m, 1H), 5.39 (d, J=6.2 Hz, 1H), 6.39 (dd,J = 15.8, 8.1 Hz, 1H), 6.44 (d, J = 15.8 
Hz, 1H), 7.18-7.37 (m, 9H) ppm 
 
Minor diastereomer: 
1H NMR (700 MHz, CDCl3) δ = 0.94 (d, J = 6.6 Hz, 3H), 1.92 (s, 3H), 3.66 (t, J = 9.83, 1H), 3.80 
(s, 3H), 4.27 (m, 1H), 5.16 (d, J=8.45, 1H), 5.99 (t, J=11.2 Hz, 1H), 6.59 (d, J=11.6 Hz, 1H), 7.18-
7.37 (m, 9H) ppm 
 
13C NMR (mixture): (176 mHz, CDCl3) δ = 169.4, 158.5, 158.4, 137.1, 137.0, 133.5, 133.0, 
133.0, 131.3, 131.0, 130.1, 129.6, 129.1, 128.7, 128.5, 128.3, 127.3, 127.0, 126.2, 114.2, 114.1, 
55.3, 54.9, 50.0, 49.5, 49.1, 23.6, 23.5, 18.8, 18.6 ppm 
 
Rf (7:3 – EtOAc:Hex) = 0.5 
 
IR (neat): 3283.5, 2969.8, 2836.8 2244.7, 1651.1, 1610.5, 1550.3, 1511.6, 1449.9, 1372.4, 1301.8, 
1250.8, 1178.4, 1147.5, 1034.9, 964.9, 908.9, 829.3, 732.1, 696.7, 650.4, 624.6, 607.5 cm-1 
 







The General Procedure A was followed performing the reaction with N-(1-
naphthylsulfonyl)acetamide (18.9 mg, 0.0758 mmol) and N-[(E)-3-(4-methoxyphenyl)allyl]-4-
methyl-N-phenacyl-benzenesulfonamide (33.0 mg, 0.0758 mmol) and purification by flash 
column chromatography (SiO2, 30:70 Hex:EtOAc) to furnish the title compound (10 mg, 28%). 
1H NMR (700 MHz, CDCl3) δ = 8.16 (d, J = 8.6 Hz, 1H), 7.83 (d, J = 8.0 Hz, 2H), 7.80 (d, J = 8.0 
Hz, 1H), 7.69 (d, J = 8.1 Hz, 1H), 7.62 – 7.55 (m, 4H), 7.45 (m, 5H), 7.22 (d, J = 8.2 Hz, 2H), 7.20 
(d, J = 8.6 Hz, 2H), 6.69 (d, J = 8.6 Hz, 2H), 5.71 (d, J = 9.2 Hz, 1H, N-H), 5.13 (ddd, J = 20.1, 
9.8, 3.8 Hz, 1H), 4.96, 4.81 (ABq, 2H, JAB = 18.9)  4.87 (d, J = 9.9 Hz, 1H), 3.64 (dd, J = 15.1, 
10.1 Hz, 1H), 3.31 (dd, J = 15.1, 3.7 Hz, 1H) ppm 
 
13C NMR (mixture): (176 MHz, CDCl3) δ = 193.7, 171.1, 158.3, 143.4, 137.2, 137.0, 134.8, 
134.1, 133.9, 132.8, 131.7, 129.5, 129.1, 128.8, 127.9, 127.4, 127.3, 126.2, 125.5, 125.3, 124.6, 
123.1, 114.2, 55.1, 52.4, 50.7, 49.3, 48.2, 23.3, 21.5 ppm 
 
Rf (7:3 – EtOAc:Hex) = 0.5 
 
IR (neat): 2833, 2790, 2752, 2730, 2709, 1699, 1658, 1597, 1511, 
1449, 1333, 1304, 1253, 1226, 1157, 1033, 980, 812, 785 cm-1 
 




2-acetamido-3-(4-methoxyphenyl)-3-(naphthalen-1-yl)propyl acetate (3.22) 
 
The General Procedure A was followed performing the reaction with N-(1-
naphthylsulfonyl)acetamide (74.8 mg, 0.300 mmol) and [(E)-3-(4-methoxyphenyl)allyl] acetate 
(74.2 mg, 0.36 mmol) and purification by flash column chromatography (SiO2, 90:10→50:50 
Hex:EtOAc) to furnish the title compound as a white foam (70 mg, 60%). 
1H NMR (700 MHz, CDCl3): δ = 8.13 (d, J = 8.5 Hz, 1H), 7.83 (d, J = 8.0 Hz, 1H), 7.74 (d, J = 
8.2 Hz, 1H), 7.67 (d, J = 7.2 Hz, 1H), 7.54 – 7.46 (m, 2H), 7.43 (t, J = 7.4 Hz, 1H), 7.25 (d, J = 
9.8 Hz, 2H), 6.77 (d, J = 8.6 Hz, 2H), 5.40 (d, J = 9.1 Hz, 1H), 5.21 – 5.08 (m, 1H), 4.93 (d, J = 
11.2 Hz, 1H), 4.18 (dd, J = 11.3, 2.9 Hz, 1H), 3.96 (dd, J = 11.3, 4.0 Hz, 1H), 3.71 (s, 3H), 2.15 
(s, 3H), 1.76 (s, 3H). ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.8, 158.5, 136.2, 134.2, 132.4, 131.8, 129.3, 129.1, 127.5, 
126.1, 125.6, 125.4, 124.1, 123.0, 114.2, 65.1, 55.2, 50.8, 46.5, 23.2, 20.9.ppm 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2929, 2752,1737, 1648, 1510, 1369, 1243, 1177, 1032, 783, 728 cm-1 
 






The General Procedure A was followed performing the reaction with N-(1-
naphthylsulfonyl)acetamide (75 mg, 0.3 mmol) and 1-(cyclopenten-1-yl)-4-methoxy-benzene (63 
mg, 0.36 mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 
Hex:EtOAc) to furnish the title compound as a light yellow foam (40 mg, 37%). 
1H NMR (700 MHz, CDCl3): δ = 7.80 (d, J = 8.2 Hz, 1H), 7.77 (t, J = 7.3 Hz, 2H), 7.66 (d, J = 
8.7 Hz, 1H), 7.51 (t, J = 7.7 Hz, 1H), 7.31 (t, J = 7.4 Hz, 1H), 7.19 (d, J = 8.8 Hz, 2H), 7.16 (t, J 
= 7.7 Hz, 1H), 6.75 (d, J = 8.8 Hz, 2H), 5.47 (dd, J = 13.3, 7.3 Hz, 1H), 4.88 (d, J = 7.4 Hz, 1H), 
3.73 (s, 3H), 2.67 – 2.59 (m, 1H), 2.59 – 2.50 (m, 1H), 2.17 (s, 1H), 1.84 (dd, J = 19.9, 10.0 Hz, 
1H), 1.78 – 1.66 (m, 1H), 1.60 (dd, J = 20.6, 9.5 Hz, 1H), 1.40 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.8, 157.6, 139.9, 139.1, 134.7, 131.9, 128.7, 128.6, 127.4, 
126.8, 126.0, 125.4, 125.3, 124.7, 113.7, 58.9, 55.1, 54.9, 41.6, 34.0, 23.1, 20.7 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2954, 1642, 1609, 1508, 1372, 1249, 1183, 1034, 827, 776 cm-1 
 






The General Procedure A was followed performing the reaction with N-(2-
thienylsulfonyl)acetamide (62 mg, 0.3 mmol) and 1-(cyclopenten-1-yl)-4-methoxy-benzene (63 
mg, 0.36 mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 
Hex:EtOAc) to furnish the title compound as a light yellow foamy oil (55 mg, 58%). 
1H NMR (700 MHz, CDCl3): δ 7.25 – 7.17 (m, 3H), 6.98 (dd, J = 4.8, 3.7 Hz, 1H), 6.81 (d, J = 
8.7 Hz, 2H), 6.75 (d, J = 3.0 Hz, 1H), 5.36 (d, J = 9.4 Hz, 1H), 5.01 (dd, J = 17.3, 9.9 Hz, 1H), 
3.78 (s, 3H), 2.63 (ddd, J = 13.9, 9.5, 4.4 Hz, 1H), 2.25 – 2.13 (m, 2H), 2.03 – 1.94 (m, 1H), 1.92 
(s, 3H), 1.81 (ddd, J = 17.8, 11.3, 4.5 Hz, 1H), 1.60 – 1.51 (m, 1H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.3, 158.0, 149.8, 139.4, 128.0, 126.7, 126.1, 124.7, 113.5, 
55.1, 54.7, 54.6, 41.3, 30.4, 23.7, 19.5 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 3292, 2927, 1651, 1607, 1510, 1372, 1248, 1181, 1032, 827 cm-1 
 






The General Procedure A was followed performing the reaction with methyl 3-
(acetylsulfamoyl)thiophene-2-carboxylate (79 mg, 0.3 mmol) and 1-(cyclopenten-1-yl)-4-
methoxy-benzene (63 mg, 0.36 mmol) and purification by flash column chromatography (SiO2, 
90:10→30:70 Hex:EtOAc) to furnish the title compound as an off white foam (62 mg, 55%). 
1H NMR (700 MHz, CDCl3): δ = 7.43 (d, J = 5.2 Hz, 1H), 7.21 (d, J = 5.2 Hz, 1H), 7.16 (d, J = 
8.7 Hz, 2H), 6.77 (d, J = 8.7 Hz, 2H), 6.39 (d, J = 6.3 Hz, 1H), 5.03 (q, J = 6.6 Hz, 1H), 3.76 (s, 
3H), 3.59 (s, 3H), 2.44 – 2.40 (bm, 1H), 2.39 – 2.33 (bm, 2H), 1.89 – 1.80 (bm, 4H), 1.77 – 1.67 
(bm, 1H), 1.67 – 1.55 (bm, 2H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.8, 163.3, 157.6, 150.4, 137.5, 131.2, 129.0, 128.4, 127.8, 
113.2, 56.5, 56.3, 55.2, 52.4, 39.9, 31.0, 23.4, 20.6 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.2 
 
IR (neat): 3290, 2949, 1719, 1649, 1510, 1434, 1371, 1246, 1182, 1031, 780 cm-1 
 






The General Procedure A was followed performing the reaction with N-(1-
naphthylsulfonyl)acetamide (75 mg, 0.3 mmol) and 1-(4-methoxyphenyl)cycloheptene (73 mg, 
0.36 mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) 
to furnish the title compound as a light yellow foam (36 mg, 31%). 
1H NMR (700 MHz, CDCl3): δ = 7.80 – 7.72 (m, 2H), 7.50 (d, J = 8.8 Hz, 1H), 7.48 (t, J = 7.8 
Hz, 1H), 7.31 (t, J = 7.4 Hz, 1H), 7.20 – 7.04 (m, 3H), 6.73 (d, J = 8.4 Hz, 2H), 5.22 (bs, 1H), 5.15 
(bs, 1H), 3.74 (s, 3H), 2.61 (dd, J = 15.0, 9.2 Hz, 1H), 2.51 – 2.40 (m, 1H), 2.36 (d, J = 22.7 Hz, 
1H), 2.21 – 2.12 (m, 1H), 1.90 (s, 1H), 1.75 (dd, J = 14.2, 6.6 Hz, 1H), 1.71 – 1.61 (m, 1H), 1.56 
(bs, 2H), 1.49 (dd, J = 12.7, 8.6 Hz, 1H), 1.35 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 168.5, 157.4, 142.1, 140.9, 135.0, 132.3, 128.8, 128.5, 127.4, 
125.6, 125.2, 125.1, 124.2, 113.6, 56.9, 55.1, 55.0, 42.1, 32.0, 29.7, 24.8, 24.6, 22.8 ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2928, 2859, 1650, 1608, 1508, 1462, 1247, 1183, 726 cm-1 
 






The General Procedure A was followed performing the reaction with N-(1-
naphthylsulfonyl)acetamide (75 mg, 0.3 mmol) and 7-methoxy-1,2-dihydronaphthalene (57.7 mg, 
0.36 mmol) and purification by flash column chromatography (SiO2, 90:10→30:70 Hex:EtOAc) 
to furnish the title compound as a light yellow foam (29 mg, 28%). 
1H NMR (700 MHz, CDCl3): δ = 8.33 (d, J = 7.9 Hz, 1H), 7.87 (d, J = 8.1 Hz, 1H), 7.73 (d, J = 
8.1 Hz, 1H), 7.57 (t, J = 7.5 Hz, 1H), 7.51 (t, J = 7.4 Hz, 1H), 7.34 (t, J = 7.7 Hz, 1H), 6.84 (d, J 
= 6.9 Hz, 1H), 6.78 (d, J = 8.5 Hz, 1H), 6.73 (d, J = 1.8 Hz, 1H), 6.63 (dd, J = 8.5, 2.2 Hz, 1H), 
5.38 (d, J = 2.5 Hz, 1H), 4.77 (bs, 2H), 3.80 (s, 3H), 3.17 – 2.98 (m, 2H), 1.99 (ddd, J = 24.0, 12.0, 
5.9 Hz, 1H), 1.74 (dd, J = 12.3, 5.9 Hz, 1H), 1.54 (s, 3H) ppm 
 
13C NMR (176 MHz, CDCl3): δ = 169.5 (s), 158.1 (s), 138.6 (s), 137.1 (s), 133.5 (s), 133.3 (s), 
131.9 (s), 130.6 (s), 129.7 (s), 128.7 (s), 127.2 (s), 126.1 (s), 125.6 (s), 125.1 (s), 123.7 (s), 113.1 
(s), 112.6 (s), 55.2 (s), 48.4 (s), 29.7 (s), 28.8 (s), 24.0 (s), 23.4 (s) 
ppm 
 
Rf (5:5 – EtOAc:Hex) = 0.1 
 
IR (neat): 2923, 2851, 1651, 1609, 1499, 1268, 1229, 1038, 907, 726, 647 cm-1 
 
HRMS (ESI+) m/z calculated for C23H23NO2 [M+H]+ 346.1802, found 346.1803.  
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Structural figure of compound 3.15, with 50% probability ellipsoids. 
Accession Number 
The structure of 3.15 has been deposited in the Cambridge Crystallographic Data Center 
under accession number CCDC: 1572215. 
Structure Determination 
 Colorless plates of 3.15 were grown from by diethyl ether/pentane vapor diffusion at 22 
°C. A crystal of dimensions 0.04 x 0.02 x 0.01 mm was mounted on a Rigaku AFC10K Saturn 
944+ CCD-based X-ray diffractometer equipped with a low temperature device and Micromax-
007HF Cu-target micro-focus rotating anode (λ = 1.54187 A) operated at 1.2 kW power (40 kV, 
30 mA). The X-ray intensities were measured at 85(1) K with the detector placed at a distance 
42.00 mm from the crystal. A total of 2028 images were collected with an oscillation width of 1.0° 
in ω. The exposure times were 15 sec. for the low angle images, 80 sec. for high angle.  Rigaku 
d*trek images were exported to CrysAlisPro for processing and corrected for absorption. The 
integration of the data yielded a total of 24869 reflections to a maximum 2θ value of 138.84° of 
which 3075 were independent and 2171 were greater than 2σ(I). The final cell constants (Table 
3.4) were based on the xyz centroids of 3709 reflections above 10σ(I). Analysis of the data showed 
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negligible decay during data collection. The structure was solved and refined with the Bruker 
SHELXTL (version 2016/6) software package, using the space group P2(1)/c with Z = 4 for the 
formula C16H18NO2SBr. All non-hydrogen atoms were refined anisotropically with the hydrogen 
atoms placed in a combination of refined and idealized positions. Full matrix least-squares 
refinement based on F2 converged at R1 = 0.0599 and wR2 = 0.1512 [based on I > 2sigma(I)], R1 
= 0.0894 and wR2 = 0.1732 for all data. Additional details are presented in Table 3.4.  
Table 3.4. Crystal data and structure refinement for 3.15.  
      Empirical formula                    C16 H18 Br N O2 S  
      Formula weight                             368.28   
      Temperature                                85(2) K  
      Wavelength                                  1.54184 A  
      Crystal system, space group         Monoclinic,  P2(1)/c  
      Unit cell dimensions                       a = 16.2401(10) A   alpha = 90 deg.  
                                                               b = 10.9158(5) A    beta = 101.798(7) deg.  
                                                               c = 9.5079(6) A   gamma = 90 deg.  
      Volume                                        1649.89(17) A^3  
      Z, Calculated density                        4,  1.483 Mg/m^3   
      Absorption coefficient                      4.607 mm^-1  
      F(000)                                                        752  
      Crystal size                                       0.040 x 0.020 x 0.010 mm  
      Theta range for data collection               2.780 to 69.421 deg.  
      Limiting indices                            -19<=h<=19, -13<=k<=13, -11<=l<=11  
      Reflections collected / unique                 24869 / 3075 [R(int) = 0.1138]  
      Completeness to theta                           = 67.684    99.9 %  
      Absorption correction                            Semi-empirical from equivalents  
      Max. and min. transmission                  1.00000 and 0.81698  
      Refinement method                                Full-matrix least-squares on F^2  
      Data / restraints / parameters                 3075 / 0 / 197  
      Goodness-of-fit on F^2                           1.042  
      Final R indices [I>2sigma(I)]                  R1 = 0.0599, wR2 = 0.1512  
      R indices (all data)                                  R1 = 0.0894, wR2 = 0.1732  
      Extinction coefficient                             n/a  












Structural figure of compound 3.23, with 50% probability ellipsoids 
Accession Number 
The structure of 3.23 has been deposited in the Cambridge Crystallographic Data Center 
under accession number CCDC: 1572214. 
Structure Determination 
 Colorless blocks of 3.23 were grown by vapor diffusion of diethyl ether into a pentane 
solution of the compound at 22 ° C.  A crystal of dimensions 0.10 x 0.10 x 0.09 mm was mounted 
on a Rigaku AFC10K Saturn 944+ CCD-based X-ray diffractometer equipped with a low 
temperature device and Micromax-007HF Cu-target micro-focus rotating anode (λ = 1.54187 A) 
operated at 1.2 kW power (40 kV, 30 mA).  The X-ray intensities were measured at 85(1) K with 
the detector placed at a distance 42.00 mm from the crystal.  A total of 2028 images were collected 
with an oscillation width of 1.0° in ω The exposure times were 1 sec. for the low angle images, 4 
sec. for high angle.  Rigaku d*trek images were exported to CrysAlisPro for processing and 
corrected for absorption. The integration of the data yielded a total of 28115 reflections to a 
maximum 2θ value of 138.62° of which 6933 were independent and 5766 were greater than 2σ(I).  
The final cell constants (Table 3.5) were based on the xyz centroids of 8542 reflections above 
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10σ(I).  Analysis of the data showed negligible decay during data collection. The structure was 
solved and refined with the Bruker SHELXTL (version 2016/6) software package, using the space 
group P1bar with Z = 4 for the formula C24H25NO2. All non-hydrogen atoms were refined 
anisotropically with the hydrogen atoms placed in a combination of refined and idealized positions. 
Full matrix least-squares refinement based on F2 converged at R1 = 0.0537 and wR2 = 0.1504 
[based on I > 2sigma(I)], R1 = 0.0634 and wR2 = 0.1646 for all data.  Additional details are 
presented in Table 3.5.   
Table 3.5. Crystal data and structure refinement for 3.23.  
      Empirical formula                      C24 H25 N O2  
      Formula weight                       359.45  
      Temperature                                               85(2) K    
      Wavelength                                                 1.54184 A  
      Crystal system, space group                  Triclinic,  P-1  
      Unit cell dimensions                       a = 9.3165(6) A   alpha = 88.002(3) deg.  
                                                               b = 12.6453(6) A    beta = 76.578(4) deg.  
                                                               c = 16.9508(5) A   gamma = 83.003(5) deg.  
      Volume                               1927.92(17) A^3  
      Z, Calculated density                                4,  1.238 Mg/m^3 
      Absorption coefficient                              0.613 mm^-1  
      F(000)                                                         768  
      Crystal size                                                0.100 x 0.100 x 0.090 mm  
      Theta range for data collection                2.680 to 69.309 deg.  
      Limiting indices                                       -11<=h<=11, -15<=k<=15, -20<=l<=20  
      Reflections collected / unique                 28115 / 6933 [R(int) = 0.0461]  
      Completeness to theta                            = 67.684    97.5 %  
      Absorption correction                             Semi-empirical from equivalents  
      Max. and min. transmission                   1.00000 and 0.76174  
      Refinement method                                 Full-matrix least-squares on F^2  
      Data / restraints / parameters                 6933 / 0 / 500  
      Goodness-of-fit on F^2                           1.046  
      Final R indices [I>2sigma(I)]                   R1 = 0.0537, wR2 = 0.1504  
      R indices (all data)                                  R1 = 0.0634, wR2 = 0.1646  
      Extinction coefficient                             0.0040(5)  
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Arene Dearomatization via a Catalytic N-Centered Radical 
Cascade Reaction 
 
*Portions of this chapter have been published on the chemistry preprint server in R. C. McAtee, 
E. A. Noten, C. R. J. Stephenson. Arene dearomatization via a catalytic N-centered radical cascade 
reaction. ChemRxiv 2019, DOI: org/10.26434/chemrxiv.9864071.v1 
4.1. Introduction 
 
Arenes obtained from inexpensive petrochemical feedstocks are incorporated on industrial 
scale into pharmaceuticals, agrochemicals, and organic materials. Selective dearomatization 
reactions1-2 of these flat, two-dimensional aromatic compounds are modular strategies to access 
substituted, three-dimensional chemical space,3 including fused, complex heterocyclic skeletons 
(Figure 4.1A).4-5 In addition, the potential to form stereogenic centers through substituent addition 
concomitant with the dearomatization process is particularly appealing. Of the selective 
dearomatization methods reported (including, UV-promoted photochemical cycloadditions,6-7 
oxidative,8 enzymatic,9-11 transition metal-mediated,12-13 and nucleophilic dearomatizations14), the 
Birch reduction of arenes to 1,4-cyclohexadienes (1,4-CHD) is most well-known relying on liquid 
ammonia as solvent and pyrophoric alkali metals at cryogenic temperatures (Figure 4.1B).15-16 
Modifications of the canonical Birch reduction conditions have expanded the scope and synthetic 
utility of the reaction.17-21 While both electrochemical22 and visible light-mediated23-27 arene 
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dearomatization reactions have been reported with proven utility, they have not been integrated 
with other reaction pathways via reactive intermediates. 
 
Figure 4.1. Arene dearomatization reactions to rapidly build molecular complexly. 
(A) Arene dearomatization reactions from petrochemicals allows for rapid assembly of complex, 
three-dimensional molecules. (B) The classic Birch reduction; benefits and limitations.  
 
An alternative strategy addressing the inherent drawbacks of the classic Birch reduction is 
to promote an arene dearomatization via a radical cascade sequence. Radical cascades, processes 
in which multiple chemical bonds are formed in a single operation, are step and atom-economical 
means to rapidly build complex organic molecules (Figure 4.2).28-30 Moreover, initiating cascade 
sequences from strong N−H bonds leading to dearomatized molecular frameworks has the 




Figure 4.2. Cascade approach to deliver complex, three dimensional frameworks.  
Concerted proton-coupled electron transfer (PCET) has emerged as a powerful strategy for 
homolytic activation of strong N−H bonds, often in the presence of weaker ones, avoiding the need 
for N-pre-functionalization.31-33 The Knowles group recently reported the activation of both 
amide34 and sulfonamide35 N−H bonds for intramolecular and intermolecular hydroamination 
reactions, respectively, of electron neutral olefins. The authors propose an excited-state redox 
catalyst and a weakly coordinating phosphate base jointly mediate the concerted homolytic 
activation of the strong N−H bonds under visible light irradiation to afford transient N-centered 
amidyl and sulfonamidyl radicals capable of adding to olefins with anti-Markovnikov 
regioselectivity. Separately, Rovis and co-workers described the generation of amidyl radicals 
from trifluoroacetamide derivatives for sequential 1,5-HAT and δ-C–H functionalization.36 By 
using superstoichiometric quantities of K3PO4 as base, trifluoroacetamides are deprotonated to the 





Figure 4.3. PCET mediated intermolecular hydroamination with sulfonamides.  
With respect to sulfonamide-based N-radical alkene carboamination platforms, Chemler 
and co-workers have developed racemic and enantioselective intramolecular Cu(II)-mediated 
oxidative N-radical cyclizations of alkenyl arylsulfonamides at elevated temperatures (120 °C) to 
garner benzosultams in good yields.37-39  In the enantioselective example, MnO2 is used as a super-
stoichiometric (3 equiv) oxidant. Later, Kanai and co-workers reported an intermolecular alkene 
carboamination reaction of aliphatic alkenes under Cu(I) catalysis and N-
fluorobenzenesulfonimide (NFSI) as both a bifunctional reagent, for C−C and C−N bond 
formation, and an oxidant for the concise synthesis of six-membered sultams.40 Very recently, 
Chen and Xiao described a process for a radical 5-exo cyclization/addition/aromatization cascade 
of β,γ-unsaturated N-tosyl hydrazones under cooperative photocatalysis and cobalt catalysis 
enabling the synthesis of dihydropyrazole-fused benzosultams.41 
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Figure 4.4. Sulfonamide-based N-radical alkene carboamination platforms. 
We reasoned that the work outlined above, along with our ongoing interests in alkene 
carboamination reactions with bifunctional arylsulfonamide reagents,42 would serve as a basis for 
developing a catalytic protocol to initiate a carboamination/dearomatization cascade starting from 
γ,δ-unsaturated N-arylsulfonyl enamides 4.1 (Figure 4.5). Ideally, this process would proceed 
through transient sulfonamidyl radical intermediates formed via a visible light-mediated proton-
coupled electron transfer or stepwise deprotonation/oxidation sequence. This strategy obviates the 
need for N-pre-functionalization, elevated reaction temperatures, and stoichiometric oxidants. The 
reaction would lead to the synthesis of 1,4-cyclohexadiene-fused sultams. 
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Figure 4.5. This work: catalytic radical cyclization/dearomatization cascade. 
Sultams are important heterocyclic motifs that are frequently encountered in numerous 
biologically active natural products and medicinally relevant compounds (Figure 4.6).43-45 Of 
note, fused sultams have been shown to exhibit a broad range of biological activities including 
calpain I and nuclear factor kappaB inhibition activities, as well as an efficient treatment for 
glaucoma. In addition, Oppolzer’s sultam has been used extensively as a chiral auxiliary for 
chemical synthesis.46-48 Herein, we describe the combination of the aforementioned reaction 
classes, whereby visible light-mediated photoredox catalysis is used to promote and control a 
sulfonamidyl radical cyclization/dearomatization cascade reaction. 
 





4.2. Results and Discussion 
 
At the outset, we recognized two major challenges in implementing this design strategy. The 
first was the potential for competitive hydroamination, wherein the vicinal carbon-centered radical 
that is formed following N-radical cyclization would undergo direct hydrogen atom transfer 
(terminating the radical process) resulting in the hydroamination product.32, 34-35, 49-56 The second 
challenge was rearomatization of the cyclohexadienyl radical intermediate. Identifying an efficient 
photocatalytic system, to convert the cyclohexadienyl radical to the cyclohexadienyl anion and 
returning the ground state of the photocatalyst, would be imperative to circumvent this obstacle. 
With judicious choice of reaction additives and modifying reaction parameters we believed such 
challenges could be surmounted.  
Initially, we choose arylsulfonamide 4.1a as the model substrate to test the feasibility of the 
visible light-induced sulfonamidyl carboamination/dearomatization cascade reaction and 
representative results are summarized in Table 4.1. The expected reaction did occur with 1 mol% 
Ir photocatalyst A ([Ir(dF(CF3ppy)2)(5,5′-CF3-bpy)]PF6, IrIII*/II = 1.68 V versus SCE in MeCN)34 
and 65 mol% of tetrabutylammonium dibutylphosphate base providing the desired 1,4-
cyclohexadiene-fused sultam 4.2a in 48% 19F-NMR yield and excellent diastereoselectivity 
(>20:1) following irradiation with blue LEDs in trifluorotoluene (0.2 M) at room temperature 
(entry 1). Dearomatized product 4.2a was unambiguously characterized by single-crystal X-ray 
analysis (CCDC: 1952459). Other iridium photocatalysts structurally similar to A (B = 
[Ir(dF(CF3ppy)2)(dtbbpy)]PF6, IrIII*/II = 1.21 V versus SCE in MeCN; C = 
Ir(dF(Meppy)2)(dtbbpy)]PF6, IrIII*/II = 0.97 V versus SCE in MeCN)57-58 were also effective in 
these reactions (entries 2, 3), but the reaction yields diminished as the oxidation potential of the 
excited-state species decreased. Importantly, decreasing the reaction concentration (0.05 M) 
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delivered the desired product in 67% yield (entry 4). Also, the reaction is moderately to equally 
successful in other solvents (entry 5-7) with tert-butanol providing a noticeable increase in yield 
(entry 8). A 1:1 mixed solvent system of trifluorotoluene/tert-butanol (0.05 M) was finally 
identified as the optimal solvent combination (entry 9). When the reactions were run using 
conditions developed by Rovis, relying on step-wise deprotonation/oxidation,36 no product was 
isolated. Control reactions of 4.1a lacking photocatalyst, base, or light were uniformly 
unsuccessful, and the starting material was recovered unchanged (entries 10-12).  
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Table 4.1 Reaction optimization and control experiments.[a] 
 
entry photocatalyst solvent yield (%) 
1 A PhCF3 (0.2 M) 48 
2 B PhCF3 (0.2 M) 32 
3 C PhCF3 (0.2 M) 7 
4 A PhCF3 (0.05 M) 67 
5 A DMF (0.05 M) 50 
6 A CH2Cl2 (0.05 M) 47 
7 A 1,2-DCE (0.05 M) 65 
8 A t-BuOH (0.05 M) 73 
9 A PhCF3/t-BuOH (0.05 M) 83 (75)[b] 
variation from best conditions (entry 9) 
10 no blue LEDs 0 
11 no photocatalyst 0 
12 no NBu4OP(O)(OBu)2 0 
[a] Reactions were run on 0.1 mmol scale, and yields are 
determined by 19F-NMR analysis relative to 1,3,5-
trifluorobenzene (1 equiv) as an internal standard. [b] Isolated 
yield of 4.2a on 0.2 mmol scale. Photocatalysts and single-crystal 
X-ray of 4.2a: 
 
With optimized conditions established, we investigated the generality of this 
carboamination/dearomatization cascade reaction with a series of diversely substituted 
arylsulfonamides (Figure 4.7). For example, arenes bearing various electron-withdrawing (4.2a, 
4.2b, 4.2f-4.2i), electron-neutral (4.2c-4.2e), and electron-donating (4.2j) groups delivered the 
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desired dearomatized products in moderate to good yields (12-80%) and excellent 
diastereoselectivity (>20:1). Unsurprisingly, the latter electron-rich product 4.2j was prone to rapid 
oxidative decomposition leading to diminished yields. Of note, dearomatized product 4.2h was 
isolated as an inseparable mixture of the aromatized benzosultam product. Next, we investigated 
modifications to the alkene tether which allowed for the synthesis of an all-carbon spirocycle 
(4.2k), fused tetracycle (4.2l), and cyclic carbamate (4.2m) in moderate to good yields (21-77%). 
Interestingly, 3-fluoro and 3,4-difluoro substituted arylsulfonamide substrates generated single 
dearomatized regioisomers in good yields (4.2n, 4.2o) highlighting the regio- and chemoselective 
nature of the C−C bond forming cyclization step. Furthermore, this methodology proved tolerant 
of diverse functionality including, electron-rich heterocycles (4.2p), olefins (4.2q), amino acids 
(4.2r), aliphatic carbocycles (4.2s), and benzyl groups (4.2t) selectively furnishing the 
corresponding dearomatized products in good yields. Lastly, a tetrasubstituted-olefin substrate 
(4.1u) allowed direct access to dearomatized tertiary-amine59 product 4.2u, suggesting the initial 
5-exo, N-radical cyclization is tolerant to steric encumbrance. Terminal olefin 4.3 failed to convert 
to the desired dearomatized product (Figure 4.7C) likely due to the instability of the resultant 
vicinal primary radical following C−N bond formation. To probe the importance of the carbonyl 
moiety and to determine whether it is a necessary functionality on the substrate, we prepared and 
subjected o-prenyl aniline derivative 4.4 (pKa ≈ 13)60 and alkyl sulfonamide 4.5 (pKa ≈ 12)61 to 
the optimized reaction conditions and found they were unreactive returning starting material 
unchanged. These experiments highlight the importance of the carbonyl moiety for this process to 
occur by lowering the pKa of the substrate (pKa for 4.2 ≈ 5).61 Importantly, many of the richly 
functionalized 1,4-cyclohexadiene products are envisaged to be valuable building blocks for post-
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functionalization transformations. Studies to explore their synthetic utility are ongoing in our 
laboratory.  
 
Figure 4.7. Reaction scope.  
All yields are isolated yields. Relative configurations of products were assigned by analogy to 2a. 
(a) General reaction scheme; all reactions were run on 0.2 mmol scale and degassed by sparging 
with argon for 15 min prior to exposure to optimized conditions. (b) Arylsulfonamide 
modifications. (c) Control experiments with differentially substituted alkene side-chains. *Product 
isolated as an inseparable mixture of diene and arene products (3:1, diene:arene). 
 
To gain insight into the reaction mechanism, we initially performed Stern-Volmer 
luminescence quenching studies with the model substrate 4.1a. it was revealed that there is no 
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luminescence quenching of the photoexcited state of catalyst A when 4.1a is used alone suggesting 
direct oxidation, followed by deprotonation, of the substrate is unlikely. This conclusion was 
further supported by cyclic voltammetry analysis (CH2Cl2 containing 0.1 M NBu4PF6) indicating 
that direct oxidation of substrate 1a occurs at potentials >1.6 V (vs SCE). Comparatively, when 
tetrabutylammonium dibutylphosphate base is used alone in the Stern-Volmer analysis, significant 
nonlinear photoluminescence quenching of the photoexcited state of catalyst A is observed. This 
observation aligns with Knowles,62 and others,63 suggesting the formation of a less emissive 
iridium-phosphate complex and may be the active ground-state catalytic species in solution. 
Importantly, no additional photoluminescence quenching is observed upon addition of substrate 
4.1a as one would expect for a proton coupled-electron transfer process. Performing cyclic 
voltammetry studies of 4.1a in the presence of varying concentrations of monobasic dibutyl 
phosphate base, revealed that current response increased for increasing concentrations of 
phosphate base but did not show a shifted, less positive potential for the oxidation of substrate 
4.1a. Additionally, we have found that the reaction fails to yield product when stronger bases are 
employed. This result suggests the formation of sulfonamidyl anion is not necessary for the 
reaction to proceed. Qualitatively, these results are consistent with a phosphate radical being 
generated under the reaction conditions and serving as a hydrogen-atom abstracting species and is 
at least partly responsible for the generation of the nitrogen radical.64,65 Moreover, a deuterium 
labeling experiment was conducted to probe the role of tert-BuOH in this reaction. By performing 
the reaction in the presence of tert-BuOD, the desired product (4.2a-D) was produced in 51% yield 
with complete deuterium incorporation (Figure 4.8A). This result suggests that the tert-BuOH is 
serving as a reaction terminating proton source of a 1,4-cyclohexadienyl intermediate in accord 
with previous mechanistic studies of the classic Birch reduction reaction.66,67  
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A prospective catalytic cycle accounting for these observations, and those made during 
reaction optimization, is shown in Figure 4.8. We suspect that the Ir-photocatalyst A and 
phosphate base first form a ground-state iridium-phosphate complex (i). Upon excitation, the Ir-
photocatalyst can undergo single-electron transfer from the phosphate salt, generating an oxygen-
centered radical (ii). Abstraction of the most activated N−H bond of the substrate (iii) generates a 
transient sulfonamidyl radical intermediate (iv). Next, the N-radical can undergo 5-exo cyclization 
onto the tethered alkene to furnish a new C−N bond and a vicinal carbon-centered radical (v). This 
alkyl radical is poised to undergo cyclization with the appended arene to generate a stabilized 
cyclohexadienyl radical (vi) that can undergo single-electron reduction by the reduced Ir(II) state 
of the photocatalyst (E1/2[IrIII/IrII]= −1.07 V vs Fc+/Fc).34,35 Favorable proton transfer between the 
cyclohexadienyl anion and tert-BuOH (tert-butoxide can then return phosphoric acid68 back to the 
phosphate salt) should follow delivering the dearomatized product, regenerating the active forms 
of both catalysts. 
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Figure 4.8. Experiment to probe mechanism and proposed catalytic cycle.  
(A) Deuterium labelling experiment. (B) Proposed catalytic cycle. 
 
Following the completion of this work, we questioned whether a similar reaction design 
could allow for the rapid assembly of arylethylamine products (see Chapter 3) via an intermediate 
N-centered radical (Figure 4.9A). Unlike with the first-generation aryl transfer chemistry, which 
relied on electron-rich olefins (Figure 4.9B), this chemistry would rely on the N-nucleophile 
activation. If successful, the scope with respect to alkene identity would be greatly expanded, 
including to electron-neutral olefins, allowing for the synthetic utility of this chemistry to be 
greatly expanded. By modifying the identity of the heteroaromatic group, alkene substitution, and 
tether length we believed that we could identify various substrate classes which undergo radical 
aryl transfer (instead of arene dearomatization) providing rapid access to diversely functionalized 
arylethylamine products in a single-pot operation. It is important to point out that this reaction 
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design is possible because photoredox catalysis allows complementary reaction mechanism to be 
developed (see Chapter 1).  
 
Figure 4.9. Proposed approach for the synthesis of arylethylamines via the intermediary of 
N-centered radicals.  
(A) Previous work showing that arylsulfonylacetamides are viable bunctional reagents for alkene 
aminoarylation via the intermedaicy of alkene radical cations from electron-rich olefins. (B) This 
proposed work: engaging native N−H bonds for the formation of N-centered radicals which can 
under alkene aminoarylation.  
 
To test the viability of aryl transfer enabled by N-centered radicals to generate 
arylethylamine products, following extrusion of SO2, several structurally distinct substrates were 
prepared and subjected to the arene dearomatization conditions as described above (Figure 4.10). 
We were delighted to see that by extending the alkene tether length by one carbon and taking 
advantage of Thorpe-Ingold effect (4.6) led to exclusive formation of the arylethylamine product 
4.7 in 35% yield while the dearomatized product 4.8 was not observed (Figure 4.10A). 
Additionally, five-membered ring heterocycles such as thiophene substrate 4.9 led to the 
anticipated arylethylamine product 4.10 in good isolated yields (Figure 4.10B). Lastly, preparing 
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substrate 4.12 allowed us to probe the influence of double ortho-substitution on the aromatic 
backbone (Figure 4.10C).  Interestingly, the sole product isolated from this reaction is 
arylethylamine 4.13 in 46% isolated yield. The dearomatized, tertiary fluoride product 4.14 was 
never detected. These experiments highlight several substrate classes which will be amenable for 
our N-radical aryl transfer methodology to form a wide variety of structurally distinct 
arylethylamine products which were not accessible under our first-generation approach (Chapter 
3). The substrate classes which should be amenable include, (1) those with extended alkene tethers, 
(2) five-membered ring heteroaromatics, and (3) doubly ortho-substituted aromatics. With these 
guiding principles established, a full set of optimization studies, substrate scope evaluation, and 
mechanism elucidation are currently underway in our laboratory and will be reported in due course.    
 
Figure 4.10. Proof-of-concept established for radical aryl transfer.  
(A) Modification of alkene tether length and taking advantage of Thorpe-Ingold effect. (B) Five-
membered ring heterocycles are amenable to this methodology. (C) Doubly ortho-substituted six-







In summary, in this Chapter we have reported the discovery and development of a 
photoredox mediated N-centered radical strategy to facilitate a carboamination/dearomatization 
cascade reaction. Simple γ,δ-unsaturated N-arylsulfonyl enamides were converted into complex 
and stereodefined 1,4-cyclohexadiene-fused sultams in satisfactory yields and excellent 
diastereoselectivity. This mild and efficient catalytic system demonstrates a broad substrate scope 
and high functional group tolerance while avoiding premature hydroamination or undesired 
rearomatization reactivity. Lastly, we presented several new substrate classes which undergo 
radical aryl transfer chemistry and not arene dearomatization. Overall, we believe the 
photochemical strategies outlined here will inspire future synthetic endeavors aimed at employing 
simple arene building blocks for the rapid synthesis of complex, three-dimensional molecular 
frameworks in a single operation.  
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4.4. Experimental Procedures and Characterization of Compounds 
 
4.4.1. General Procedures, Materials, and Methods 
 
General Considerations 
All chemicals were used as received and stored as recommended by the supplier. Reactions were 
monitored by thin layer chromatography (TLC) using glass-backed plates pre-coated with 230–
400 mesh silica gel (250 mm thickness) with fluorescent indicator F254, available from EMD 
Millipore (cat. #: 1.05715.0001). Plates were visualized with a dual short wave/long wave UV 
lamp. Column flash chromatography was performed using 230-400 mesh silica (SiliCycle cat. #: 
R12030B) gel or via automated column chromatography. NMR spectra were recorded on Varian 
MR400, Varian Inova 500, Varian Vnmrs 500, or Varian Vnmrs 700 spectrometers. Chemical 
shifts for 1H NMR were reported as δ, parts per million, relative to the signal of CHCl3 at 7.26 
ppm and for DMSO 2.50 ppm. Chemical shifts for 13C NMR were reported as δ, parts per million, 
relative to the center line signal of the CDCl3 triplet at 77.0 ppm and for DMSO 39.52 ppm for 
center of septet. 19F NMR chemical shifts were reported as δ, parts per million, relative to CFCl3 
at 0.0 ppm. The abbreviations s, br. s, d, dd, br. d, ddd, t, q, br. q, qi, m, and br. m stand for the 
resonance multiplicity singlet, broad singlet, doublet, doublet of doublets, broad doublet, doublet 
of doublet of doublets, triplet, quartet, broad quartet, quintet, multiplet and broad multiplet, 
respectively. IR spectra were recorded on a Perkin-Elmer Spectrum BX FT-IR spectrometer fitted 
with an ATR accessory. Melting points were obtained using a Mel-Temp 3.0 (model no. 1401). 
Mass Spectra were recorded at the Mass Spectrometry Facility at the Department of Chemistry of 
the University of Michigan in Ann Arbor, MI on an Agilent Q-TOF HPCL-MS with ESI high 
resolution mass spectrometer using electrospray ionization (ESI), positive ion mode, or electron 
impact ionization (EI). Fluorescence quenching was recorded using a PTI Horiba Quanta Master 
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using Felix GX software. We thank Dr. James Windak and Dr. Paul Lennon at the University of 
Michigan Department of Chemistry instrumentation facility for conducting these experiments. X-
Ray crystallography work was done by Dr. Jeff. W. Kampf. UV-Vis measurements were obtained 
on a Shimadzu UV-1601 UV-Vis Spectrometer. Electrochemical data was collected on a CHI600E 
potentiostat with the accompanying CH Instruments software. H150 Blue grow lights from Kessil 




General Reaction Set-up 
Unless stated otherwise, all reactions were run on a 0.2 mmol scale in a 2-dram vial equipped with 
an oval shaped stir bar. 2 x H150 Blue Kessil lamp sufficiently irradiated 1-3 reaction vials at one 
time, at ~5 cm away (A). At this distance, with an overhead fan dissipating the standing 
atmosphere, the air temperature surrounding the reactions did not exceed 25 ̊ C. The reactions were 
stirred at a rate of ~550 rpms on an IKA magnetic stir plate. The photochemical dearomatization 
reactions were covered with ~0.5 m x 0.5 m dimension Blue Light Filter Amber Reaction Boxes 
(B) purchased from PLAS Labs, Inc (Lansing, MI). In addition, each experimentalist who may 
have been exposed to blue light wore UVEX Skyper Orange Safety Glasses which were purchased 
through Amazon.  
 
 
                 A      B 
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Reaction Discovery, Optimization Studies, and Control Reactions 
To an oven-dried 1-dram vial was added 1a (33.5 mg, 0.1 mmol), base, and photocatalyst. The vial 
contents were then dissolved in the indicated solvent or solvent mixture. The reaction solution was 
degassed by sparging with argon for 15 min. Then, the vial was quickly capped and sealed with 
parafilm. The reaction was irradiated with two, H150 blue Kessil lamps positioned ~5 cm away 
and cooled with an overhead fan. After 14 h, 1,3,5-trifluorobenzene was added to the reaction as 
a stoichiometric internal standard (10.3 μL, 0.1 mmol, 1 equiv). An aliquot was removed from the 









Table 4.3. Reaction optimization. 
 
aYield determined by 19F NMR spectroscopy using 1,3,5-trifluorobenzene as the internal standard. 
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4.4.2. Substrate and Reagent Synthesis and Characterization 
Photoredox Catalysts 
[Ir(dF(CF3)ppy)2(5,5’d(CF3)bpy)]PF6 (A) was prepared 
according to a procedure previously reported in the 
literature.65 Spectral data matched values reported in the 
literature.42 
 
[Ir(dF[CF3]ppy)2(dtbbpy)]PF6 (B) was prepared as previously 
reported in the literature.65 Spectral data matched values reported 
in the literature.65 
 
 
[Ir(dF[Me]ppy)2(dtbbpy)]PF6 © was prepared according to a 
procedure reported in the literature.65 Spectral data matched values 
reported in the literature.66 
 
Tetrabutylammonium dibutylphosphate 
Tetrabutylammonium dibutylphosphate was prepared as previously 





General Procedure A for sulfonamide coupling with carboxylic acids 
 
In a flame-dried round bottom flask under inert atmosphere, carboxylic acid (1.1 equiv) was 
dissolved in dry CH2Cl2 (0.1 M with respect to aryl sulfonamide). Aryl sulfonamide (1 equiv) and 
DMAP (0.1 equiv) were sequentially added in one portion each and the mixture was stirred for 
approximately 1 min at RT. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.5 
equiv) was added in one portion and the reaction was stirred at room temperature under an argon 
atmosphere for 14-16 hours. The reaction was concentrated in vacuo to provide a viscous oil and 
the residue was purified with flash chromatography on silica gel (0 to 10% acetone in CH2Cl2 
gradient). To obtain the products as solids, the concentrated chromatography fractions were 
triturated with pentane and dried under a vigorous nitrogen stream.  
General Procedure B for Steglich esterification 
 
In a flame-dried round bottom flask under inert atmosphere, carboxylic acid (1 equiv.) was 
dissolved in dry CH2Cl2 (0.1 M with respect to carboxylic acid). 4-hydroxybenzenesulfonamide 
(1.1 equiv.) and DMAP (0.1 equiv.) were sequentially added in one portion each and the mixture 
was stirred for approximately 1 min at RT. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (1.5 equiv) was added in one portion and the reaction was stirred at room 
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temperature under an argon balloon for 14-16 hours. The reaction was concentrated in vacuo and 





Prepared according to a previous literature report.10 Spectral data matched values reported in the 
literature.  
1H NMR (500 MHz, CDCl3) = δ 11.46 (br s, 1H), 5.13 – 5.07 (m, 1H), 2.40 – 2.35 (m, 2H), 






Prepared via a Wittig olefination from modified literature procedure.11 To a suspension of (3-
carboxypropyl)triphenylphosphonium bromide (4.29 g, 10 mmol, 2 equiv.) in THF (20 mL, 
anhydrous) in a 100 mL RBF with 2 stir bars (for better agitation of resulting suspension) was 
added sodium bis(trimethylsilyl)amide (20 mL, 20 mmol, 4 equiv., 1 M in THF) dropwise at room 
temperature. The bright orange mixture was stirred at this temperature for 30 minutes. A solution 
of cyclobutanone (5 mmol, 0.37 mL, 1 equiv.) in THF (5 mL, anhydrous) was added dropwise. 
The reaction was refluxed (80 °C) for 7.5 hours. After cooling to room temperature, the reaction 
contents were transferred to a separatory funnel with 100 mL Et2O and 100 mL 1 M NaOH 
solution. The aqueous layer was washed with Et2O (2 x 50 mL), acidified with conc. HCl to pH = 
1, and washed with Et2O (3 x 50 mL). The organic washes of the acidic aqueous phase were dried 
with Na2SO4, filtered, and concentrated. The resulting crude was purified by silica gel 
chromatography (5-35% EtOAc in hexanes) to deliver the title product as a clear colorless oil. 201 
mg, 29% yield. Spectral data matched values reported in the literature. 
1H NMR (400 MHz, CDCl3) = δ 11.43 (br s, 1H), 5.04 (tp, J = 7.2, 2.6 Hz, 1H), 2.69 – 2.58 (m, 
4H), 2.37 (t, J = 7.4 Hz, 2H), 2.20 (q, J = 7.2 Hz, 2H), 1.93 (p, J = 7.9 Hz, 2H) ppm 
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Prepared via a Wittig olefination according to a previous literature report.10 Spectral data matched 
values reported in the literature. 
1H NMR: (500 MHz, CDCl3) = δ 10.74 (br s, 1H), 8.05 (d, J = 7.8 Hz, 1H), 7.50 (t, J = 7.5 Hz, 






Prepared according to a previous literature report.11 Spectral data matched values reported in the 
literature. 







Prepared according to General Procedure A. 414 mg, 82%. White solid. 
1H NMR (500 MHz, CDCl3) = δ 8.53 (br s, 1H), 8.21 (d, J = 8.3 Hz, 2H), 7.82 (d, J = 8.4 Hz, 2H), 
5.02-4.95 (m, 1H), 2.33 – 2.22 (m, 4H), 1.64 (s, 3H), 1.54 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 171.1, 142.1, 136.0, 135.7 (q, J = 33.2 Hz), 135.4, 134.7, 129.1, 
126.3 (q, J = 3.6 Hz), 125.5, 123.2 (q, J = 273 Hz), 121.4, 120.9, 36.6, 25.7, 23.2, 17.7 ppm 
19F NMR (377 MHz, CDCl3) = δ -63.33 ppm 
IR (neat): 3125, 2901, 1698, 1459, 1404, 1354, 1221, 1133, 1090, 1061, 1038 cm-1 
HRMS (ESI+) m/z calculated for C14H17F3NO3S+ [M+H]+: 335.0803, found 335.0813. 
































Prepared according to General Procedure A. 403 mg, 71%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.76 – 8.62 (m, 1H), 8.12 – 8.07 (m, 2H), 7.24 – 7.19 (m, 2H), 
4.98 (t, J = 6.9 Hz, 1H), 2.31 – 2.22 (m, 4H), 1.64 (s, 3H), 1.54 (s, 3H ppm 
13C NMR (176 MHz, CDCl3) δ 170.7, 166.1 (d, J = 257 Hz), 134.7, 134.6 (d, J = 3.1 Hz), 131.5 
(d, J = 9.8 Hz), 121.5, 116.4 (d, J = 22.8 Hz), 35.7, 25.8, 23.2, 17.8 ppm 
19F NMR (377 MHz, CDCl3) δ -102.64 – -102.74 (m) ppm 
IR (neat) 3190, 2914, 1696, 1594, 1495, 1455, 1356, 1223, 1180, 1135 cm-1 
HRMS (EI+) m/z calculated for C13H16FNO3S [M]+: 285.0835, found 285.0834. 






























Prepared according to General Procedure A. 401 mg, 63%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.85 (s, 1H), 8.00 (d, J = 8.4 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 
4.97 (t, J = 6.4 Hz, 1H), 2.33 – 2.21 (m, 4H), 1.63 (s, 3H), 1.53 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 171.0, 140.9, 137.0, 134.6, 130.0, 129.4, 121.5, 36.6, 25.7, 23.2, 
17.8 ppm 
IR (neat) 3244, 2971, 1727, 1577, 1433, 1411, 1331, 1282, 1181, 1081 cm-1 
HRMS (ESI+) m/z calculated for C13H17ClNO3S [M+H]+: 302.0612, found 302.0617. 

































Prepared according to General Procedure A. 664 mg, 48%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.81 (s, 1H), 7.92 (d, J = 8.6 Hz, 2H), 7.68 (d, J = 8.6 Hz, 2H), 
5.00 – 4.95 (m, 1H), 2.31 – 2.22 (m, 4H), 1.64 (s, 3H), 1.53 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.9, 137.6, 134.6, 132.4, 130.0, 129.5, 121.5, 36.6, 25.8, 23.2, 
17.8 ppm 
IR (neat) 3246, 2970, 1728, 1573, 1433, 1411, 1388, 1331, 1123, 1084 cm-1 
HRMS (ESI+) m/z calculated for C13H17BrNO3S [M+H]+: 346.0107, found 346.0117. 

































Prepared according to General Procedure A. 301 mg, 77%. White solid. 
1H NMR (400 MHz, CDCl3) = δ 8.11 (br s, 1H), 7.91 (d, J = 8.7 Hz, 2H), 7.76 (d, J = 8.6 Hz, 
2H), 5.04 – 4.95 (m, 1H), 2.29 – 2.23 (m, 4H), 1.67 (s, 3H), 1.56 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.3, 138.4, 138.3, 135.1, 129.9, 121.5, 102.2, 36.7, 25.8, 23.22, 
17.8 ppm 
IR (neat) 3248, 2908, 1728, 1567, 1434, 1410, 1384, 1330, 1170, 1084 cm-1 
HRMS (ESI+) m/z calculated for C13H17INO3S [M+H]+: 393.9968, found 393.9978. 































Prepared according to General Procedure A. 213 mg, 33%. White solid. 
1H NMR (400 MHz, CDCl3): = δ 8.75 (br s, 1H), 8.19 (d, J = 8.3 Hz, 2H), 7.85 (d, J = 8.3 Hz, 
2H), 5.01 – 4.93 (m, 1H), 2.33 – 2.20 (m, 4H), 1.64 (s, 3H), 1.54 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.9, 142.7, 134.4, 132.9, 129.3, 121.4, 117.7, 117.7, 117.2, 
36.6, 25.8, 23.1, 17.8 ppm 
IR (neat) 3203, 2916, 2235, 1699, 1444, 1402, 1355, 1288, 1187, 1170, 1084 cm-1 
HRMS (ESI+) m/z calculated for C14H17N2O3S [M+H]+: 293.0954, found 293.0968. 






























Prepared according to General Procedure A. 244 mg, 58%. White solid. 
1H NMR (400 MHz, CDCl3) = δ 8.21 (br s, 1H), 8.13 (d, J = 8.9 Hz, 2H), 7.37 (d, J = 8.8 Hz, 2H), 
5.03 – 4.96 (m, 1H), 2.32 – 2.22 (m, 4H), 1.66 (s, 3H), 1.55 (s, 3H) ppm 
13C NMR (175 MHz, CDCl3) = δ 170.6, 153.3, 136.8, 134.9, 131.0, 121.5, 120.8, 120.3 (q, J = 
260 Hz) 36.7, 25.8, 23.2, 17.9 ppm 
19F NMR (377 MHz, CDCl3) = δ -57.68 ppm 
IR (neat): 3142, 2902, 1698, 1592, 1457, 1408, 1381, 1354, 1300, 1241 cm-1 
HRMS (ESI+) m/z calculated for C14H17F3NO4S+ [M+H]+: 352.0825, found 352.0834. 




























Methyl 4-(N-(5-methylhex-4-enoyl)sulfamoyl)benzoate (4.1h) 
 
Prepared according to General Procedure A. 456 mg, 70%. White solid. 
1H NMR (500 MHz, CDCl3) = δ 9.02 (br s, 1H), 8.19 (d, J = 8.6 Hz, 2H), 8.12 (d, J = 8.6 Hz, 2H), 
4.99 – 4.93 (m, 1H), 3.96 (s, 3H), 2.33 – 2.27 (m, 2H), 2.27 – 2.20 (m, 2H), 1.61 (s, 3H), 1.51 (s, 
3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 171.1, 165.7, 142.5, 135.0, 134.5, 130.2, 128.5, 121.5, 52.9, 
36.6, 25.7, 23.1, 17.7 ppm 
IR (neat) 3236, 2962, 1719, 1435, 1400, 1349, 1279, 1175, 1116, 1084 cm-1 
HRMS (ESI+) m/z calculated for C15H20NO5S+ [M+H]+: 326.1057, found 326.1060. 

































Prepared according to General Procedure A. 531 mg, 70%. Colorless foam. 
1H NMR (500 MHz, CDCl3) = δ 9.16 (br s, 1H), 8.15 (d, J = 8.5 Hz, 2H), 7.75 (d, J = 8.5 Hz, 2H), 
7.63 – 7.56 (m, 2H), 7.48 (t, J = 7.4 Hz, 2H), 7.46 – 7.39 (m, 1H), 5.06 – 4.96 (m, 1H), 2.39 – 2.32 
(m, 2H), 2.32 – 2.24 (m, 2H), 1.63 (s, 3H), 1.53 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 171.2, 147.0, 139.2, 137.1, 134.2, 129.2, 129.0, 128.8, 127.7, 
127.5, 121.6, 36.6, 25.7, 23.2, 17.7 ppm 
IR (neat) 3234, 2912, 1693, 1594, 1481, 1433, 1338, 1165, 1124, 1086 cm-1 
HRMS (ESI+) m/z calculated for C19H22NO3S+ [M+H]+: 344.1315, found 344.1318 
































Prepared according to General Procedure A. 743 mg, 64%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.95 (br s, 1H), 7.99 (d, J = 9.0 Hz, 2H), 6.99 (d, J = 9.0 Hz, 2H), 
4.99 – 4.95 (m, 1H), 3.87 (s, 3H), 2.29 – 2.21 (m, 4H), 1.62 (s, 3H), 1.52 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 171.0, 164.1, 134.2, 130.8, 130.0, 121.7, 114.2, 55.8, 36.5, 25.7, 
23.2, 17.7 ppm 
IR (neat) 3231, 2914, 1696, 1595, 1579, 1498, 1437, 1339, 1261, 1158 cm-1 
HRMS (ESI+) m/z calculated for C14H20NO4S+ [M+H]+: 298.1108, found 298.1117. 

































Prepared according to General Procedure A. 175 mg, 41%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.67 (br s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.83 (d, J = 8.4 Hz, 2H), 
4.94 (tp, J = 7.2, 2.4 Hz, 1H), 2.58 (t, J = 7.9 Hz, 2H), 2.54 (t, J = 7.9 Hz, 2H), 2.30 (t, J = 7.2 Hz, 
2H), 2.15 (q, J = 7.2 Hz, 2H), 1.89 (p, J = 7.9 Hz, 2H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.8, 143.8, 142.1, 135.8 (q, J = 33.3 Hz), 129.2, 126.3 (q, J = 
3.7 Hz), 123.2 (q, J = 273 Hz), 117.2, 36.5, 31.0, 29.3, 23.2, 17.0 ppm 
19F NMR (377 MHz, CDCl3) = δ -63.32 ppm 
IR (neat) 3134, 2920, 1699, 1458, 1404, 1357, 1319, 1165, 1132, 1089 cm-1 
HRMS (ESI+) m/z calculated for C15H17F3NO3S+ [M+H]+: 348.0876, found 348.0887. 































Prepared according to General Procedure A. 194 mg, 81%. Colorless oil. 
1H NMR (400 MHz, CDCl3) = δ 9.13 (s, 1H), 8.28 (d, J = 8.3 Hz, 2H), 7.84 (d, J = 8.4 Hz, 3H), 
7.49 (t, J = 7.5 Hz, 1H), 7.33 (t, J = 7.7 Hz, 1H), 7.17 (d, J = 7.7 Hz, 1H), 6.40 (s, 1H), 2.02 (s, 
3H), 1.67 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 165.2, 142.2, 142.2, 137.1, 135.7 (q, J = 33.2 Hz), 132.7, 131.1, 
130.4, 130.2, 129.4, 127.5, 126.2 (q, J = 3.5 Hz), 123.2 (q, J = 273 Hz), 122.9, 26.0, 19.5 ppm 
19F NMR (377 MHz, CDCl3) = δ -63.30 ppm 
IR (neat) 3106, 2912, 1679, 1596, 1428, 1404, 1361, 1321, 1164, 1122 cm-1 
HRMS (ESI+) m/z calculated for C18H17F3NO3S [M+H]+: 384.0876, found 384.0881. 




























In a 100 mL flame-dried flask, 4-(trifluoromethyl)benzenesulfonamide (901 mg, 4.0 mmol, 1 
equiv.) was suspended in 40 mL dry dichloromethane. The reaction was cooled to 0 °C, then 
triethylamine (1.56 mL, 11.2 mmol, 2.8 equiv.) was added dropwise. Methyl chloroformate (0.37 
mL, 4.8 mmol, 1.2 equiv.) was added dropwise and the reaction was stirred at 0 °C for 30 minutes. 
At this point, all starting material was consumed (TLC). The reaction was allowed to warm to 
room temperature, then transferred to a separatory funnel with 10 mL additional dichloromethane. 
The organic phase was washed with 50 mL 1 M HCl, 50 mL water, dried over MgSO4, and 
concentrated under reduced pressure to afford the product as a white solid (863 mg, 76%). 
Partial characterization is provided below.  
1H NMR (400 MHz, CDCl3) = δ 8.20 (d, J = 8.2 Hz, 2H), 8.08 – 7.50 (br s, 1H), 7.83 (d, J = 8.3 
Hz, 2H), 3.73 (s, 3H) ppm 
19F NMR (377 MHz, CDCl3) = δ -63.33 ppm 
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Prepared according to a modified literature procedure.12 To a 20 mL microwave vial with a stir bar 
was added methyl ((4-(trifluoromethyl)phenyl)sulfonyl)carbamate (350 mg, 1.24 mmol, 1 equiv.) 
and 3-methylbut-2-en-1-ol (10 mL, 98.5 mmol, 80 equiv.). The vial was sealed and heated with 
microwave irradiation at 100 °C for 30 minutes. Upon cooling to room temperature, the alcohol 
was distilled off under reduced pressure at 50 °C using a BioChromato Smart Evaporator. The 
residue was purified using flash chromatography on silica gel (0 – 10% acetone in DCM gradient) 
to give the product as a white solid. (254 mg, 61%). 
1H NMR (500 MHz, CDCl3) = δ 8.19 (d, J = 8.2 Hz, 2H), 7.82 (d, J = 8.3 Hz, 2H), 7.40 (br s, 1H), 
5.28 – 5.20 (m, 1H), 4.58 (d, J = 7.2 Hz, 2H), 1.74 (s, 3H), 1.66 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 150.4, 142.0, 141.5, 135.7 (q, J = 33.3 Hz), 129.2, 126.3 (q, J = 
3.7 Hz), 123.2 (q, J = 273 Hz), 117.1, 64.3, 25.8, 18.1 ppm 
19F NMR (377 MHz, CDCl3) = δ -63.30 ppm 
IR (neat) 3257, 1769, 1443, 1407, 1354, 1322, 1213, 1157, 1121, 1112 cm-1 
HRMS (ESI+) m/z calculated for C13H19F3N2O4S+ [M+NH4]+: 355.0934, found 355.0947. 










Prepared according to General Procedure A. 260 mg, 46%. Colorless oil. 
1H NMR (700 MHz, CDCl3) = δ 8.85 (s, 1H), 7.89 – 7.85 (m, 1H), 7.76 (dt, J = 8.0, 2.0 Hz, 1H), 
7.54 (td, J = 8.1, 5.2 Hz, 1H), 7.35 (tdd, J = 8.3, 2.5, 0.6 Hz, 1H), 5.00-4.96 (m, 1H), 2.33 – 2.23 
(m, 4H), 1.63 (s, 3H), 1.53 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.9, 162.3 (d, J = 252 Hz), 140.6 (d, J = 7.2 Hz), 134.6, 130.9 
(d, J = 7.7 Hz), 124.3 (d, J = 3.3 Hz), 121.5, 121.4 (d, J = 21 Hz), 115.8 (d, J = 25 Hz), 36.6, 25.7, 
23.2, 17.7 ppm 
19F NMR (376 MHz, CDCl3) = δ -109.30 ppm 
IR (neat) 3241, 3068, 2915, 1724, 1594, 1478, 1429, 1406, 1335, 1229, 1118 cm-1 
HRMS (ESI+) m/z calculated for C13H17FNO3S [M+H]+: 286.0908, found 286.0907. 






























Prepared according to General Procedure A. 387 mg, 58%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.78 (s, 1H), 7.95 – 7.90 (m, 1H), 7.90 – 7.86 (m, 1H), 7.34 (q, 
J = 8.9 Hz, 1H), 4.99 (t, J = 7.0 Hz, 1H), 2.33 – 2.23 (m, 4H), 1.64 (s, 3H), 1.55 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.9, 151.5 (dd, J = 259.5, 12.7 Hz), 150.1 (dd, J = 255, 13.4 
Hz), 135.2 (dd, J = 5.6, 4.1 Hz), 134.8, 126.0 (dd, J = 4.0, 7.8 Hz), 121.4, 118.6 (dd, J = 20.5, 1.4 
Hz), 118.2 (d, J = 18.7 Hz), 36.6, 25.7, 23.2, 17.8 ppm 
19F NMR (376 MHz, CDCl3) = δ -126.95 (m), -133.25 (dt, J = 20.6, 8.5 Hz) ppm 
IR (neat) 3196, 2919, 1702, 1606, 1511, 1441, 1348, 1277, 1174, 1123, 1075 cm-1 
HRMS (ESI+) m/z calculated for C13H16F2NO3S [M+H]+: 304.0813, found 304.0817. 































Prepared according to General Procedure B. 318 mg, 51%. Tan solid. 
1H NMR: (400 MHz, DMSO-d6) = δ 8.13 (dd, J = 5.0, 1.3 Hz, 1H), 8.06 (dd, J = 3.8, 1.3 Hz, 1H), 






Prepared according to General Procedure B. 430 mg, 69%. White solid. 
1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.7 Hz, 2H), 7.23 (d, J = 8.7 Hz, 2H), 4.79 (br s, 2H), 
2.58 (tt, J = 11.2, 3.5 Hz, 1H), 2.13 – 2.00 (m, 2H), 1.88 – 1.78 (m, 2H), 1.74 – 1.66 (m, 1H), 1.65 
– 1.56 (m, 2H), 1.46 – 1.26 (m, 3H) ppm 
 




Prepared according to General Procedure B. 606 mg, 77%. Pale yellow solid. At room 
temperature, N-Boc rotamers of this compound are well-resolved by 1H NMR. 
1H NMR (400 MHz, CDCl3) δ 7.94 (app dd, J = 20.0, 8.7 Hz, 2H), 7.24 (d, J = 8.7 Hz, 2H), 5.08 
(br s, 2H), 4.48 (ddd, J = 19.4, 8.5, 4.4 Hz, 1H), 3.67 – 3.40 (m, 2H), 2.48 – 2.29 (m, 1H), 2.23 – 








Prepared according to general procedure B. 446 mg, 70%. White solid. 
1H NMR (700 MHz, CDCl3) δ 7.92 (d, J = 8.5 Hz, 2H), 7.40 – 7.30 (m, 5H), 7.22 (d, J = 8.5 Hz, 
2H), 4.84 (br s, 2H), 3.89 (s, 2H) ppm 
 




Prepared according to General Procedure A. 195 mg, 50%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.60 (br s, 1H), 8.14 (d, J = 8.7 Hz, 2H), 8.00 (dd, J = 3.8, 0.9 
Hz, 1H), 7.72 (dd, J = 5.0, 0.9 Hz, 1H), 7.43 (d, J = 8.7 Hz, 2H), 7.21 – 7.19 (m, 1H), 5.01 (t, J = 
6.9 Hz, 1H), 2.33 – 2.23 (m, 4H), 1.66 (s, 3H), 1.56 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.5, 159.7, 154.8, 135.8, 135.4, 134.5, 134.4, 131.8, 130.3, 
128.3, 122.3, 121.5, 36.5, 25.6, 23.1, 17.7 ppm 
IR (neat): 3244, 2254, 1718, 1434, 1339, 1252, 1203, 1179, 1157, 1060 cm-1 
HRMS (ESI+) m/z calculated for C18H20NO5S2+ [M+H]+: 394.0777, found 394.0782. 



















Prepared according to General Procedure A from 4-hydroxybenzenesulfonamide using 2.1 equiv. 
of 5-methylhex-4-enoic acid, 2.6 equiv. EDC-HCl, and 0.2 equiv DMAP. 113 mg, 57%. Viscous, 
colorless oil. 
1H NMR (700 MHz, CDCl3) = δ 8.35 (br s, 1H), 8.09 (d, J = 8.8 Hz, 2H), 7.27 (d, J = 8.5 Hz, 2H), 
5.16 (t, J = 7.2 Hz, 1H), 5.02 – 4.98 (m, 1H), 2.61 (t, J = 7.4 Hz, 2H), 2.44 (q, J = 7.3 Hz, 2H), 
2.30 – 2.23 (m, 4H), 1.72 (s, 3H), 1.66 (s, 6H), 1.56 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 171.2, 170.4, 155.2, 135.7, 134.8, 134.1, 130.3, 122.4, 121.8, 
121.6, 36.6, 34.7, 25.9, 25.8, 23.6, 23.2, 17.9, 17.8 ppm 
IR (neat) 3242, 2915, 1763, 1723, 1696, 1590, 1435, 1204, 1177, 1159 cm-1 
HRMS (ESI+) m/z calculated for C20H28NO5S+ [M+H]+: 394.1683, found 394.1688. 




























Prepared according to General Procedure A. 458 mg, 58%. Clear, glassy solid. At room 
temperature, N-Boc rotamers of this compound are well-resolved by 1H and 13C NMR. 
1H NMR (500 MHz, CDCl3) = δ 8.64 (br s, 1H), 8.09 (app dd, J = 19.8, 8.5 Hz, 2H), 7.29 (app t, 
J = 8.1 Hz, 2H), 5.03 – 4.96 (m, 1H), 4.50 (app ddd, J = 31.8, 8.5, 4.4 Hz, 1H), 3.67 – 3.42 (m, 
2H), 2.47 – 2.31 (m, 1H), 2.31 – 2.21 (m, 4H), 2.21 – 2.10 (m, 1H), 2.10 – 1.91 (m, 2H), 1.64 (s, 
3H), 1.54 (s, 3H), 1.46 (app d, J = 13.6 Hz, 9H). 
13C NMR (176 MHz, CDCl3) = δ 171.1, 170.9, 170.6, 170.6, 155.1, 154.8, 154.7, 153.8, 136.1, 
136.0, 134.6, 134.6, 130.5, 130.3, 122.3, 121.9, 121.6, 121.6, 80.7, 80.5, 59.3, 59.2, 46.8, 46.6, 
45.2, 36.6, 31.1, 30.1, 28.8, 28.6, 25.8, 25.5, 25.3, 23.9, 23.2, 17.8 ppm 
IR (neat) 3202, 2976, 2931, 1772, 1670, 1403, 1366, 1347, 1204, 1124 cm-1 
HRMS (ESI+) m/z calculated for C23H33N2O7S+ [M+H]+: 481.2003, found 481.2013  

























Prepared according to General Procedure A. 345 mg, 69%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.38 (br s, 1H), 8.08 (d, J = 8.8 Hz, 2H), 7.26 (d, J = 8.8 Hz, 2H), 
5.03 – 4.98 (m, 1H), 2.58 (tt, J = 11.2, 3.4 Hz, 1H), 2.29 – 2.23 (m, 4H), 2.09 – 2.03 (m, 2H), 1.85 
– 1.79 (m, 2H), 1.72 – 1.67 (m, 1H), 1.66 (s, 3H), 1.63 – 1.57 (m, 2H) 1.56 (s, 3H), 1.41 – 1.27 
(m, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 173.8, 170.4, 155.4, 135.6, 134.8, 130.3, 122.3, 121.6, 43.3, 
36.6, 29.0, 25.8, 25.8, 25.4, 23.2, 17.8 ppm 
IR (neat) 3255, 2932, 2854, 1755, 1721, 1685, 1585, 1448, 1406, 1147 cm-1 
HRMS (ESI+) m/z calculated for C20H28NO5S+ [M+H]+: 394.1683, found 394.1684. 






























Prepared according to General Procedure A. 131 mg, 55%. White solid. Isolated with a small 
amount of an inseparable impurity (<10%). 
1H NMR (700 MHz, CDCl3) = δ 8.80 (s, 1H), 8.07 (d, J = 8.8 Hz, 2H), 7.46 – 7.30 (m, 5H), 7.27 
(d, J = 8.8 Hz, 2H), 5.01 – 4.94 (m, 1H), 3.90 (s, 2H), 2.27 – 2.21 (m, 4H), 1.63 (s, 3H), 1.53 (s, 
3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.8, 169.3, 154.9, 135.8, 134.3, 132.8, 130.2, 129.3, 128.9, 
127.6, 122.1, 121.5, 41.3, 36.4, 25.6, 23.0, 17.6 ppm 
IR (neat) 3122, 2930, 1751, 1686, 1587, 1445, 1406, 1354, 1209, 1188 cm-1 
HRMS (ESI+) m/z calculated for C21H24NO5S+ [M+H]+: 402.1370, found 402.1377 



























Prepared according to General Procedure A. 238 mg, 68%. White solid. Isolated with a small 
amount of an inseparable impurity (<10%). 
1H NMR (400 MHz, CDCl3) = δ 8.21 (d, J = 8.2 Hz, 2H), 8.05 (br s, 1H), 7.82 (d, J = 8.3 Hz, 2H), 
2.32 (app s, 4H), 1.63 (s, 3H), 1.59 (s, 3H), 1.58 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.8, 142.0, 135.8, 129.2, 127.6, 126.3, 124.8, 123.2, 35.1, 
29.2, 20.8, 20.3, 17.9 ppm 
19F NMR (376 MHz, CDCl3) = δ -63.33 ppm 
IR (neat) 3266, 2931, 2862, 1730, 1421, 1404, 1344, 1320, 1172, 1138 cm-1 
HRMS (ESI+) m/z calculated for C15H19F3NO3S+ [M+H]+: 350.1032, found 350.1034  






























Prepared according to General Procedure A using commercially available 4-pentenoic acid. 
247 mg, 40%. White solid. 
1H NMR (700 MHz, CDCl3) = δ 8.69 (br s, 1H), 8.21 (d, J = 8.2 Hz, 2H), 7.83 (d, J = 8.2 Hz, 
2H), 5.71 (ddt, J = 16.9, 10.5, 6.5 Hz, 1H), 5.01 – 4.95 (m, 2H), 2.39 (t, J = 7.3 Hz, 2H), 2.32 (q, 
J = 6.9 Hz, 2H) ppm 
13C NMR (176 MHz, CDCl3) = δ 170.3, 141.9, 135.8 (q, J = 33.2 Hz), 135.7, 129.2, 126.3 (q, J = 
3.6 Hz), 123.2 (q, J = 273 Hz), 116.7, 35.7, 28.2 ppm 
19F NMR (376 MHz, CDCl3) = δ -63.34 ppm 
IR (neat) 3108, 2985, 1696, 1460, 1406, 1357, 1325, 1158, 1126, 1090 cm-1 
HRMS (ESI+) m/z calculated for C12H13F3NO3S+ [M+H]+: 308.0563, found 308.0563 


























Procedure for the preparation of aniline S4b was adapted from a procedure previously reported.13  
A solution of aniline (730 μL, 8.00 mmol) and tert-butyl-(2-methylbut-3-en-2-yl) carbonate14 S4a 
(2.00 g, 10.8 mmol) in THF (20 mL) and DMF (1 mL) was treated with Pd(PPh3)4 (186 mg, 2 
mol%) and stirred at room temperature for 20 h. The mixture was diluted with ethyl acetate (20 
mL) and washed with brine (15 mL), dried over Na2SO4, filtered and concentrated in vacuo. The 
crude residue was purified by flash chromatography (95:5 Hex:EtOAc) to give aniline S4b as a 
light-yellow oil (947 mg, 73%). All spectra and characterization data matches that previously 
reported in the literature.13,15 
Partial characterization of aniline S4b is provided below.  
1H NMR (500 MHz, CDCl3) = δ 7.19 – 7.04 (m, 2H), 6.76 – 6.62 (m, 3H), 6.01 (dd, J = 17.5, 
10.7 Hz, 1H), 5.26 – 5.01 (m, 2H), 3.70 (s, 1H), 1.39 (s, 7H) ppm 
HRMS (ESI+) m/z calculated for C11H15N (M+H)+ 162.1277, found 162.1275. 
Procedure for the preparation of arylsulfonamide 4.4 was adapted from a procedure previously 
reported.15 
Step 1: To a solution of aniline S4b (574 mg, 3.56 mmol) in MeCN:H2O (10 mL:1.0 mL) under 
inert atmosphere was added pTsOH-H2O (68 mg, 0.36 mmol, 0.1 equiv), and it was heated at 80 
 277 
°C overnight. After cooling back to room temperature, it was washed with water (20 mL). The 
aqueous layer was extracted with EtOAc (20 mL x 2). The combined organic layers were washed 
with brine (30 mL), dried over Na2SO4, filtered, and concentrated. The crude product was directly 
used in next step without further purification. 
Step 2: To a solution of the above crude material in pyridine (5 mL) at room temperature under 
inert atmosphere was added 4-(trifluoromethyl)benzenesulfonyl chloride (1045 mg, 4.27 mmol, 
1.2 equiv). After one hour, EtOAc (20 mL) was added, and it was washed with 10% aq HCl (100 
mL). The aqueous layer was extracted with EtOAc (20 mL x 2). The combined organic layers were 
washed with brine (30 mL), dried over Na2SO4, filtered, and concentrated. Flash column 
chromatography (Hex:EtOAc, 10:1) afforded 435 mg (33% over two steps) of compound 4.4 as a 
white solid. 
1H NMR (700 MHz, CDCl3) = δ 7.83 (d, J = 8.2 Hz, 2H), 7.70 (d, J = 8.3 Hz, 2H), 7.44 (dd, J = 
8.1, 1.3 Hz, 1H), 7.21 (td, J = 7.7, 1.7 Hz, 1H), 7.13 (td, J = 7.5, 1.3 Hz, 1H), 7.09 (dd, J = 7.6, 1.6 
Hz, 1H), 6.63 (s, 1H), 4.95 (ddt, J = 7.0, 5.5, 1.5 Hz, 1H), 2.95 (d, J = 7.1 Hz, 2H), 1.74 (s, 3H), 
1.69 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 143.2, 135.1, 134.6 (q, J = 33.2 Hz), 134.3, 133.7, 130.2, 127.6, 
127.5, 126.5, 126.1 (q, J = 3.7 Hz), 123.8, 123.1 (q, J = 272.9 Hz), 121.0, 31.1, 25.6, 17.8 ppm 
19F NMR (377 MHz, CDCl3) = δ -63.17 ppm 
IR (neat) = 3230, 1452, 1405, 1317, 1154, 1128, 1106, 1060, 907, 840, 755, 716, 674 cm-1 









In a flame-dried flask with a stir bar, lithium aluminum hydride (24 mg, 0.6 mmol, 1.05 equiv) 
was suspended in 3 mL THF and cooled to -78 °C. A solution of 5-methyl-N-((4-
(trifluoromethyl)phenyl)sulfonyl)hex-4-enamide (200 mg, 0.596 mmol, 1 equiv) in 3 mL THF was 
slowly added to the LAH solution down the side of the flask over ~2 minutes. The reaction was 
stirred at -78 °C for 3 hours, removed from the dry ice/acetone bath and allowed to warm to RT 
for 30 minutes. Quenched with 0.5 mL sat. aq. potassium sodium tartrate, added dropwise slowly 
at RT. The reaction was transferred to a separatory funnel with 50 mL EtOAc and 50 mL sat. aq. 
potassium sodium tartrate. The organic phase was isolated and the aqueous phase was washed with 
EtOAc (2 x 50 mL). The combined organic phases were washed with brine, dried over MgSO4, 
filtered, and concentrated. The residue was purified with flash chromatography on silica gel (0 to 
25% EtOAc in hexanes gradient) to give the product as a white solid (137 mg, 72%).  
1H NMR (700 MHz, CDCl3) = δ 8.00 (d, J = 8.1 Hz, 2H), 7.79 (d, J = 8.2 Hz, 2H), 5.01 – 4.96 
(m, 1H), 4.76 – 4.49 (m, 1H), 3.01 – 2.96 (m, 2H), 1.96 (q, J = 7.0 Hz, 2H), 1.65 (s, 3H), 1.55 – 
1.48 (m, 5H) ppm 
13C NMR (176 MHz, CDCl3) = δ 143.9, 134.5 (q, J = 33.1 Hz), 133.2, 127.7, 126.4 (q, J = 3.6 
Hz), 123.4 (q, J = 273 Hz), 122.8, 43.2, 29.8, 25.8, 25.1, 17.8 ppm 
19F NMR (377 MHz, CDCl3) = δ -63.15 ppm 
IR (neat) 3256, 2913, 1431, 1404, 1318, 1294, 1196, 1153, 1122, 1060 cm-1 
HRMS (ESI+) m/z calculated for C14H19F3NO2S+ [M+H]+: 322.1083, found 322.1088. 









To an oven dried 2-dram vial was added substrate 4.1 (0.2 mmol), NBu4OP(O)(OBu)2 (58 mg, 
0.13 mmol, 0.65 equiv), and photocatalyst A (2 mg, 1 mol%). The vial contents were then 
dissolved in a 1:1 mixture of t-BuOH:PhCF3 (2 mL each, 0.05 M). The reaction solution was 
degassed by sparging with argon for 15 min. Then the vial was quickly capped and sealed with 
parafilm. The reaction was irradiated with two, H150 blue Kessil lamps positioned ~5 cm away 
and cooled with an overhead fan. After 14 h, the reaction was directly concentrated in vacuo. The 
resultant residue was subjected to flash column chromatography over silica providing the pure 




C8-trifluoromethyl cyclohexadiene-fused sultam (4.2a) 
Prepared according to Procedure C with 67.1 mg, 0.2 mmol of 4.1a. White powder (50.5 mg, 
75% yield). Rf = 0.5 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV. 
 
1H NMR (700 MHz, CDCl3) = δ 7.02 (t, J = 3.2 Hz, 1H), 6.38 (s, 1H), 4.16 (dd, J = 8.4, 5.8 Hz, 
1H), 3.49 (s, 1H), 3.19 – 2.99 (m, 2H), 2.58 – 2.42 (m, 2H), 2.20 (dddd, J = 13.3, 10.0, 8.5, 6.6 
Hz, 1H), 1.92 (dddd, J = 13.1, 9.8, 7.1, 5.8 Hz, 1H), 1.14 (s, 3H), 0.79 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.7, 134.3, 131.3, 127.9 (q, J = 31.4 Hz), 125.8 (q, J = 5.6 
Hz), 122.8 (q, J = 272.3 Hz), 67.0, 45.3, 41.4, 30.9, 23.9, 22.0, 19.0, 13.8 ppm 
19F NMR (377 MHz, CDCl3) = δ -69.85 ppm 
IR (neat) = 2983, 1738, 1392, 1344, 1312, 1297, 1169, 1123, 986, 896, 706 cm-1 




C8-fluoro cyclohexadiene-fused sultam (4.2b) 
Prepared according to Procedure C with 57.1 mg, 0.2 mmol of 4.1b. Off-white, tan powder (34.1 
mg, 60% yield). Rf = 0.5 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.95 – 6.85 (m, 1H), 5.33 (d, J = 14.8 Hz, 1H), 4.23 – 4.00 (m, 
1H), 3.60 – 3.41 (m, 1H), 3.24 – 2.94 (m, 2H), 2.57 – 2.40 (m, 2H), 2.25 – 2.10 (m, 1H), 1.99 – 
1.84 (m, 1H), 1.04 (s, 3H), 0.80 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 157.7 (d, J = 257.0 Hz), 135.2 (d, J = 2.5 Hz), 131.3 (d, 
J = 11.5 Hz), 99.2 (d, J = 18.1 Hz), 67.1, 46.5 (d, J = 7.5 Hz), 41.5 (d, J = 1.7 Hz), 31.0, 27.0 (d, 
J = 29.8 Hz), 22.0, 19.1, 13.4 ppm 
19F NMR (377 MHz, CDCl3) = δ -102.48 (d, J = 17.0 Hz) ppm 
IR (neat) = 2975, 1734, 1719, 1339, 1208, 1180, 1148, 1105, 1006, 954, 847 cm-1 





C8-chloro cyclohexadiene-fused sultam (4.2c) 
Prepared according to Procedure C with 60.4 mg, 0.2 mmol of 4.1c. Off-white, tan powder (31.5 
mg, 52% yield). Rf = 0.3 (7:3, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (500 MHz, CDCl3) = δ 6.91 (t, J = 3.4 Hz, 1H), 5.97 – 5.83 (m, 1H), 4.11 (dd, J = 8.5, 
5.7 Hz, 1H), 3.46 (q, J = 6.9 Hz, 1H), 3.34 – 3.05 (m, 2H), 2.59 – 2.42 (m, 2H), 2.30 – 2.07 (m, 
1H), 2.01 – 1.81 (m, 1H), 1.09 (s, 3H), 0.81 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.7, 134.4, 132.0, 130.9, 120.3, 66.9, 47.6, 41.6, 33.3, 30.9, 
22.0, 19.1, 13.7 ppm 
IR (neat) = 2971, 2935, 1736, 1676, 1339, 1205, 1175, 983, 953, 839, 643 cm-1 
HRMS (ESI+) m/z calculated for C13H16ClNO3S (M+H)+ 302.0612, found 302.0611. 
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C8-bromo cyclohexadiene-fused sultam (4.2d) 
Prepared according to Procedure C with 69.2 mg, 0.2 mmol of 4.1d. Off-white, tan powder (45.2 
mg, 65% yield). Rf = 0.5 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (400 MHz, CDCl3) = δ 6.85 (t, J = 3.2 Hz, 1H), 6.13 (s, 1H), 4.10 (dd, J = 8.5, 5.7 Hz, 
1H), 3.54 – 3.12 (m, 3H), 2.50 (ddd, J = 9.6, 7.4, 2.7 Hz, 2H), 2.18 (dq, J = 16.6, 8.4 Hz, 1H), 1.91 
(dq, J = 14.9, 7.9 Hz, 1H), 1.09 (s, 3H), 0.82 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 134.2, 132.3, 124.4, 120.2, 66.8, 48.2, 41.4, 35.4, 30.9, 
21.9, 19.0, 13.7 ppm 
IR (neat) = 2969, 1737, 1471, 1344, 1169, 1124, 1103, 982, 954, 701, 655 cm-1 





C8-iodo cyclohexadiene-fused sultam (4.2e) 
Prepared according to Procedure C with 78.6 mg, 0.2 mmol of 4.1e. Off-white, tan powder (52.2 
mg, 66% yield). Rf = 0.4 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.71 (q, J = 3.0 Hz, 1H), 6.41 (d, J = 2.8 Hz, 1H), 4.08 (dt, J = 
8.5, 4.0 Hz, 1H), 3.46 – 3.19 (m, 3H), 2.48 (ddd, J = 15.8, 7.7, 4.8 Hz, 2H), 2.26 – 2.09 (m, 1H), 
1.90 (ddt, J = 13.8, 10.7, 6.6 Hz, 1H), 1.08 (s, 3H), 0.81 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 134.0, 132.9, 132.7, 93.4, 66.8, 48.9, 41.4, 39.3, 30.9, 
21.9, 19.0, 13.8 ppm 
IR (neat) = 2970, 2928, 1729, 1330, 1219, 1163, 1134, 951, 822, 716 cm-1 
HRMS (ESI+) m/z calculated for C13H16INO3S (M+H)+ 393.9968, found 393.9975. 
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C8-cyano cyclohexadiene-fused sultam (4.2f) 
Prepared according to Procedure C with 58.5 mg, 0.2 mmol of 4.1f. Off-white, tan powder (22.7 
mg, 39% yield). Rf = 0.5 (1:9, Acetone:CH2Cl2), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.94 (t, J = 3.0 Hz, 1H), 6.62 (s, 1H), 4.13 (dd, J = 8.6, 5.6 Hz, 
1H), 3.49 (td, J = 7.5, 4.1 Hz, 1H), 3.27 – 3.04 (m, 2H), 2.58 – 2.39 (m, 2H), 2.19 (dddd, J = 19.9, 
15.0, 10.7, 6.4 Hz, 1H), 1.96 – 1.83 (m, 1H), 1.13 (s, 3H), 0.80 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.5, 139.3, 133.9, 130.5, 117.3, 112.0, 66.8, 46.0, 41.7, 30.8, 
27.7, 22.0, 19.0, 14.2 ppm 
IR (neat) = 2967, 2938, 2220, 1739, 1338, 1203, 1178, 1138, 1090, 996, 955, 845 cm-1 




C8-trifluoromethoxy cyclohexadiene-fused sultam (4.2g) 
Prepared according to Procedure C with 70.3 mg, 0.2 mmol of 4.1g. Off-white, tan powder (56.5 
mg, 80% yield). Rf = 0.5 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.91 (t, J = 3.2 Hz, 1H), 5.64 (s, 1H), 4.13 (dd, J = 8.5, 5.8 Hz, 
1H), 3.54 (q, J = 7.0 Hz, 1H), 3.21 – 2.99 (m, 2H), 2.60 – 2.41 (m, 2H), 2.19 (dddd, J = 13.5, 10.1, 
8.5, 6.7 Hz, 1H), 1.92 (dddd, J = 13.1, 9.8, 7.2, 5.8 Hz, 1H), 1.07 (s, 3H), 0.80 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.7, 145.3, 134.6, 131.2, 120.2 (q, J = 258.5 Hz), 109.9, 67.0, 
46.5, 41.6, 30.9, 28.3, 22.0, 19.1, 13.5 ppm 
19F NMR (377 MHz, CDCl3) = δ -57.44 ppm 
IR (neat) = 2980, 1739, 1701, 1341, 1256, 1175, 1132, 1097, 1009, 955, 828, 673 cm-1 
HRMS (ESI+) m/z calculated for C14H16F3NO4S (M+H)+ 352.0825, found 352.0837. 
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C8-methyl carboxylate cyclohexadiene-fused sultam (4.2h) 
Prepared according to Procedure C with 65.1 mg, 0.2 mmol of 4.1h. White powder (20.2 mg, 
31% yield isolated as an inseparable 3:1 mixture of diene:arene products). Rf = 0.3 (1:1, 
Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
diene 1H NMR (700 MHz, CDCl3) = δ 7.03 (s, 1H), 6.97 (s, 1H), 4.16 (dd, J = 8.5, 5.7 Hz, 1H), 
3.80 (s, 3H), 3.52 (td, J = 7.4, 4.0 Hz, 1H), 3.26 – 3.11 (m, 2H), 2.56 – 2.41 (m, 2H), 2.25 – 2.12 
(m, 2H), 1.97 – 1.86 (m, 1H), 1.16 (s, 3H), 0.78 (s, 3H) ppm 
arene 1H NMR (700 MHz, CDCl3) = δ 8.15 (d, J = 1.6 Hz, 1H), 8.09 (dd, J = 8.3, 1.6 Hz, 1H), 
8.01 (d, J = 8.3 Hz, 1H), 4.40 (dd, J = 8.2, 6.1 Hz, 1H), 3.97 (s, 3H), 2.63 (dd, J = 9.3, 7.5 Hz, 
2H), 2.37 (dq, J = 12.7, 7.9 Hz, 1H), 2.26 – 2.10 (m, 1H), 1.49 (s, 3H), 1.33 (s, 3H) ppm 
mixture of diene and arene 13C NMR (176 MHz, CDCl3) = δ 173.3, 172.7, 165.8, 165.3, 144.1, 
139.8, 134.4, 133.6, 133.6, 133.2, 129.2, 128.8, 127.7, 125.0, 67.1, 64.7, 52.8, 52.2, 46.3, 41.4, 
39.4, 30.9, 30.5, 26.1, 23.3, 22.0, 20.4, 19.0, 14.1 ppm 
mixture of diene and arene IR (neat) = 2971, 2948, 2246, 1737, 1700, 1441, 1341, 1263, 1203, 
1175, 1088, 922, 724 cm-1 
diene HRMS (ESI+) m/z calculated for C15H19NO5S (M+H)+ 326.1057, found 326.1055. 




C8-phenyl cyclohexadiene-fused sultam (4.2i) 
Prepared according to Procedure C with 68.7 mg, 0.2 mmol of 4.1i. Clear, colorless oil which 
solidifies to a white solid over time (22.8 mg, 33% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow 
spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 7.42 – 7.35 (m, 4H), 7.35 – 7.31 (m, 1H), 7.13 – 7.09 (m, 1H), 
6.15 – 6.07 (m, 1H), 4.17 (dd, J = 8.4, 5.9 Hz, 1H), 3.52 (td, J = 7.1, 4.1 Hz, 1H), 3.42 – 3.22 (m, 
2H), 2.56 – 2.45 (m, 2H), 2.19 (dddd, J = 13.4, 9.8, 8.5, 6.7 Hz, 1H), 1.93 (dddd, J = 13.3, 9.7, 
7.5, 6.0 Hz, 1H), 1.16 (s, 3H), 0.82 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 173.0, 139.6, 136.0, 134.4, 133.5, 128.6, 128.2, 125.3, 119.5, 
67.3, 46.4, 41.8, 31.0, 28.8, 22.1, 19.1, 13.7 ppm 
IR (neat) = 2974, 2919, 2234, 1734, 1714, 1340, 1218, 1163, 1090, 956, 772 cm-1 




C8-methoxy cyclohexadiene-fused sultam (4.2j) 
Prepared according to a modification of Procedure C with 89.2 mg, 0.3 mmol of 4.1j, 
NBu4OP(O)(OBu)2 (58 mg, 0.13 mmol, 0.43 equiv), and photocatalyst A (3 mg, 1 mol%). in 1.5 
mL of PhCF3 (0.2 M). Off-white, tan powder (10.4 mg, 12% yield). Rf = 0.3 (1:1, Hex:EtOAc), 
one yellow spot (multiple spots are observed on TLC following decomposition), KMnO4, UV. 
The title diene product is unstable and readily undergoes decomposition. Partial characterization 
is provided below.  
 
1H NMR (500 MHz, CDCl3) = δ 6.92 (t, J = 3.2 Hz, 1H), 4.65 (d, J = 3.1 Hz, 1H), 4.10 (dd, J = 
8.4, 5.9 Hz, 1H), 3.61 (s, 3H), 3.46 (q, J = 5.9 Hz, 1H), 3.09 – 2.81 (m, 2H), 2.49 (ddd, J = 9.2, 
7.5, 1.8 Hz, 2H), 2.28 – 2.09 (m, 1H), 2.00 – 1.83 (m, 1H), 1.06 (s, 3H), 0.75 (s, 3H) ppm 
IR (neat) = 2941, 1736, 1688, 1580, 1340, 1186, 1163, 1023, 977, 731, 649 cm-1 





C8-trifluoromethyl C10-cyclobutyl cyclohexadiene-fused sultam (4.2k) 
Prepared according to Procedure C with 69.5 mg, 0.2 mmol of 4.1k. Off-white, tan powder (14.8 
mg, 21% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 7.02 (s, 1H), 6.73 – 6.62 (m, 1H), 4.17 (t, J = 7.5 Hz, 1H), 3.55 
(q, J = 7.8, 6.2 Hz, 1H), 3.24 – 3.04 (m, 2H), 2.59 (td, J = 9.0, 7.8, 3.2 Hz, 2H), 2.37 (dtd, J = 14.7, 
8.7, 6.4 Hz, 1H), 2.25 (dq, J = 15.9, 8.3 Hz, 1H), 2.09 (dq, J = 12.8, 5.3 Hz, 1H), 2.05 – 1.95 (m, 
1H), 1.92 – 1.72 (m, 3H), 1.62 (q, J = 8.5, 7.5 Hz, 1H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 133.9, 131.6, 128.2 (q, J = 31.2 Hz), 126.4 (q, J = 5.6 
Hz), 122.9 (q, J = 272.3 Hz), 64.7, 47.1, 42.7, 30.8, 24.1, 23.3, 19.9, 19.7, 14.1 ppm 
19F NMR (377 MHz, CDCl3) = δ -69.80 ppm 
IR (neat) = 2943, 1730, 1653, 1341, 1299, 1205, 1159, 1108, 1101, 958, 696 cm-1 




C8-trifluoromethyl benzo-fused cyclohexadiene-fused sultam (4.2l) 
Prepared according to Procedure C with 76.7 mg, 0.2 mmol of 4.1l. White powder (59.0 mg, 77% 
yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 7.95 (d, J = 7.6 Hz, 1H), 7.67 (td, J = 7.6, 1.3 Hz, 1H), 7.62 – 
7.52 (m, 2H), 7.10 (t, J = 3.7 Hz, 1H), 6.49 (dt, J = 4.0, 1.8 Hz, 1H), 5.10 (s, 1H), 3.76 (s, 1H), 
3.10 (s, 2H), 1.52 (s, 3H), 0.35 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 163.8, 141.5, 134.5, 133.5, 130.7, 130.7, 129.5, 128.2 (q, J = 
31.3 Hz), 125.9, 125.6 (q, J = 5.7 Hz), 124.2, 122.8 (q, J = 272.4 Hz), 69.1, 44.9, 43.2, 23.9, 22.4, 
14.0 ppm 
19F NMR (377 MHz, CDCl3) = δ -69.77 ppm 
IR (neat) = 2973, 1729, 1467, 1350, 1315, 1168, 1109, 1011cm-1 





C8-trifluoromethyl carbamate cyclohexadiene-fused sultam (4.2m) 
Prepared according to Procedure C with 67.5 mg, 0.2 mmol of 4.1m. Off-white, tan powder (49.0 
mg, 73% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 7.06 (s, 1H), 6.36 (s, 1H), 4.42 (t, J = 8.8 Hz, 1H), 4.36 (dd, J = 
8.4, 4.2 Hz, 1H), 4.21 (dd, J = 9.2, 4.2 Hz, 1H), 3.55 (d, J = 8.5 Hz, 1H), 3.12 (q, J = 6.2, 5.6 Hz, 
2H), 1.11 (s, 3H), 0.87 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 149.8, 133.8, 131.9, 128.3 (q, J = 31.9, 31.3 Hz), 125.0 (q, J = 
5.7 Hz), 122.6 (q, J = 272.4 Hz), 64.2, 63.2, 45.1, 40.5, 23.9, 21.6, 13.7 ppm 
19F NMR (377 MHz, CDCl3) = δ -69.90 ppm 
IR (neat) = 2924, 1779, 1365, 1301, 1159, 1114, 1048, 967, 708, 648 cm-1 




C9-fluoro cyclohexadiene-fused sultam (4.2n) 
Prepared according to Procedure C with 57.1 mg, 0.2 mmol of 4.1n. Light-yellow powder (23.4 
mg, 41% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.98 (s, 1H), 5.48 (ddt, J = 17.7, 4.0, 2.3 Hz, 1H), 4.09 (dd, J = 
8.3, 6.2 Hz, 1H), 3.59 (q, J = 5.9 Hz, 1H), 3.15 – 2.93 (m, 2H), 2.55 – 2.42 (m, 2H), 2.25 – 2.11 
(m, 1H), 1.91 (dddd, J = 13.5, 9.7, 7.6, 6.2 Hz, 1H), 1.17 (d, J = 3.8 Hz, 3H), 0.89 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 155.9 (d, J = 258.4 Hz), 134.1 (d, J = 10.6 Hz), 133.9 (d, 
J = 2.1 Hz), 102.7 (d, J = 19.4 Hz), 66.8, 46.9 (d, J = 26.4 Hz), 41.6 (d, J = 4.3 Hz), 30.8, 25.8 (d, 
J = 7.5 Hz), 23.4 (d, J = 7.6 Hz), 19.1, 13.5 ppm 
19F NMR (377 MHz, CDCl3) = δ -100.54 (d, J = 17.6 Hz) ppm 
IR (neat) = 2976, 2936, 1738, 1703, 1343, 1170, 1132, 977, 855, 673, 634 cm-1 





C8, C9-difluoro cyclohexadiene-fused sultam (4.2o) 
Prepared according to Procedure C with 60.7 mg, 0.2 mmol of 4.1o. Off-white, tan powder (27.9 
mg, 46% yield). Rf = 0.4 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.85 (s, 1H), 4.10 (t, J = 7.0 Hz, 1H), 3.76 (s, 1H), 3.39 – 3.15 
(m, 2H), 2.59 – 2.42 (m, 2H), 2.20 (dddd, J = 18.6, 10.3, 6.3, 1.9 Hz, 1H), 2.00 – 1.84 (m, 1H), 
1.18 (s, 3H), 0.90 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.6, 141.7 (dd, J = 256.1, 12.6 Hz), 139.5 (dd, J = 257.5, 12.7 
Hz), 134.1 (d, J = 9.2 Hz), 130.8 (d, J = 10.2 Hz), 66.6, 48.1 (d, J = 21.9 Hz), 42.11 (dd, J = 4.1, 
2.0 Hz), 30.8, 27.4 (d, J = 25.2 Hz), 23.1 (d, J = 7.2 Hz), 19.0, 13.5 ppm 
19F NMR (377 MHz, CDCl3) = δ -137.19, -137.33 ppm 
IR (neat) = 2976, 1735, 1345, 1200, 1178, 1120, 1010, 962, 879, 826 cm-1 




C8-thiophene-2-carboxylate cyclohexadiene-fused sultam (4.2p) 
Prepared according to Procedure C with 78.7 mg, 0.2 mmol of 4.1p. Off-white, tan powder (35.9 
mg, 46% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 7.88 (dd, J = 3.7, 1.3 Hz, 1H), 7.66 (dd, J = 4.9, 1.3 Hz, 1H), 
7.16 (dd, J = 5.0, 3.7 Hz, 1H), 6.96 (t, J = 3.6 Hz, 1H), 5.65 (dd, J = 4.3, 2.0 Hz, 1H), 4.21 – 4.06 
(m, 1H), 3.58 (td, J = 7.1, 4.1 Hz, 1H), 3.35 – 3.02 (m, 2H), 2.51 (ddd, J = 9.2, 7.4, 2.0 Hz, 2H), 
2.27 – 2.12 (m, 1H), 2.01 – 1.86 (m, 1H), 1.07 (s, 3H), 0.92 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 160.1, 146.5, 134.8, 134.6, 133.8, 132.2, 132.0, 128.1, 
111.2, 67.2, 46.6, 41.6, 31.0, 28.3, 22.0, 19.1, 13.5 ppm 
IR (neat) = 2975, 2916, 1736, 1701, 1520, 1469, 1342, 1272, 1204, 1175, 1131, 875, 743 cm-1 





C8-homoprenyl carboxylate cyclohexadiene-fused sultam (4.2q) 
Prepared according to Procedure C with 78.7 mg, 0.2 mmol of 4.1q. Light-yellow powder (33.3 
mg, 42% yield). Rf = 0.2 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.91 (t, J = 3.1 Hz, 1H), 5.46 (dd, J = 4.4, 1.9 Hz, 1H), 5.10 (ddt, 
J = 8.6, 7.2, 1.4 Hz, 1H), 4.11 (dd, J = 8.4, 5.8 Hz, 1H), 3.51 (td, J = 7.1, 4.2 Hz, 1H), 3.18 – 2.87 
(m, 2H), 2.49 (ddd, J = 9.1, 7.3, 3.5 Hz, 2H), 2.44 (t, J = 7.5 Hz, 2H), 2.34 (q, J = 7.5 Hz, 2H), 
2.21 – 2.11 (m, 1H), 1.92 (dddd, J = 13.3, 9.5, 7.6, 5.8 Hz, 2H), 1.70 (d, J = 1.8 Hz, 3H), 1.63 (s, 
3H), 1.04 (s, 3H), 0.86 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 171.5, 146.6, 134.5, 133.6, 132.1, 121.8, 110.5, 67.2, 
46.5, 41.6, 34.3, 31.0, 28.2, 25.7, 23.5, 22.0, 19.1, 17.7, 13.4 ppm 
IR (neat) = 2972, 2932, 2257, 1742, 1452, 1343, 1168, 1129, 908, 726 cm-1 
HRMS (ESI+) m/z calculated for C20H27NO5S (M+H)+ 394.1683, found 394.1690. 
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C8-N-Boc-proline cyclohexadiene-fused sultam (4.2r) 
Prepared according to Procedure C with 75.0 mg, 0.16 mmol of 4.1r. Light-yellow foam (33.6 
mg, 45% yield). Rf = 0.2 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.96 – 6.84 (m, 1H), 5.58 – 5.45 (m, 1H), 4.33 (ddd, J = 37.3, 
8.6, 3.9 Hz, 1H), 4.11 (td, J = 8.8, 5.5 Hz, 1H), 3.62 – 3.38 (m, 3H), 3.13 (ddt, J = 23.1, 7.3, 2.6 
Hz, 1H), 3.06 – 2.90 (m, 1H), 2.56 – 2.41 (m, 2H), 2.41 – 2.22 (m, 1H), 2.22 – 2.10 (m, 1H), 2.10 
– 1.84 (m, 4H), 1.45 (d, J = 16.4 Hz, 9H), 1.03 (d, J = 2.7 Hz, 3H), 0.88 – 0.80 (m, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 171.2, 154.4, 153.6, 146.6, 146.5, 134.6, 134.5, 132.2, 
131.8, 110.7, 80.3, 80.2, 67.2, 67.11, 58.9, 46.6, 46.4, 41.5, 31.0, 29.9, 28.4, 28.0, 24.5, 23.6, 22.0, 
19.1, 13.4 ppm 
IR (neat) = 2975, 2249, 1745, 1702, 1405, 1361, 1339, 1163, 1143, 906, 729 cm-1 
HRMS (ESI+) m/z calculated for C23H32N2O7S (M+H)+ 481.2003, found 481.2000. 
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C8-cyclohexyl carboxylate cyclohexadiene-fused sultam (4.2s) 
Prepared according to Procedure C with 78.7 mg, 0.2 mmol of 4.1s. Off-white, tan powder (41.7 
mg, 53% yield). Rf = 0.4 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 6.91 (t, J = 3.7 Hz, 1H), 5.44 (dd, J = 4.3, 1.9 Hz, 1H), 4.11 (dd, 
J = 8.4, 5.7 Hz, 1H), 3.51 (td, J = 7.1, 4.1 Hz, 1H), 3.18 – 2.86 (m, 2H), 2.49 (ddd, J = 10.0, 7.2, 
3.3 Hz, 2H), 2.40 (tt, J = 11.3, 3.7 Hz, 1H), 2.23 – 2.11 (m, 1H), 2.01 – 1.85 (m, 3H), 1.77 (dq, J 
= 7.8, 3.9 Hz, 2H), 1.72 – 1.60 (m, 1H), 1.54 – 1.43 (m, 2H), 1.38 – 1.15 (m, 3H), 1.04 (s, 3H), 
0.86 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 174.1, 172.8, 146.6, 134.5, 132.1, 110.4, 67.2, 46.6, 42.9, 41.6, 
31.0, 28.8, 28.8, 28.1, 25.6, 25.2, 25.2, 22.0, 19.1, 13.4 ppm 
IR (neat) = 2937, 2857, 1742, 1704, 1450, 1344, 1132, 1001, 894, 668 cm-1 




C8-benzyl carboxylate cyclohexadiene-fused sultam (4.2t) 
Prepared according to Procedure C with 74.5 mg, 0.19 mmol of 4.1t. Light-yellow oil (20.3 mg, 
27% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 7.41 – 7.33 (m, 2H), 7.33 – 7.27 (m, 3H), 6.89 (t, J = 3.7 Hz, 
1H), 5.49 (dd, J = 4.4, 1.9 Hz, 1H), 4.10 (dd, J = 8.5, 5.7 Hz, 1H), 3.73 (s, 2H), 3.50 (td, J = 7.1, 
4.2 Hz, 1H), 3.19 – 2.85 (m, 3H), 2.57 – 2.42 (m, 2H), 2.24 – 2.07 (m, 2H), 1.99 – 1.84 (m, 1H), 
1.03 (s, 3H), 0.84 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 169.7, 146.6, 134.5, 133.0, 132.0, 129.2, 128.8, 127.5, 
110.8, 67.2, 46.5, 41.6, 41.1, 31.0, 28.1, 22.0, 19.1, 13.4 ppm 
IR (neat) = 2971, 1740, 1340, 1164, 1125, 1006, 952, 698 cm-1 




C8-trifluoromethyl-C11-methyl cyclohexadiene-fused sultam (4.2u) 
Prepared according to Procedure C with 69.9 mg, 0.2 mmol of 4.1u. Light-yellow powder (23.6 
mg, 34% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow spot, KMnO4, UV.  
 
1H NMR (700 MHz, CDCl3) = δ 7.02 (d, J = 3.8 Hz, 1H), 6.36 (dq, J = 3.5, 1.8 Hz, 1H), 3.81 (t, 
J = 3.9 Hz, 1H), 3.08 (q, J = 6.6, 6.2 Hz, 2H), 2.57 (ddd, J = 18.1, 10.2, 7.8 Hz, 1H), 2.47 (ddd, J 
= 18.1, 10.3, 5.0 Hz, 1H), 2.23 (ddd, J = 13.2, 10.3, 7.9 Hz, 1H), 1.80 (ddd, J = 13.1, 10.2, 5.0 Hz, 
1H), 1.67 (s, 3H), 1.10 (s, 3H), 0.88 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.8, 134.5, 131.1, 128.1 (q, J = 31.4 Hz). 126.5 (q, J = 5.5 
Hz), 122.8 (q, J = 272.5 Hz), 72.1, 43.7, 40.7, 29.9, 28.2, 23.8, 23.0, 21.4, 17.9 ppm 
19F NMR (377 MHz, CDCl3) = δ -69.85 ppm 
IR (neat) = 2962, 1754, 1654, 1337, 1300, 1253, 1163, 1116, 977, 896, 707 cm-1 




4.4.4. Mechanistic Investigations 
 
Stern – Volmer Fluorescence Quenching 
 
Fluorescence quenching experiments were conducted on a Horiba PTI QuantaMaster 8000 using 
FelixGX software. Samples were prepared in dichloromethane (CH2Cl2 is a successful solvent for 
this reaction) due to the poor solubility of the photocatalyst in 1:1 trifluorotoluene:tBuOH. Each 
sample was degassed in the sealed septum screw-capped cuvette by sparging with argon for 30 
seconds immediately prior to each measurement. The solutions were irradiated at 420 nm and 
luminescence was measured at 593 nm. Io/I values were generated from the average of three scans 
taken per quencher concentration. Solutions of a given concentration were produced and measured 
in triplicate (triplicate of triplicates). 
Conclusion: The sulfonyl enamide substrate does not quench the excited state of the photocatalyst. 
Additionally, when the substrate is present in solution with tetrabutylammonium dibutyl 
phosphate, there is no additional quenching of the excited state of the photocatalyst beyond the 
contribution from the phosphate base by itself. This data suggests that neither direct oxidation of 
the substrate by the photocatalyst nor oxidative proton-coupled electron transfer (PCET) of a 
sulfonyl amide-phosphate complex is primarily responsible for N-radical formation and initiation 
of the cyclization cascade. Comparatively, when tetrabutylammonium dibutylphosphate base is 
used alone, significant nonlinear photoluminescence quenching of the photoexcited state of 
catalyst A is observed. This observation aligns with Knowles, and others, suggesting the formation 











[Photocatalyst] = 0.2 mM 
 
                                   Without base                                                 With 0.6 mM base  
                                       
 [substrate] (mM) Average Io/I  [substrate] (mM) Average Io/I      
0.15 1.071446586  0.15 1.945956 
0.3 1.083896878  0.3 1.892258 
0.6 1.100651471  0.6 1.859189 
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Experiment A: Constant [Ir], fixed substrate:phosphate ratio, variable [substrate:phosphate]  
 
[Photocatalyst] = 0.05 mM, [phosphate] = 0.65*[substrate] 
 


































Experiment B: Constant [Ir], variable [phosphate], no substrate 
 

















We wish to make a direct comparison of the fluorescence quenching between experiment A, where 
the base is present in a fixed ratio to the sulfonamide; and experiment B, where the sulfonamide is 
absent, but the concentrations of the base are the same as those in experiment A. For this reason, 
experiment B is plotted such that the x-axis will remain the same when the two experiments are 
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Superimposed Experiment A and Experiment B 
 
 
Experiment A (0.65 equiv base with substrate) 





































Cyclic voltammetry was performed using a CHI620E electrochemical analyzer (from CH 
Instruments) and was performed with a three-electrode set-up, using a glassy carbon working 
electrode (3 mm diameter), a graphite counter electrode and a silver/silver ion nonaqueous 
reference electrode. All experiments were conducted in dichloromethane with 0.1 M NBu4PF6.  
In all experiments containing the substrate, the concentration of the substrate was 10 mM. In the 





Conclusions: The oxidation of the substrate occurs at a potential >1.6 V vs Ag/Ag+. This result 
suggests that direct oxidation and subsequernt deprotonation of the substrate (1a) is an unlikely 
process. A solution of the tetrabutylammonium dibutylphosphate base alone exhibits an oxidation 
wave at ~1 V vs Ag/Ag+. As the concentration of tetrabutylammonium dibutylphosphate base 
increases relative to substrate 1a, the current response increases for the oxidation wave ~1 V vs 
Ag/Ag+. These data seem to suggest that as the tetrabutylammonium dibutylphosphate base is 
oxidatively active at oxidation potentials attainable by photocatalyst A and that the base may be 
the species being oxidized (to phosphate radical) in solution and thus initiating the N-radical 
cascade process. Importantly, there is no obvious oxidation potential shift (to less positive 




Deuterium Labeling Studies 
D-C8-trifluoromethyl cyclohexadiene-fused sultam (4.2a-D) 
 
To an oven dried 2-dram vial was added substrate 4.1a (67.1 mg, 0.2 mmol), NBu4OP(O)(OBu)2 
(58 mg, 0.13 mmol, 0.65 equiv), and photocatalyst A (2 mg, 1 mol%). The vial contents were then 
dissolved in a 1:1 mixture of t-BuOD:PhCF3 (2 mL each, 0.05 M). The reaction solution was 
degassed by sparging with argon for 15 min. Then the vial was quickly capped and sealed with 
parafilm. The reaction was irradiated with two, H150 blue Kessil lamps positioned ~5 cm away 
and cooled with an overhead fan. After 14 h, the reaction was directly concentrated in vacuo. The 
resultant residue was subjected to flash column chromatography over silica providing the pure 
diene 4.2a-D. Off-white, tan powder (33.4 mg, 51% yield). Rf = 0.3 (1:1, Hex:EtOAc), one yellow 
spot, KMnO4, UV. 
1H NMR (700 MHz, CDCl3) = δ 7.02 (d, J = 2.9 Hz, 1H), 6.38 (s, 1H), 4.16 (dd, J = 8.5, 5.8 Hz, 
1H), 3.48 (s, 1H), 3.17 – 2.99 (m, 1H), 2.60 – 2.43 (m, 2H), 2.20 (dddd, J = 13.7, 10.3, 8.6, 6.6 
Hz, 1H), 1.99 – 1.83 (m, 1H), 1.14 (s, 3H), 0.78 (s, 3H) ppm 
13C NMR (176 MHz, CDCl3) = δ 172.7, 134.3, 131.3, 127.8 (q, J = 31.2 Hz), 125.9 (q, J = 5.6 
Hz), 122.8 (q, J = 272.0 Hz), 67.0, 45.3, 41.4, 30.9, 24.3 – 22.8 (m), 22.0, 19.0, 13.8 ppm 
19F NMR (377 MHz, CDCl3) = δ -69.85 ppm 
IR (neat) = 2982, 1738, 1473, 1344, 1299, 1168, 1122, 986, 897, 700 cm-1 




4.4.5. X-Ray Crystallographic Data 
  
Crystallographic data for C8-trifluoromethyl cyclohexadiene-fused sultam 4.2a 
 
Structural figure of compound 4.2a, with 50% probability ellipsoids. 
Accession Number The structure of 4.2a has been deposited in the Cambridge Crystallographic 
Data Center under accession number CCDC: 1952459.  
Structure Determination:71 
 Colorless needles of 4.2a were grown from a dichloromethane/pentane solution of the 
compound at 23 °C. A crystal of dimensions 0.18 x 0.15 x 0.12 mm was mounted on a Rigaku 
AFC10K Saturn 944+ CCD-based X-ray diffractometer equipped with a low temperature device 
and Micromax-007HF Cu-target micro-focus rotating anode (  = 1.54187 A) operated at 1.2 kW 
power (40 kV, 30 mA). The X-ray intensities were measured at 85(1) K with the detector placed 
at a distance 42.00 mm from the crystal. A total of 2028 images were collected with an oscillation 
width of 1.0  in   The exposure times were 1 sec. for the low angle images, 3 sec. for high angle. 
Rigaku d*trek images were exported to CrysAlisPro for processing and corrected for absorption. 
The integration of the data yielded a total of 20775 reflections to a maximum 2  value of 138.66  
of which 2593 were independent and 2538 were greater than 2 (I). The final cell constants (Table 
4.4) were based on the xyz centroids of 10883 reflections above 10 (I). Analysis of the data 
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showed negligible decay during data collection. The structure was solved and refined with the 
Bruker SHELXTL (version 2018/3) software package, using the space group P2(1)/n with Z = 4 
for the formula C14H16NO3F3S. All non-hydrogen atoms were refined anisotropically with the 
hydrogen atoms placed in idealized positions. Full matrix least-squares refinement based on F2 
converged at R1 = 0.0371 and wR2 = 0.0952 [based on I > 2sigma(I)], R1 = 0.0377 and wR2 = 
0.0958 for all data. Acknowledgement is made for funding from NSF grant CHE-0840456 for X-
ray instrumentation. 
Table 4.4. Crystal data and structure refinement.  
      Empirical formula                 C14 H16 F3 N O3 S  
      Formula weight                    335.34  
      Temperature                       85(2) K  
      Wavelength                        1.54184 A  
      Crystal system, space group       Monoclinic,  P2(1)/n  
      Unit cell dimensions              a = 11.0713(2) A   alpha = 90 deg.  
                                        b = 6.16810(10) A    beta = 99.5210(10) deg.  
                                        c = 21.0140(3) A   gamma = 90 deg.  
      Volume                            1415.26(4) A^3  
      Z, Calculated density             4, 1.574 Mg/m^3  
      Absorption coefficient            2.492 mm^-1  
      F(000)                            696  
      Crystal size                      0.180 x 0.150 x 0.120 mm  
      Theta range for data collection   4.253 to 69.332 deg.  
      Limiting indices                  -13<=h<=12, -7<=k<=7, -25<=l<=25  
      Reflections collected / unique    20775 / 2593 [R(int) = 0.0488]  
      Completeness to theta  = 67.684    98.5 %  
      Absorption correction             Semi-empirical from equivalents  
      Max. and min. transmission        1.00000 and 0.66699  
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      Refinement method                 Full-matrix least-squares on F^2  
      Data / restraints / parameters    2593 / 0 / 201  
      Goodness-of-fit on F^2            1.069  
      Final R indices [I>2sigma(I)]     R1 = 0.0371, wR2 = 0.0952  
      R indices (all data)              R1 = 0.0377, wR2 = 0.0958  
      Extinction coefficient            n/a  
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